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With ever increasing advancements in imaging, there is an increasing abundance of images
being acquired in the clinical environment. However, this increase in information can be a
burden as well as a blessing as it may require significant amounts of time to interpret the
information contained in these images. Computer assisted evaluation is one way in which better
use could be made of these images. This thesis presents the combination of texture analysis of
images acquired during the treatment of cancer with machine learning in order to improve
radiotherapy. The first application is to the prediction of radiation induced pneumonitis. In 13-
37% of cases, lung cancer patients treated with radiotherapy develop radiation induced lung
disease, such as radiation induced pneumonitis. Three dimensional texture analysis, combined
with patient-specific clinical parameters, were used to compute unique features. On radiother-
apy planning CT data of 57 patients, (14 symptomatic, 43 asymptomatic), a Support Vector
Machine (SVM) obtained an area under the receiver operator curve (AUROC) of 0.873 with
sensitivity, specificity and accuracy of 92%, 72% and 87% respectively. Furthermore, it was
demonstrated that a Decision Tree classifier was capable of a similar level of performance
using sub-regions of the lung volume. The second application is related to prostate cancer
identification.
T2 MRI scans are used in the diagnosis of prostate cancer and in the identification of the
primary cancer within the prostate gland. The manual identification of the cancer relies on
the assessment of multiple scans and the integration of clinical information by a clinician.
This requires considerable experience and time. As MRI becomes more integrated within the
radiotherapy work flow and as adaptive radiotherapy (where the treatment plan is modified
based on multi-modality image information acquired during or between RT fractions) develops
it is timely to develop automatic segmentation techniques for reliably identifying cancerous
regions. In this work a number of texture features were coupled with a supervised learning
model for the automatic segmentation of the main cancerous focus in the prostate - the focal
lesion. A mean AUROC of 0.713 was demonstrated with 10-fold stratified cross validation
strategy on an aggregate data set. On a leave one case out basis a mean AUROC of 0.60 was
achieved which resulted in a mean DICE coefficient of 0.710. These results showed that is was
possible to delineate the focal lesion in the majority (11) of the 14 cases used in the study.
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In recent decades continuous technological advancements have made the acquisition of medical
images much cheaper and faster. These advances have been accompanied by an increase in the
volume of imaging data that is generated by hospitals. This ever increasing amount of data can
be time consuming to analyse and may contain an abundance of under exploited information
from a great many patients. This phenomenon has been compounded by the prevalence of
volumetric data in recent years - it is now common for three dimensional (isotropic) data to be
acquired in the normal course of diagnosis and treatment, particularly when considering cancer
patients. Alongside these advances in imaging, radiotherapy techniques and treatment options
have also developed rapidly to allow higher doses to be administered to tighter constraints,
leading to more sophisticated and effective treatment of different cancers.
Both of these advances in imaging and radiotherapy have intertwined the two areas and they
are often used in tandem in many clinical work flows. This is particularly true in the treatment
of cancer. For example, a typical patient with prostate cancer may undergo an MRI and CT
scan for the purpose of diagnosis and radiotherapy planning, respectively.
This thesis seeks to identify approaches that can aid the clinician in their decision making pro-
cesses, during the clinical work flow, by making use of image analysis and machine learning. In
particular, texture analysis will be used to extract features from CT and MR images which are
fed into a classification pipeline in order to predict radiation induced pneumonitis and identify
focal disease in the prostate.
1
1.2. Clinical Context and Objectives 2
1.2 Clinical Context and Objectives
In 2011, there were 331,487 new cases of cancer and 161,823 deaths reported in the United
Kingdom [30]. There are a wide range of treatments available depending on the location and
stage of the cancer and any other co-morbidities. Examples of such treatments are chemother-
apy, cryotherapy, surgery and radiotherapy. Many of these rely on imaging for diagnosis and
planning, especially radiotherapy. This work presents novel methods for improving the treat-
ment of two different cancers: lung cancer and prostate cancer. Imaging and radiotherapy often
play a key role in the treatment of these two cancer types and it is for this reason that there is
a significant opportunity for research into the application of advanced image processing and
machine learning techniques to improve patient diagnosis and treatment. It is this context that
this thesis is presented.
1.2.1 Prediction of Radiation Induced Pneumonitis
Lung cancer has the second highest incidence rate and the highest mortality rate in the world.
In men it is the most commonly diagnosed cancer and also the leading cause of cancer death,
in women it is the fourth most diagnosed and second leading cause of cancer death [58].
In 2011 43,463 people in the UK were diagnosed with lung cancer and there were 35,184
reported deaths attributed to lung cancer [31]. Treatment often involves surgery, chemotherapy,
radiotherapy or a combination of these options. However radiotherapy, in a significant minority
of cases, may induce pneumonitis.
Radiation induced pneumonitis is a specific instance of radiation induced lung injury and
occurs in 13-37% of cases [92] after radiotherapy for lung cancer (See Section 2.5.4 for further
details). Existing research into this problem has tended to approach the topic from a clinical
angle and focus on the use of a wide range of clinical parameters or dose information to attempt
to predict its occurrence. However many of these parameters can require considerable effort to
collect and process and so an automated approach would be able to reduce additional burdens
on clinical staff.
The objective of the approach presented in this thesis (Chapter 5) is to use a small amount of
clinical data that is already collected as standard practice in the care of a lung cancer patient
coupled with a number of texture features derived from a CT scan of a patient’s lungs to predict
the likelihood of radiation induced pneumonitis occurring. Three dimensional (3D) texture
features are calculated from the lung parenchyma and passed to a classifier after preprocessing
with principal component analysis (PCA). A binary prediction is then made as to whether this
patient will develop pneumonitis. These predictions are then compared with a gold standard
(follow up data) to assess the viability of the method.
A significant benefit of this approach is that the process may be run automatically and off line
upon acquisition of a CT scan. Even if the texture analysis and classification requires several
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hours to complete, the predicted outcome would almost certainly be ready before a clinician
requires it. This would potentially allow for the modification of the dose plan so that treatment
may proceed in a manner which minimises the risk of radiation induced pneumonitis. That is,
the ability to predict the occurrence of radiation induced pneumonitis would assist clinicians in
planning the most effective therapy for each patient with lung cancer.
1.2.2 Segmentation of Prostate Focal Lesion
Prostate cancer is the second most commonly diagnosed cancer in men and the sixth leading
cause of cancer deaths in men worldwide, making up 14% of the total new cancer cases and
6% of male cancer deaths in 2008 [58]. In 2011, 41,736 men in the UK were diagnosed with
prostate cancer and there were 10,793 reported deaths attributed to prostate cancer [32]. MRI
is often used for diagnosis and radiotherapy is a popular treatment choice when intervention is
required.
When radiotherapy is used in the treatment of prostate cancer the whole gland is almost always
treated - the whole of the prostate is within the clinical target volume [18]. However, in a
significant number of prostate cancer cases, the disease is contained within a much smaller part
of the prostate (the “focal lesion” or “focal disease”), usually near the periphery. If this region
can be reliably identified then avenues for sparing the remaining healthy prostate may open
up. This would enable the reduction of the side effects of irradiating the whole prostate with
a therapeutic dose. One potential treatment plan would be to reduce the average dose to the
whole prostate and “boost” the focal disease with a much higher dose. Currently, one of the
main issues with this approach is in identifying the focal disease in a reliable and timely fashion
within the normal radiotherapy planning time line (See Section 2.6.4 for further details).
A first step towards a potential solution is presented in Chapter 6 where the focal disease is
automatically delineated using texture analysis on MRI data. A set of three dimensional texture
descriptors are calculated for every point in the prostate volume and an AdaBoost classifier is
used to predict whether a pixel is healthy prostate tissue or cancerous tissue. These labels are
then mapped back onto the MRI image for evaluation and comparison with a contour outlined
by an expert clinician. Transfer of these contours to planning CT scans by registration (as
demonstrated in [41]) could allow for the creation of radiotherapy plans that boost the focal
disease.
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1.3 Contributions
The contributions made by the author towards lung cancer treatment are:
• the development of a novel image analysis approach for the prediction of radiation
induced pneumonitis using radiotherapy planning CT images,
• the combination of 3D texture features with clinical features (such as smoking history)
to create a classification pipeline,
• the demonstration of the efficacy of the approach for prediction of pneumonitis using
features derived from the:
– whole lung volume
– region surrounding the GTV
– V20.
The contributions made by the author towards prostate cancer treatment are:
• the development of a novel pathway for the automatic delineation of focal disease in the
prostate volume using 3D texture features,
• the demonstration of the ability of 3D texture features (derived from diagnostic MRI
images) to correctly classify focal disease when considering an aggregate data set made
up from multiple cases,
• the demonstration of the efficacy of the same texture features when applied in a leave
one case out fashion and combined with a reconstruction and morphological cleaning
step to create a clinically viable approach.
1.4 Outline of thesis
The rest of this thesis is structured as follows: Chapter 2 provides a more substantial medical
background and context, focussing on the imaging modalities and radiotherapy relevant to
Chapters 5 and 6 and also lung and prostate cancer. Chapter 3 explicates texture analysis theory
and applications with a particular focus on the methods used in later this work. Chapter 4
follows a similar approach for machine learning, examining the supervised learning methods
used in Chapters 5 and 6.
Chapter 5 lays out the methodology used to predict radiation induced pneumonitis using ra-
diotherapy planning CT scans and a set of clinical features. Results are then presented and
analysed. Additional approaches that use a subset of the information from the lung and results
related to the dose volume are also presented.
Chapter 6 presents the work related to the identification of the prostate cancer focal disease
using texture. Initial classification results are presented, morphological cleaning applied and
the resulting contours are analysed and discussed.
The final chapter presents conclusions and potential avenues for further work.
Chapter 2
Medical Context and Background
2.1 Introduction
In this chapter a short introduction to the roles of CT imaging, MR imaging and radiotherapy
in a modern clinical environment are introduced to provide a basic working knowledge of the
images and clinical parameters used in Chapters 5 and 6. This is followed by an overview of
lung cancer and radiation induced pneumonitis and finally prostate cancer with an emphasis on
the treatment of focal disease where this work seeks to contribute.
2.2 CT Imaging
X-ray Computed Tomography (CT) [95] combines the measurement of x-ray attenuation through
an object with a back propagation algorithm to create a series of slices of a patient which then
form a 3D image. Two example slices from a CT scan can be seen in Figure 2.1. The main
advantages of this modality are:
• high contrast between bone and soft tissue,
• high spatial resolution (1mm or better),
• no superimposition of 3D structures onto a 2D plane,
• quick acquisition times,
• consistent image geometry.
The main disadvantages are:
• x-rays are ionising which results in a dose of radiation being delivered to a patient each
time a CT scan is acquiredi,
• poor soft tissue contrast,
• contrast agents may be required for some diagnostic applications,
i. The dose from a CT scan (on the order of mGy) is much less than the dose delivered during radiotherapy
treatment (on the order of tens of Gy) and is less of a concern during cancer treatment than when used for other
purposes. See the Ionising Radiation (Medical Exposure) Regulations 2000 (IRMER). Downloadable from gov.
uk/government/publications/the-ionising-radiation-medical-exposure-regulations-2000. Al-
though it should be noted that the dose can become more of an issue for 4DCT and 4DCBCT acquisitions.
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• some patients may be incapable of maintaining required breath holding (though this is
less problematic with the increased development and availability of 4DCT),
• artefacts when implanted metal objects are present, such as an artificial hip.
Figure 2.1: Example CT images. Left: an axial slice from a CT scan used for RT planning of a
patient with lung cancer. Right: an axial slice from a CT scan used for RT planning of a patient
with prostate cancer.
2.2.1 History
X-ray tomography was first developed at the beginning of the 20th century [72]. Initially a
purely mechanical approach was used to rotate an x-ray source and film joined by a connecting
rod, which allowed for the imaging of a single slice of the object of interest (a human body, for
example). New and improved methods for conventional tomography were developed over the
course of the next 60 years, resulting in sharper images.
With the advancements in computing in the 1960s, computed tomography became a possibil-
ity and the first commercial scanner was produced by EMI (Electric and Musical Industries
Ltd) and installed at Atkinson Morley Hospital in 1971. This first machine took a little over
five minutes to acquire a scan using a single x-ray tube and detector with a translate-rotate
motion. By 1973 the second generation of scanners had been developed, still using a translate-
rotate motion but now with 30 detectors and a single tube, which decreased the scan time to
approximately one minute. The third generation of scanners, introduced in 1976, had a rotate
only motion and a single tube. Using approximately 800 detectors, a single image could be
acquired in one to five seconds. The next major advancement (around 1980) was the expansion
to approximately 2000 fixed detectors and a rotating x-ray tube. Images still required between
one to five seconds to acquire.
Until this time all scanners used axial scanning in which the patient must be moved in discrete
steps between the acquisition of each slice. This process is repeated until the desired volume
has been captured. Around 1990 helical scanning was introduced which allowed for the smooth
motion of tube and couch, leading to reduced movement artefacts and higher throughput.
Modern scanners are equipped with multiple parallel rows of detectors to enable simultaneous
acquisition of multiple slices. They operate in axial or helical mode and have tube rotation
times of 0.3s. These features allow for fast scanning of large volumes and higher resolution
along the z-axis for true 3D imaging.
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Examples of recent innovations in the field include a) 4DCT which over samples the patient
and tags each scan with a time or breathing signal to allow for the creation of 3D CT data sets
at set points in the breathing cycle and b) dual source CT (for example, Siemens) which offers
very high temporal resolution to freeze heart motion by using two x-ray tubes at right angles in
order to increase the temporal resolution of the scan to a quarter of the tube rotation time.
Currently ongoing research may result in a) the use of compressive sensing techniques in the
reconstruction of the projection data for better image quality at lower doses [100] or b) X-
ray phase contrast imaging to reduce dose by measuring phase changes instead of absorption,
however, this is still at the research stage because miniaturisation of narrow band x-ray sources
is required.
2.2.2 Physics and Image Acquisition
Figure 2.2: A CT scanner at the Western General Hospital.
A CT scanner, Figure 2.2, generates x-rays by using a high voltage electric field to accel-
erate electrons emitted by a hot cathode. These high energy electrons strike a metal target
(typically Tungsten) which causes the generation of a continuous spectrum of x-rays due to
Bremsstrahlung and characteristic peaks due to electron transitions in the outer shell of the
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target atoms. Bremsstrahlung (braking radiation) is radiation generated by the deceleration of
one charged particle by another; in this case the electrons are slowed by the Tungsten nuclei.
Each electron typically releases many x-rays as it moves through the metal target generating
the curve shown in Figure 2.3. If an electron emits a single x-ray then the x-ray will be of the
same energy as the kinetic energy that the electron obtained from the electric field. This is the
maximum energy x-ray that can be emitted and is the reason for the sharp cut off in Figure 2.3.
The characteristic peaks are produced when the incident electrons cause a bound electron to
be ejected from its orbital shell, subsequently allowing an electron in a higher energy shell
to transition into the empty lower energy state and emit a photon with energy equal to the
difference of the two orbital states. This process is called fluorescent radiation.
It is normal for the beam to then be filtered (to “harden” the beam) in order to remove lower
energy x-rays, as they do not contribute to image quality but increase the patient’s received
dose. The final step is to pass the beam through a set of collimators to produce parallel rays for
imaging of the patient.
Photon Energy
Intensity
Figure 2.3: A typical x-ray spectrum (red) generated by the crashing of electrons into a heavy
metal target. The characteristic lines due to electron transitions can be seen in addition to
the Bremsstrahlung curve with a peak at a third of the maximum energy. The blue line is the
equivalent unfiltered spectrum in a vacuum.
The transition of these x-rays are measured at many angles and an attenuation map is con-
structed by back projection. This attenuation map is an array of Hounsfield Units (HU) which
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µx is the attenuation of the x-ray beam (I) passing through a distance (d) of material x:
Ix = Ie−µxd (2.2)
The mapping of CT numbers to the grey level scale can be varied to allow for improved
visualisation by choosing mappings that “stretch out” the Hounsfield Units of interest across a
greater range of grey levels. In radiotherapy planning the Hounsfield Units are used for dose
calculation.
Accelerating potentials are usually in the 50kV to 120kV range and the effective x-ray energy
is approximately one third of this. Up to energies of 50keV the photoelectric effect dominates
and between 50keV and 100keV both the photoelectric and Compton effects are important. X-
ray energies up to 100keV are typical for diagnostic imaging as the photoelectric and Compton









The photoelectric effect is preferred as it allows for the contrast of soft tissue and bone due to
the different atomic number (Z) of bones and soft tissue.
Reconstruction
As briefly mentioned above, the CT image is created by back projection [64]. This involves
taking a series of measurements at different angles to determine the attenuation coefficient
along the line between the source and detector. These measurements are then projected back on
top of a matrix: in the naïve implementation the value of the attenuation coefficient is equally
divided into the cells of the matrix that fall on the line between the source and detector. By
repeating this process for many angles an image is built up. Basic back projection suffers from
a blurring effect that can be alleviated by filtering the data, before back projection, with a
one dimensional kernel function to correct for unequal sample densities in the spatial domain.
These unequal sample densities are caused by the radial sampling of the rectangular grid of the
image. In an ideal scenario, with an infinite number of angles and infinite samples along each
view, the back projected image will exactly correspond to the “correct” image.
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Another method of reconstruction is to make use of the Fourier slice theorem. This states that
the Fourier transform of a 2D function projected onto a 1D line is equal to a slice through the
origin, parallel to the projection line, of the 2D Fourier transform of the original function. This
allows for the Fourier transform of each view to be combined to construct the two dimensional
image in the frequency domain. The inverse Fourier transform can then be used to obtain the
image in the spatial domain.
2.2.3 Roles in Medical Imaging
CT scans have two main roles in medicine; diagnosis and radiotherapy planning. CT scans are
used to diagnose many different diseases, often alongside other modalities. Examples include
lung cancer, brain tumours, spinal injuries, complex bone fractures and assessment of coronary
arteries.
The other main application is to provide the information required for radiotherapy dose calcu-
lation and planning. A planning CT is acquired and the tumour and organs at risk (OAR) are
outlined in order to calculate the dose delivered to each organ and the tumour. This enables the
correct treatment of the disease with minimal impact on surrounding healthy tissue. The HU
that make up the CT image are a measurement of electron density which is required to calculate
the dose deposited in radiotherapy (see Section 2.4 for more details).
2.2.4 Cone-Beam CT
CBCT [94] is an imaging modality similar to CT: x-rays and tomography are used to recon-
struct an image of a patient. However the x-rays used in CBCT are divergent - forming a cone
shape as they are emitted from the x-ray source rather than conventional CT where they pass
through a collimator. CBCT is used for patient alignment during radiotherapy delivery, patient
follow up and is becoming common in dental applications.
CBCT gives a poorer quality image than conventional CT (primarily due to the divergent
beams), data acquisition takes longer and the cone beam reconstruction takes much longer
than conventional CT reconstruction (1 minute versus near real time for conventional CT, due
to the assumptions that allow quicker reconstruction of conventional CT no longer holding).
However CBCT is a useful supplementary modality as a CBCT scanner can be integrated into
a radiotherapy linac to allow for pre-treatment and post-treatment patient alignment. CBCT
can also be acquired during treatment to monitor tumour response without the need for extra
scans on another machine. It should also be noted that CBCT technology is improving with the
availability of 4D CBCT and improvements to image contrast and quality.
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Figure 2.4: A example of a CBCT scan of a patient with lung cancer. Notice the poorer image
quality compared to a CT image - particularly the reconstruction artefacts (Figure 2.1).
2.3 MR Imaging
Magnetic Resonance Imaging (MR/MRI) [114] is an imaging modality that exploits the dif-
ferent relaxation times of nuclear spin states to construct images. The main advantages of MR
are:
• good soft tissue contrast,
• image slices can be acquired in any plane,
• non-ionising, there is no radiation dose deposited in the patient.
While the disadvantages include:
• slow acquisition times in the range of 15 to 90 minutes are typical,
• magnetic medical implants can prevent the use of MRI due to the strong magnetic fields
used,
• geometry is less consistent than CT imaging,
• the imaging process involves loud noises from the rapid switching of gradient fields
which may unsettle some patients in the confined space of an MRI scanner,
• contrast agents can be required for some diagnostic usage.
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Figure 2.5: An example slice from an MRI (T2) scan of a patient with prostate cancer.
2.3.1 History
MR Imaging was only possible after the development of Nuclear Magentic Resonance (NMR)
as NMR is a fundamental building block of MRI [12]. NMR uses a strong uniform magnetic
field and a radio frequency pulse to identify the chemical composition of a liquid by measure-
ment of the relaxation times of the magnetisation of nuclei in a sample.
Electron spin was discovered in 1921 by Compton, and in 1924 Pauli proposed that nuclear
spin also existed. In 1946 a joint Stanford and Harvard group were the first to detect an NMR
signal. By the 1970s, NMR had become a powerful tool for the structural analysis of molecules
- NMR spectra allows the relative position of different atoms within a molecule to be inferred.
With the advent of superconducting magnets in the 1970s the strength of the magnetic field was
increased and in 1973 Lauterbur created the first NMR image of sample tubes in a chemical
spectrometer. By creating a magnetic gradient, localised NMR measurements can be made
and later processed to form an image. The first commercial scanner was produced in 1981
(<0.2T) and in 1985 the first 1.5T scanner was manufactured. The next few years brought
major advancement in the signal to noise ratios and the resolution of the images. Today MRI
scanners are a common tool used in diagnosis and research and are widely available in the
western world with magnetic field strengths in the 1.5T to 7T range.
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2.3.2 Physics and Image Acquisition
There are a large number of protons in human tissues (water and fat, for example). Each proton
has a quantum spin of 12 and thus a magnetic moment. When a person is subjected to a very
strong magnetic field inside an MR scanner all of these protons precess around an axis in the
direction of the magnetic field in one of two energy eigenstates determined by the nuclear
Zeeman effect:
∆E = γ h̄B0 (2.5)
where h̄ is the reduced Planck constant, B0 is the magnetic field strength and γ = 42.5Mhz/T for
hydrogen. The lower energy state is made up of protons precessing parallel to B0 and the higher
energy state anti-parallel to B0. Protons can be excited from the lower to the higher energy state
by the absorption of a photon of the correct (resonance) energy. For the strength of fields used
in MRI, this corresponds to a photon in the radio frequency range and this frequency is called
the Larmor frequency.
The quantity that is measured in MRI is the time taken for the spins of the protons to recover
after being excited by a radio pulse. T1 MR measures the time taken for the longitudinal
magnetisation to relax. This is a spin-lattice interaction governed by how easily the protons
lose heat to the surrounding environment, this is determined by the molecule the proton is a
part of: lipids will have a shorter T1 than water as lipid molecules are much larger than water and
will interact with their local environment more. T2 MR measures the loss of phase coherence
between spins, the transverse magnetisation relaxation. Nearby protons can interact and cause
each other to flip alignment. These interactions cause a loss of phase coherence between the
protons and this results in the transverse magnetisation decaying with time constant T2. In
practice magnetic field inhomogeneities cause this time constant to be shortened: this time
constant is called T ∗2 . T2 is shorter for larger molecules as it is dependent upon the presence of
nearby protons.
In order to acquire an image additional magnetic fields are applied, using coils, to create linear
variations in B0 in the x,y and z directions. These variations in the magnetic field cause the
Larmor frequency to vary with position inside the patient. Slice position can then be chosen
by varying the centre frequency of the applied pulse and the slice thickness can be chosen by
varying the magnetic gradient strength and the bandwidth of the pulse:
Bz = B0 +Gzz (2.6a)
fz = γ (B0 +Bzz) (2.6b)
where Bz and is the magnetic field gradient at a z coordinate and fz is the Larmor frequency at
that z same position. As such, the MR data is not acquired in the spatial domain, but rather in
k-space (the spatial frequency domain). More detail in the reconstructed image requires more
sampling over k-space which requires more time to acquire resonance signals over different
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gradients. More contrast is achieved by greater sampling of the centre of k-space.
Other acquisition methods exist [10], including:
• Echo Planar Imaging - very fast, uses multiple phase encodings per excitation but puts
stress on MR equipment as very fast gradient switching is required.
• Diffusion Weighted Imaging - measures the rate of perfusion. However, numbers ob-
tained are not true perfusion like PET imaging.
• Fluid attenuation inversion recovery (FLAIR) - the T1 time of the MR pulse sequence is
adjusted to remove the effects of fluid on the scan.
2.4 External Beam Radiotherapy
External beam radiotherapy uses ionising radiation to kill human cells within the body. By
using radiation beams from multiple directions a dose can be deposited in a region of choice
while a much lower dose is delivered to organs at risk of receiving radiation, organs at risk
(OAR). This basic principle of building up dose by using multiple beams underlies external
beam radiotherapy and allows for the treatment of cancer at many locations within the body.
The main advantages of radiotherapy include:
• non-invasive treatment,
• easy to treat most parts of the body,
• can be used alongside surgery and chemotherapy,
• curative treatment option.
While the disadvantages are:
• side effects include fatigue, nausea, skin soreness and possible infertility,
• chance of secondary cancers developing due to radiation exposure,
• not suitable for curative treatment of non-localised tumours such as bone metastases,
though it can be used palliatively in such situations.
2.4.1 History
X-rays were discovered in 1895 [53] and only a few weeks later they were used to treat a cancer
patient. In 1899, two Swedish doctors used x-rays to treat several patients with head and neck
cancer. Until 1922 doses were delivered in a single exposure which brought severe side effects,
then it was demonstrated that fractionated radiotherapy was equally effective at treating cancer
whilst causing fewer side effects. By the 1950s 8MV linear accelerators (linacs),which allow
for much higher energy x-rays to be produced, had been developed. These higher energy x-rays
allowed for better treatment and increased skin sparing for patients.
Since the 1950s radiotherapy has continued to develop with advances including the integration
of CT into the planning process, more sophisticated dose calculation methods, conformal
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Figure 2.6: Percentage Depth Dose for various photon energies. These curve display the skin
sparing effect - note the small amount of dose delivered in the first few centimetres and how
the skin sparing effect increases with beam energy. Data taken from [4].
radiotherapy, intensity modulated radiotherapy and stereotactic ablative radiotherapy. There
is currently much active research into adaptive (image guided) radiotherapy.
2.4.2 Physics and Treatment Procedure
X-ray Production
X-rays for radiotherapy are generated in a similar fashion to those used for CT imaging (Sec-
tion 2.2.2) except they are of a higher energy, typically 6-10MeV [13]. These x-rays are
produced by accelerating electrons in a linac which uses either a magnetron (lower energy)
or a klystron (higher energy) to generate microwave energy. This microwave energy is used to
accelerate the electrons in a waveguide and these electrons are shaped by a magnetic field to
form a beam. For higher energies this equipment is too long to be mounted vertically and so the
beam must be bent downwards towards the patient from the horizontally mounted wave guide.
This bending is achieved by using a magnetic field to bend the beams through 270° degrees
(rather than 90°) which helps to compensate for the spread of trajectories caused by the range
of electron energies. This beam is passed through a slit which only allows electrons of the
desired energy to pass (due to the different electron trajectories). In order to generate the x-ray
photons the electron beam is directed towards a heavy metal target with which they interact
to produce a beam of photons which are passed through a collimator to produce a beam of
collinear photons. (In the case of electron treatments, the heavy metal target is replaced with a
2.4. External Beam Radiotherapy 16
scattering foil to spread out the electron beam to evenly cover the treatment field.) This beam of
x-rays is passed through a flattening filter to ensure a uniform intensity across the beam profile.
An ionisation chamber is the next step in the path of the beam which allows for monitoring of
the dose delivered by the beam and to indicate when the beam should be shut off to prevent
overexposure. At this point a secondary set of collimators can be used to shape the beam profile
in order to conform the beam to a treatment volume. Traditionally this shaping was done with
physical wedges, this progressed to “virtual wedges” where one of the collimator jaws moves
in a gradual fashion during the radiation delivery. Modern machines are now equipped with
multi-leaf collimators which consist of a series of pairs of metal leaves which can be adjusted
during delivery to generate complex beam profiles for the detailed conforming of the beam to
a target volume.
Dose
X-rays incident on a patient will interact with the matter in the patient by various processes: the
photoelectric effect, Compton scattering and pair production. These processes transfer energy
from the x-rays to electrons, it is these secondary electrons that cause nearly all of the ionisation
in the body.
Absorbed dose is measured in Gray (Gy), 1Gy = 1J/kg. The typical dose prescribed for treat-
ment depends on the type and stage of cancer, patient health, whether the treatment is curative
or palliative and other co-morbidities a patient may have. Usually therapeutic doses are between
20 and 80Gy delivered in several fractions. Energies of a few MeV are typical for radiotherapy
as this is the region in which Compton scattering dominates. Compton scattering is nearly
independent of atomic number which helps reduce the dose received by bones.
When a photon interacts with matter in the body a shower of secondary photons and electrons
is initiated causing the dose to spread about the initial direction in a cone. Since the energy
is deposited over the range of the electron tracks there is a “build-up” effect: the maximum
dose is not delivered until a depth roughly equal to the range of the electrons generated by the
Compton scattering interactions. This process is known as the “skin-sparing effect” because it
results in the skin being spared a high dose of ionising radiation during treatment. Without this
effect the skin would receive a very high dose and radiotherapy may not be a viable treatment
for many diseases.
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Biological Effect
The primary means by which radiotherapy kills cells is by causing a break in the DNA molecules
within the cell nucleus. DNA has a double helix structure: a break in one of the strands of
the helix can be repaired by cellular repair enzymes, however a break in both strands cannot
be repaired by the cell and will either stop proper cell function or prevent successful cell
replication, both of which lead to cell death. Breakages in the DNA are caused by interaction
with free radicals produced by the incident ionising radiation, as the dose is increased the
number of free radicals increases and a double break in the DNA becomes more likely.
Fractionation
After exposure to radiation the tissue in the body is able to recover. When it was observed
that healthy tissues recover quicker than cancer cells it was realised that a fractionated delivery
would spare healthy tissue while killing the cancerous tissue. A fractionated scheme involves
the administration of a prescribed dose in many smaller “fractions”, typically over the course
of several weeks. A further benefit of fractionation is that it may allow for the reoxygenation
of cells within the tumour (required for free radical production) as the tumour shrinks with the
treatment of the periphery - allowing previously radioresistant cells to be killed. Fractionation
schemes have been developed using empirical results from clinical trials due to the complexity
of biological radiation models [38].
Planning
In order to treat a patient a radiotherapy plan must be created. A plan consists of the arrange-
ment of several beams and their shaping. The first step in the planning sequence is to acquire
a CT scan and to outline the disease and any OAR from radiation (the CT numbers (HU)
also provide a measure of electron density, allowing for the dose calculation). The Clinical
Target Volume (CTV) is the volume which includes the Gross Tumour Volume (GTV) and
any subclinical malignant disease that is to be treated. The CTV is then expanded to a Planning
Target Volume (PTV). In order to ensure proper treatment of the CTV, the PTV adds a margin to
compensate for organ motion, error in the delineation of the CTV and also for any unobservable
cancer that may be in the vicinity of the visible tumour. After the CT scan has been outlined
appropriately and the prescribed dose and any constraints have been set a suitable plan can be
drafted. This once involved manually choosing the number of beams, their orientation and any
shaping required to properly treat the PTV while attempting to spare any nearby organs at risk.
Now, however, this step in the planning procedure is formulated as a numerical optimisation
problem - the beams and their orientations are chosen algorithmically in order to satisfy dose
constraints imposed on the tumour and OARs by a clinician.
There are many dose calculation algorithms in clinical use with trade-offs between their speed
and accuracy. The convolution/superposition algorithm uses the precomputed probability dis-
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tribution of a single photon interaction (pre-calculated using Monte Carlo simulations) and the
attenuation coefficient from each point in the patient (from CT numbers) to calculate how much
dose is deposited in the body. However the attenuation of the electrons and scattered photons
is dependent on the attenuation map preventing the use of Fourier space for this calculation.
Being a convolution problem, in the spatial domain, the algorithm is an N6 problem which
would be impossible to solve without a way to reduce the runtime. A common way to achieve
this speed up is by using the collapsed cone algorithm which divides space around a point into
a series of cones and assumes that all the energy within the cone is deposited along the cone’s
axis. The complexity of this algorithm is MN3, where M is the number of cones used, which
makes this a viable approach. Monte Carlo approaches are also used where the path of a large
number incident photons (or electrons/protons, depending on the therapy) are simulated for a
given beam configuration in order to calculate the dose a patient will receive for a given RT
plan. Monte Carlo methods are computationally expensive, but can bring great accuracy and
flexibility in planning.
2.4.3 Advances in External Beam Radiotherapy
There have been many advances in improving delivery and treatment on top of this basic
approach, some of which are briefly described below.
Intensity Modulated RT
IMRT involves the modification of the intensity of radiation across the beam profile to match
the shape of the tumour. Beam modulation is achieved by altering the shape of multi-leaf
collimators (MLCs). There are several types of IMRT:
• multiple static fields, “step and shoot”, where the beam is switched off as the MLCs are
changed,
• dynamic MLC, “sliding window”, where the beam remains on while the MLCs move,
this is faster,
• rotational IMRT (or “volumetric modulated arc therapy” (VMAT)) continuously moves
the gantry and the MLCs while the beam stays on,
• tomotherapy is similar to rotational IMRT, but the radiation is delivered in a helical path
similar to a CT scan.
IMRT is too complicated to manually place beams until the plan looks acceptable, the delivery
protocol must be optimised by a software planning system. In order to optimise a plan there
must be a set of criteria for evaluation: usually the Dose and the Dose Volume Histogram
(DVH). The Dose Volume Histogram is either differential or cumulative. Differential: what
volume receives a particular dose. Cumulative: what volume receives at least a particular dose.
An example of using the DVH to prescribe a plan would be requiring that at least 99% of
the PTV receives 95% of the prescribed dose, less than 1% of the volume receives 105% of
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Figure 2.7: An example dose volume histogram taken from a radiotherapy plan used to treat a
patient with lung cancer. Each line corresponds to a different region of interest: body (green),
GTV (red), spinal cord (cyan), right lung (orange), left lung (brown), whole lung (purple) and
the oesophagus (pale green). Note that the x- and y-axes cover the range [0,105] and [0,100],
respectively. These axes can be read in the electronic copy of this document.
the prescribed dose and the median lies between 99% and 101%. Or another example may be
that 95% of the PTV receives 60Gy while no more than half of the rectum exceeds 50Gy. An
objective function is then minimised to create a plan which is then inspected for viability. Since
mathematical optimality is not always the same as clinical optimality the dose constraints may
be modified based on the first iteration of the plan to interactively create a suitable plan. For
instance, when a PTV is near the skin a plan may build up dose and undo the skin sparing
effect, requiring manual intervention to adjust the planning constraints.
Rotational IMRT
Rotational IMRT (or VMAT) sweeps the beam source through an arc while also changing the
MLC shape to conform to the shape of the PTV. Both the gantry speed and the dose delivered
during the arc can also be varied in order to meet dose constraints. The use of sweeping
beams in VMAT allows for a high dose to be directed to the PTV while sparing surrounding
tissues with a short treatment time - a typical VMAT treatment may only take two minutes.
However there is more of a dose wash effect with this approach - low dose to a large region,
which for example may play a role in the occurrence of radiation induced pneumonitis or in
secondary cancer rates in breast cancer patients [1]. The main disadvantage to VMAT lies in
the increased planning and verification burden due to the increased complexity of accounting
for the changing MLCs and gantry position during irradiation.
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Stereotactic Ablative Radiotherapy
SABR uses small fields with a high dose per fraction delivered from many angles to irradiate a
PTV and is used to treat particularly small tumours. SABR is most commonly used for treating
lung cancer, though it may also be used for treating secondary cancers in other parts of the body.
The beams that are used allow for the delivery of a large dose to the PTV while minimising the
damage to surrounding healthy tissue as the smaller fields result in a lower dose to these healthy
tissues than standard RT. SABR requires fewer fractions (3-8) than other forms of RT and may
be administered using a standard linac or by specialised equipment such as the CyberKnife
robot, though it typically requires the use of 4DCT for planning.
Image Guided Radiotherapy
IGRT is a field of active research with many different forms and uses. Imaging equipment
such as CBCT is used to image patients before radiotherapy. This allows realignment of the
patient and a reduction in intra-fraction and inter-fraction alignment errors and consequently
an improved delivery of the prescribed dose. Another example of IGRT is to monitor patient
position throughout the radiotherapy delivery which allows for the stopping of treatment if a
patient moves out of safe boundaries, though this also requires the acquisition of a breathing
trace from the patient. An example of a commercial IGRT system that provides these function-
alities is the ExacTrac X-ray patient monitoring system which allows for real time verification
of patient position before and during radiotherapy.
IGRT can also refer to the use of imaging methods to automatically or semi-automatically re-
segment the GTV and OAR in order to verify and possibly adjust the radiotherapy plan at the
start of each fraction. This would require the development of accurate, reliable and fast image
analysis algorithms to delineate regions of interest in real time. This system would then need to
be coupled to a fast dose planning system. This is an ambitious goal and will only be reached
in a piece wise fashion by the increased use of imaging to monitor patient treatment and the
development of both, more robust and fast image processing frameworks in addition to fast
dose planning systems.
2.5 Lung Cancer
In men lun cancer is the leading cause of cancer death and the the most commonly diagnosed
cancer. In women it is the fourth most diagnosed and second leading cause of cancer death.
Overall, lung cancer has the second highest incidence rate and the highest mortality rate in the
world [58]. In 2011 43,463 people in the UK were diagnosed with lung cancer and there were
35,184 reported deaths attributed to lung cancer [31]. The causes of lung cancer include smok-
ing (active and passive), exposure to radon gas, genetic predisposition and contact with certain
2.5. Lung Cancer 21
substances, for example asbestos. Diagnosis methods include biopsy, functional imaging and
structural imaging methods. Once a patient has been diagnosed the treatment is dictated by
the disease progression, disease type and the general health of the patient. Treatment options
include surgery, chemotherapy, radiotherapy or a combination of these options.
2.5.1 Anatomy
Figure 2.8: Lung anatomy [81].
The lungs are a pair of air-filled organs that reside on either side of the chest. Air passes through
the nose and mouth, through the trachea (windpipe) which then splits into branches called
bronchi which continue to split throughout the lung, getting smaller and smaller to facilitate
efficient oxygen transfer to the blood, the primary function of the lungs. Each lung is divided
into lobes, 3 on the right and two on the left. The structure and location of the lungs can be
seen in Figure 2.8.
2.5.2 Diagnosis
Lung cancer diagnosis typically begins with a referral from a GP (general practioner). If a
patient is exhibiting symptoms (breathlessness, a persistent cough, coughing up blood) they
will be referred for a chest x-ray.
Chest X-ray
A chest x-ray is a quick and cheap method used to obtain an initial diagnosis: a single 2D
projection of the chest is acquired and analysed. A tumour will be visible as a white/grey mass
on the image. However the chest x-ray lacks the discriminating power to tell the difference
between a tumour and other problems like a lung abscess which may look very similar on
theses images. If there is a possibility lung cancer is present the patient will be referred to a
specialist.
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CT Scan
The next step after a potential positive result from the chest x-ray is a CT scan (Section 2.2)
which allows for a much more detailed view of any potential tumours. A contrast agent may be
used to improve the image quality.
PET-CT Scan
Another common step in the diagnosis of lung cancer is to carry out a PET-CT or a PET scan
which allows for the determination of the presence and extent of the cancer by measuring
metabolic uptake. PET (Positron Emission Tomography) makes uses of a radioactive tracer
molecule (such as FDG - fluorodeoxyglucose) that is injected into the patient. This tracer is a
molecule that is preferentially taken up by cancerous regions where it then decays to produce
a positron which is annihilated by a nearby electron to emit a pair of gamma photons. These
two photons are picked up by a ring of detectors to determine their point of origin by measure-
ment of their time of flight. The detection of many photons allows for the reconstruction of a
tomographic image.
Biopsy
The final step in a patient’s diagnosis may be a biopsy. This allows for a tissue sample to be
taken and assessed under a microscope to ascertain the stage and grade of the cancer present.
The biopsy may be taken by bronchoscopy if the cancer is near the centre of the chest, otherwise
more invasive surgical techniques may be used.
Staging
Lung cancer is divided into two types, small cell lung cancer (SCLC) and non-small cell lung
cancer (NSCLC). Small cell lung cancer is the less common of the two and has only two stages:
limited and extensive. The rest of this section will focus on the more common non-small cell
lung cancer.
The staging system for NSCLC is a scale of 1 to 4 and is based upon the extent of the cancer in
the lung and on its spread to the lymph nodes or other organs. The higher the stage, the further
the disease has progressed. Details of the stages are laid out in Table 2.1. After the type (small
cell or non-small cell) and stage of disease has been determined an appropriate treatment plan
is created for the patient.
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Stage 1 Cancer is confined to the lung and has not spread to the nearby lymph nodes.
1A tumour size: <3cm
1B tumour size: 3-5cm
Stage 2 Cancer is larger and may have spread throughout the lungs or to the lymph
nodes.
2A tumour size: 5-7cm OR tumour size of <5cm and the cancer is present in
the nearby lymph nodes.
2B tumour size >7cm OR tumour size of 5-7cm and the cancer is present in
the nearby lymph nodes OR the cancer has spread to muscle tissue but
not lymph nodes OR the cancer has made its way to the bronchus OR
the cancer has caused lung collapse OR there are multiple small tumours
present through the lung.
Stage 3 3A cancerous tissue has spread to either to the lymph nodes or into other
surrounding tissues such as the chest wall.
3B cancer has spread to another important part of the body such as the heart or
a main blood vessel.
Stage 4 The cancer has spread to both lungs, to another part of the body or there is a
build up of fluid containing cancerous cells around the heart and lungs.
Table 2.1: The staging system used for NSCLC. Higher numbers are indicitave of more
advanced cancer.
2.5.3 Treatment Procedure
There are several ways to treat NSCLC and the main factors that determine the choice of
treatment are the grade of disease, the stage of the disease and the general health of the patient.
(SCLC is usually treated with chemotherapy or chemotherapy and radiotherapy together or
possibly with surgery if the cancer is diagnosed at a very early stage.)
Surgery
Surgical removal of a whole lung (pneumonectomy), a lung lobe (lobectomy) or a smaller
segment of the lung (segmentectomy) are all surgical options depending on the stage of the
cancer, the further the disease has progressed the more radical the removal of lung tissue. In
order for a patient to be suitable for surgery they must have a good general state of health.
Possible complications due to surgery include inflammation of the lung and bleeding.
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Chemotherapy
Chemotherapy involves the patient taking a course of drugs (typically cisplatin and etoposide
or carboplatin with etoposide) that interfere with cell division processes. Cancer cells grow
more quickly and divide at a higher rate than healthy cells. By interfering with the cell division
process the cancer cells are killed at a much quicker rate than healthy cells, allowing for the
treatment of the cancer. The side-effects vary according to the drugs used and each patient may
respond to varying degrees. Common side-effects include hair loss, fatigue, mouth ulcers and
nausea. Chemotherapy may be used a) post surgery to destroy remnant cancer b) alongside
radiotherapy to improve treatment or c) palliatively to treat the symptoms when there is no
curative treatment option.
Radiotherapy
External beam radiotherapy (discussed in more detail in Section 2.4) is the primary radio-
therapeutic choice for treating lung cancer, though brachytherapy may also be used in cases
where the cancer is accessible by bronchoscopy. Radiotherapy may be used post-surgery and
alongside chemotherapy. Some of the side-effects include skin soreness, chest pain, fatigue and
difficulty swallowing.
In cases where the tumour is very small, inoperable or the patient declines surgery, SABR
(Section 2.4.3) may be used instead of conventional external beam radiotherapy.
2.5.4 Radiation Induced Pneumonitis
Radiation Induced Pneumonitis (a specific instance of radiation induced lung injury) is a con-
dition that develops post radiotherapy in 13-37% of patients [92]. It is an inflammation of lung
tissue which leads to impaired respiratory function and in many cases can be the cause of death.
The causal mechanisms of radiation induced pneumonitis are not well understood and there has
been significant research into the prediction of the occurrence of radiation induced lung injury.
Much of the literature focuses on the use of dose and chemotherapy parameters related to
the patient’s treatment and other clinical factors such as age, tumour location and pre-existing
lung conditions. The literature suggests that the V45 ii, V40, V30, V20, V5 and Mean Lung
Dose (MLD) are indicative of the risk of pneumonitis [14, 26, 33, 82, 91, 113, 121]. Particular
constraints on the DVH have been shown to negatively correlate with pneumonitis and may be
a preventative strategy [59] during treatment.
More recent research has shown that the effective lung dose may be a better parameter than
the MLD for grade 3 pneumonitis and suggests that, for a constant MLD, high doses to small
volumes carry a larger risk than low doses to large volumes [82]. In addition to these dose
ii. The Vx is the volume that receives at least x% of the dose.
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parameters, chemotherapy parameters [33, 55, 56, 82, 91, 96], age [26, 33, 82], sex [33], tumour
location [82, 121], smoking history [59, 121], COPD [91, 121] and gross tumour volume [121]
have all been shown to be significant in the prediction of pneumonitis. It has also been shown
that a given daily dose ≥ 2Gy, the V20 and a lower-lobe tumour location are predictors of fatal
pneumonitis [82]. There is also evidence that predictors for pneumonitis may not be consistent
between grade 2 and grade 3 radiation induced pneumonitis [33].
In Chapter 5 a method for the prediction of radiation induced pneumonitis by image analysis
of planning CT scans is presented. This is a novel method that is capable of predicting whether
a patient will develop radiation induced pneumonitis prior to treatment. There has been much
research into identifying existing lung disease by image analysis [5, 67, 102, 103, 116, 119] but
none into the use of image analysis techniques for the prediction and prevention of radiation
induced pneumonitis. The work most closely related to that of Chapter 5 is that of Chen et
al, where it was demonstrated that 66 dose and 27 non-dose parameters can achieve predictive
performance of Area Under ROC of 0.76 using a neural network [23] or a support vector
machine [22].
2.6 Prostate Cancer
Prostate cancer was responsible for up 14% of the total new cancer cases and 6% of male
cancer deaths in 2008, it is the second most commonly diagnosed cancer in men and the
sixth leading cause of cancer deaths in men worldwide [58]. In 2011, 41,736 men in the
UK were diagnosed with prostate cancer and there were 10,793 reported deaths attributed to
prostate cancer [32]. The causes of prostate cancer are poorly understood and there exists a
variety of methods for diagnosis including prostate-specific antigen (PSA) testing, digital rectal
examination (DRE), imaging and biopsy. Once a patient has been diagnosed the treatment is
dictated by the severity and progression of the disease. Low risk tumours are often left untreated
while a policy of “watchful waiting” is employed to monitor the condition. High risk tumours
may be treated with surgery, radiotherapy, chemotherapy, cryosurgery, high intensity focussed
ultrasound (HIFU), hormone therapy or some combination of these options.
2.6.1 Anatomy
The prostate is a small gland that is part of the male reproductive system. It is approximately
the size of a walnut and is located below the bladder and next to the rectum, surrounding the
urethra. The main function of the prostate is to secrete a fluid which makes up the majority of
the volume of semen. The location and relative size of the prostate can be seen in Figure 2.9.
There are four zones in the prostate: the peripheral, central, transition and anterior fibromus-
cular zones. Of these the peripheral zone is the largest and also the most common origin for
prostate cancer.
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Figure 2.9: Prostate anatomy [81].
2.6.2 Diagnosis
Diagnosis of prostate cancer is often difficult as the symptoms can also be the result of benign
enlargement of the prostate and this is why several complementary tests are used for diagnosis,
usually beginning with PSA.
PSA
PSA is a protein produced by the prostate gland and its levels can increase in the presence of
cancer tissue. It can therefore be used as a marker for prostate cancer, although PSA tests have
a relatively poor sensitivity/specificity profile [54]. There is currently no PSA screening in the
UK as the costs and risks are thought to outweigh the benefits [42] due to the large number of
false positive results.
DRE
The next step after a PSA test is a digitaliii rectal examination (DRE) by a GP, which examines
the surface of the prostate for any abnormal changes. A tumour will often make the prostate
hard and bumpy while benign prostate enlargement is more likely to feel firm and smooth.
Therefore, the primary benefit of DRE is to rule out benign prostate enlargement that comes
naturally with age.
iii. Here digital is used in the sense of relating to a finger.
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Biopsy
If a patient is deemed to be at risk of prostate cancer following PSA testing, DRE and after
taking into account age, family history and ethnicity they will be referred to a hospital for a
biopsy test. Most commonly this test is done by transrectal ultrasound (TRUS) guided biopsy.
The TRUS biopsy allows samples of the prostate to be taken for further histological testing
and assessment (preferably at least five cores are taken from each prostate lobe). However,
the ultrasound only permits the clinician to identify regions or geometric position within the
prostate, it does not enable them to see the tumour. This means that several samples must be
taken at various points in the prostate and up to 1 in 5 cancers may be missed by this test.
Grading
After biopsy the extracted tissues are examined under microscopy to determine the presence
of cancer cells and the Gleason score of any cancer found. The Gleason grade is a measure of
the aggressiveness of cells. The Gleason score is calculated by the summation of two Gleason
grades: the most common Gleason grade within a biopsy sample and the highest Gleason grade
of the rest of the cells. The scale used for each grading ranges from 1-5. Grades 1 and 2 are
not cancer so scores will be in the range 6-10. A score of 6 would indicate that all the cells
are likely to grow slowly whilst a score of 10 that all of the cells are likely to grow quickly.
Appropriate treatment options are influenced by the Gleason score.
Imaging
MRI scans may be used after PSA testing and the grading of biopsy results. The MRI allows
for a determination of the extent of the cancer spread and if it is used, the scan is acquired once
surgery or radiotherapy has been prescribed. A CT scan or bone scan (nuclear medicine) may
also be used to check for the spread of cancer to the patient’s bones.
T Stage
The T stage is a measure of the size of the primary tumour. There is a simple scale, TX: the
tumour cannot be measured, T0: the primary tumour cannot be found, Tis: cancer cells are
growing only in the most superficial layer of tissue and T1-T4: where the number indicates the
size and spread of the cancer into surrounding tissues; the higher the number, the greater the
size and spread.
Patients finally diagnosed with prostate cancer can be divided into two main groups: those with
low risk cancer and those with high risk cancer. The former group (low PSA levels, grade and
T stage) are usually left untreated and carefully monitored for any change in symptoms and
PSA tests. However some men may elect to undergo treatment at this stage rather than wait.
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The patients with high risk cancers will undergo treatment to deal with the cancer as outlined
in the next section.
2.6.3 Treatment Procedure
Treatment options for prostate cancer depend upon the extent and aggressiveness of the disease
in each patient. Men with cancer that is determined to be low risk or who are considered
unlikely to require treatment within their predicted lifetime are often not treated but instead
monitored regularly in a period of “watchful waiting”. During this time there are regular DRE
and PSA tests and at the first sign of change in the cancer the patient will be considered for
further treatment. Once it is established that the patient is to be treated there are a number of
options available; hormone therapy; prostatectomy; chemotherapy; cryosurgery; high intensity
focused ultrasound; brachytherapy; and external beam radiotherapy.
Hormone Therapy
Hormone therapy is used to shrink the tumour by inhibiting the presence or the affect of
testosterone in the prostate. Testosterone influences the size of the prostate and also of prostate
cancers so a reduction in testosterone will lead to a shrinking of the tumour and reduced
symptoms of prostate cancer. This treatment is useful when the tumour is protruding from
the prostate gland but has not yet reached any other structures such as the lymph nodes or
bones. The treatment can be administered by LHRH (Luteinizing-hormone-releasing hormone)
analogue injection which lowers the testosterone levels in a temporary and reversible manner.
The injections are administered either every month or every 3 months and patients can be taught
to inject themselves. Another option is anti-androgen tablets which either lower testosterone
levels or inhibit its function. These may be taken alone or in combination with LHRH analogue
injections. A third option is an orchidectomy: a one off surgical procedure to remove the parts
of the testicles that produce testosterone. This is irreversible, unlike hormone injection or anti-
androgen tablets. Whichever method is chosen the common side-effects include hot flushes, a
loss of sexual desire, impotence and occasionally breast tenderness or enlargement. Ultimately,
hormone therapy does not provide a cure for prostate cancer but is an effective method for
managing the disease as it can keep the cancer in check for a number of years. It may also be
used in conjunction with radiotherapy or other treatments to improve patient outcome.
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Prostatectomy
Prostatectomy is the surgical removal of the prostate and the cancerous tumour. It has the
advantage that the true stage and grade of the cancer can be determined post surgery. If the
cancer is confined to the prostate the entire removal of the gland is curative, otherwise further
treatment may be required, such as external beam radiotherapy. PSA levels drop to zero after
surgery and will only increase again if the disease returns allowing for early detection of
recurrent disease. The removal of the enlarged prostate should also help alleviate urinary
problems caused by cancer obstructing the flow of urine from the bladder. Potential side-effects
of surgery include wound discomfort, a short period of incontinence and impotence. Surgery is
best suited for early stage prostate cancer and in order to be eligible for surgery patients must
be fit for anaesthetic and have a Gleason score of 8 or less.
Chemotherapy
Chemotherapy is usually considered after hormone therapy failure and is often used in later
stage prostate cancers with continuing hormone therapy or other treatments like radiotherapy.
By itself, chemotherapy is not always curative, but is used to reduce symptoms and slow cancer
growth. It involves the patient taking a course of drugs (typically docetaxel, mitoxantrone,
paclitaxel or cabazitaxel) that interfere with cell division processes. Cancer cells grow more
quickly and divide more often than healthy cells, so by interfering with the cell division the
cancer cells are killed at a much quicker rate than healthy cells, thus allowing for the treatment
of the cancer. The side-effects vary according to the drug used and each patient may respond
to varying degrees. Common side-effects include anaemia, low immune resistance, bruising or
bleeding, loss of appetite, nausea, hair loss, fatigue and diarrhoea. Because of these side-effects
a patient must be relatively fit before treatment.
Cryosurgery
Cryosurgery is used when the prostate cancer is locally advanced and has not spread outside
of the prostate gland. In the UK it is usually used in the case of recurrent prostate cancer
after radiotherapy, sometimes hormone therapy is required beforehand to shrink large prostates
before surgery. A cryogenic gas, such as argon, is injected through a number of needles placed
into the prostate gland through the skin and guided by ultrasound. During the surgery the
prostate temperature is lowered to −140°C while the surrounding area is maintained at a safe
temperature. The very low temperature kills any prostate and cancer cells. The advantages of
cryosurgery are that it is minimally invasive, is repeatable and can be used when patients are
not suitable for major surgical procedures. The main disadvantages are impotence, short term
incontinence and damage to the rectum in a small number of cases.
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High Intensity Focused Ultrasound
HIFU involves the use of a rectal ultrasound probe: high intensity ultrasound waves are fo-
cussed on the prostate to generate localised intense heat with minimal damage to surrounding
areas. The procedure is carried out under general anaesthetic and can take up to three hours.
HIFU is a relatively new technique and is currently under active research.
Brachytherapy
Radioactive (I125, half life of approximately 60 days) seeds are implanted into the prostate using
a series of needles guided by ultrasound to deliver a therapeutic dose to the prostate and spare
surrounding regions. Brachytherapy is best suited to cases where the cancer is confined to the
prostate (T1 or T2 stage), there is a Gleason score of 7 or less and the prostate is relatively small.
As with many of the other treatments, urinary problems and impotence may arise post treatment
and radiation protection precautions are necessary around small children and pregnant women
for two months post implantation.
Figure 2.10: Diagram showing the typical administration of brachytherapy for a prostate
cancer patient. Image from [112].
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External Beam Radiotherapy
External beam radiotherapy, details of which can be found in Section 2.4, is a common treat-
ment choice for prostate cancer. Typical treatment consists of hormone therapy followed by
radiotherapy: at the Edinburgh Cancer Centre a patient undergoes three months of hormone
treatment, followed by the implantation of fiducial markers and then the administration of 3 or 4
field conformal radiotherapy. IMRT may be used in some circumstances where dose constraints
cannot otherwise be met. Some of the short term side-effects include fatigue, urinary and bowel
problems, nausea and skin soreness. Longer term side-effects may include urinary problems,
bowel problems and impotence.
State of the Art Developments
The Efinger project is researching a “multi-scale mechanical measurements” approach for the
diagnosis of prostate cancer [47]. The project is seeking to develop a minimally invasive probe
(transurethral, transrectal or laparoscopic) to measure the mechanical properties of the prostate
in vivo. These mechanical properties are indicative of the histological properties of the prostate
and can therefore be used in diagnosis.
The da Vinci surgical robot is a new technique for minimally invasive surgical procedures,
including prostate cancer [74]. The system combines robotics and 3D vision systems to al-
low surgeons to perform much less invasive surgeries resulting in faster recoveries and fewer
complications.
2.6.4 Focal Lesion Boosting
External beam radiotherapy, like the other methods outlined in Section 2.6.3, treats the whole
of the prostate gland in all cases, regardless of the stage of disease. Treating the whole gland
on low risk patients means that a therapeutic dose is delivered to the tumour but the healthy
tissue in the prostate is also subjected to a large dose. There is potential for improving patient
treatment when there is a dominant cancer focus in the prostate. That is, when the prostate
cancer is located in a single dominant focus (a focal lesion) it may be possible to “boost”
the focal disease. This boosting would involve administering a larger dose to the focal disease
and this may allow for the overall reduction in dose to the surrounding (healthy) prostate tissue.
However “focal boosting” is not in widespread use due to the challenges that must be overcome
to implement a viable, safe and effective clinical protocol.
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Challenges & Current Research
The challenges faced by focal therapy are primarily identifying the focal disease, developing
effective treatment plans and determining the efficacy of this approach versus the conventional
whole gland treatments.
Identification: There is great difficulty in manually identifying regions of focal disease in the
prostate. A range of modalities are used including PET/CT, SPECT and single parameter MRI.
The process for each of these modalities is very time consuming and requires a great deal of
clinical expertise. There has been some preliminary research into the use of machine learning
for this kind of identification. Shah et al [97] looked at localising peripheral zone prostate
cancers on multi-parametric MRI with histological gold standard information and achieved an
f-measure of 89% with a support vector machine. Groenendaal et al [48] considered a logis-
tic regression model for the voxelwise prediction of peripheral prostate cancer on diffusion-
weighted imaging, dynamic contrast-enhanced magnetic resonance, achieving an area under
ROC of 0.89 when using a histological gold standard for evaluation. Chapter 6 outlines an
automated approach for the generation of focal disease contours on T2 MRI. One advantage of
the approach presented in this work is that a contour is generated in a fully automated process
unlike the methods laid out above which only present a classification of the voxels and do not
proceed to generating a contour of the disease. There remains work to be done in transferring
this identification from MRI to the radiotherapy planning CT to allow for this information to
inform treatment planning.
Treatment Plans: After the identification of the focal disease a radiotherapy plan must be
designed that will suitably irradiate the disease while still maintaining the prescribed dose
constraints for other organs at risk. This may not always be possible, depending on the focal
disease location.
Efficacy: There are no firm clinical conclusions about the efficacy of focal prostate therapy.
There are ongoing trials to determine if this should be another option for the treatment of
prostate cancer. A recent review, [7], concluded that:
“conclusions regarding optimal techniques and/or efficacy of this approach are
elusive, and this approach cannot be considered standard of care. There is a need
to build consensus and evidence. Ongoing prospective randomized trials are un-
derway and will help to better define the role of differential prostate boosts based
on imaging defined GTVs.”
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2.7 Summary
This chapter has laid out a brief introduction to x-ray CT and MR imaging, radiotherapy and
prostate and lung cancer and the challenges of treating these diseases. This basic understanding
of the problem is the first step in developing tools and systems to aid the clinicians treating
patients with cancer. CT imaging, MR imaging and radiotherapy are all used for the treatment
of many different cancers. This chapter has focussed on lung cancer and prostate cancer. In
Chapter 5 a methodology for the automatic prediction of radiation induced pneumonitis is
presented and in Chapter 6 a framework for the segmentation of prostate focal disease is
demonstrated. It is hoped that both of these contributions may begin to address at least some of
the challenges outlined earlier in this chapter.
Chapter 3
Texture and Medical Image Analysis
“the feel, appearance, or consistency of a surface or a substance” i
3.1 Introduction
Texture is a property of a surface that is easily recognised but is an incredibly difficult concept
to define and characterise. Almost all surfaces have natural texture caused by the physical
variation of the profile of the surface. Visual texture is caused be the aforementioned physical
surface texture (like variations in roughness) or by differences in reflectivity due to colour
changes on a surface. It is this visual texture that image analysis is concerned with. When
images are considered, texture is the variation of pixel intensities as a function of position. A
way to visualise the texture of an image is to use the pixel location as x and y coordinates
and the grey level at each location as the z coordinate to create a surface. A large amount of
significant information can be extracted from the texture within an image which has led to many
applications of texture analysis in the last half century. A taxonomy of common texture analysis
methods is presented in Section 3.3 and short review of example applications of texture, with a
particular focus on medical imaging, in Section 3.3.6.
There is no agreed upon definition of texture in the field of image analysis and computer vision.
Some definitions are arrived at from a conceptual approach while others are derived from the
practical application at hand. This lack of a proper definition emphasises how broad a concept
texture can be and has led to the large number of different methods used to characterise texture
in different circumstances. A good, though broad, definition of texture is provided by Petrou:
“Texture is the variation of data at scales smaller than the scales of interest.”[88]
This definition neatly captures the nature of texture, though it does not move one closer towards
a unified theory of texture. Nevertheless this will be the working definition used in this thesis
and chapter. An example that illustrates this definition: if one is attempting to identify organs
on an MR scan, the texture is the variation of the grey levels within each of the organs that
is then characterised in order to differentiate between the organs. That is, if one is attempting
i. Oxford English Dictionary
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to segment the bladder and the prostate on a MR scan, the texture is the grey level variations
within the bladder and within the prostate caused by the prostate and bladder being composed
of different tissues which appear differently on an MRI.
Texture in an image can also be problematic when low level vision methods are used. For
example, edge detection algorithms can run into issues when extra edges within an object
are detected due to the texture of an object. Returning to the MR example above: the texture
of different regions within the prostate may reduce the quality of a segmentation of the whole
prostate. (Another example of this, illustrated by a block of marble, can be seen in Petrou [88].)
The remainder of this chapter will cover the role of texture in the human visualisation process,
present a taxonomy of texture approaches and applications, discuss the nature of texture in
three dimensions and then offer a more detailed discussion of several texture measures that are
used in this work.
3.2 Relation to Human Visualisation
The interaction between human vision and texture is important because most texture analysis
algorithms will be evaluated against a human baseline. Yet this may not always be the case, as
shown by the work in Chapter 5 where texture is used to detect information that is undetectable
by the human visual system. A further example would be the texture based classification of a
disease evaluated by a histological gold standard. Texture is central to human vision as it affords
clues as to the composition of object surfaces and it is used in pre-attentive recognition [60].
(Pre-attentive recognition is the ability to unconsciously recognise an object or pattern by
looking at it).
Julesz postulated that the human visual system cannot discriminate between textures with
different third order statistics but with identical first and second order statistics [61, 62] (defined
in Section 3.6). This raises the question of how the performance of a texture algorithm is
measured. An algorithm which can discriminate between textures that the pre-attentive human
visual system cannot may outperform humans in some tasks, or it may find too many different
regions if the aim is to emulate the performance of humans. However, in some cases where the
second order statistics between pairs of textures are identical it is still possible to pre-attentively
discriminate the pairs. This led to the discovery that the texture discrimination is based solely
on the density of “textons” [63]. The textons identified by Julesz were “color, elongated blobs
(line segments) of given width, orientation, and length, and the terminators (end-points) of
these elongated blobs”.
Understanding biological systems can inspire algorithmic development like artificial neural
networks or in the case of texture, multichannel filtering approaches: the demonstration that the
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brain converts retinal images into filtered images of various frequencies and orientations [20]
has led to the investigation of signal processing techniques for texture analysis.
In summary, because texture is an inherently visual conception texture analysis is closely
related to and influenced by our understanding of the human visualisation system.
3.3 Taxonomy of Approaches
There are a variety of approaches to texture analysis reflecting the different problems being
addressed but also because of the lack of a unified framework for understanding and character-
ising texture, as explained earlier. Because of this lack of a single framework there are a range of
different approaches that have been applied to the field of texture analysis. This section presents
texture analysis methods belonging to the standard classes. Statistical, geometric, model based
and signal processing methods are discussed.
3.3.1 Statistical
Statistical measures attempt to implicitly capture the textural properties of a region by mea-
suring the distribution of grey level values. Statistical measures were among the first to be de-
veloped for texture analysis and many different descriptors are available. Many of the features
that can be calculated by statistical methods are correlated with each other and so a feature
reduction/selection method is usually employed when these features are used. Examples of
statistical methods include first order statistics, grey level co-occurrence matrices, grey level
run length matrices, grey level size zone matrices (each of which will be further elaborated upon
later on in this chapter) and autocorrelation features. The autocorrelation function measures
the self-similarity of a region and so is a measure of the regularity and fineness/coarseness of a
region.
3.3.2 Structural/Geometric
Structural (or geometric) approaches define texture as being made up of small, well-defined
primitives that are placed according to a set of rules. This kind of formulation is well suited
to texture synthesis as it allows for the creation of deterministic and regular stochastic textures
but is not as well suited to characterising naturally occurring texture as the primitives or the
rules may be difficult to predict and establish reliably. Morphological methods also fall into this
class of structural methods. Morphological methods use mathematical morphology operations
to determine textural characteristics. An example of a morphology based method is opening
an image with progressively larger structuring elements to determine how many pixels in the
image are removed at each scale, this gives a pattern spectrum which can be used to describe
the texture in an image.
3.3. Taxonomy of Approaches 37
3.3.3 Model Based
Model based techniques seek to parameterise the texture according to a theoretical model. For
example a Markov random field (MRF), an autoreggressive model or a fractal model. Taking
the MRF model as an example: an MRF is defined as a field in which the value of a point
depends directly on only the values of the neighbouring pixels. In order to use an MRF to
characterise texture, a clique (or neighbourhood of each pixel) must be defined in addition to a
function which used to calculate the probability of a pixel being a certain value given the value
of its neighbours in the clique. The parameters of this function are used to characterise texture.
Once these parameters have been learnt, the MRF may be used to synthesise texture that looks
similar to the original. Additionally completely synthetic texture may be generated by the use
of MRFs by manual selection of the model parameters.
3.3.4 Signal Processing
Texture measures based on signal processing techniques include spatial domain filters, the
Fourier transform and extensions of these algorithms. Spatial domain methods include using
edge detection algorithms to count the density of edges in a region and moment based features.




If R is a rectangle and the moments are calculated for every pixel in the image, then the moment
based approach is equivalent to applying a series of spatial filters to the image to generate
features at each pixel. More common are frequency domain approaches: Fourier transform
methods perform poorly as they lack any localisation terms and hence are restricted to mea-
suring global properties. However Gabor filters and wavelets have widespread applications in
texture analysis due to their ability to characterise local frequency responses. Gabor filters will
be further explained in Section 3.9.
3.3.5 Stationary/Non-Stationary Texture
A stationary texture image has only one type of texture present, while a non-stationary image
has more than one type of texture. Typically an image with stationary texture is classified and
a label is applied to the whole image, while images with non-stationary texture are segmented
to delineate the structures or regions containing the different texture in the image. Different
texture analysis methods are used for stationary and non-stationary images: FOS, GLCM and
GLRLMii are each global measures and are used for stationary texture images while local
measures like Gabor filters and Linear Binary Patterns (LBPs) are used for non-stationary
ii. These are defined later in the chapter.
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texture cases. However global methods can be transformed into local methods by applying them
on local sub-regions of an image to generate local texture descriptors and localised methods
can be used as global measures by averaging or computing a global statistic of local texture
features.
3.3.6 Applications in Medical Image Analysis
Texture analysis has been used widely in the literature over the course of a number of years in
the medical imaging field. This section provides a short overview of some recent applications
in the field.
Korfiatis et al [65] demonstrated that 3D co-occurrence features are capable of classifying
interstitial lung disease - lung parenchyma was separated into three classes: normal, ground
glass and reticular. Linear Binary Operators have been used for content-based image retrieval
in [17]. Diagnosis of liver tumour disease with an accuracy of 94% was demonstrated by [66].
Chicklore et al explored the use of texture features in functional imaging (PET) and concluded
that, although more work is required, texture may play a useful role in the analysis of images
from functional modalities [24]. Texture has also been shown to be useful in the characterising
of structural changes during radiotherapy in head and neck cancer patients [93]. For a compre-
hensive review of three dimensional texture in medical imaging, the reader is directed to the
excellent review by Depeursinge et al [36]. This review explores various uses of texture across
a range of modalities and patient organs. More recently, Prasanna et al [89] have developed a
novel technique and demonstrated its ability to distinguish between “two subtly different types
of pathologies on MRI in the context of brain tumours and breast cancer”.
This short collection of example applications demonstrates the potential for the clinical utility
of texture based approaches and this author believes that texture will continue to be a widely
researched topic in the coming decade.
3.4 Texture Analysis in Three Dimensions
The extension of texture analysis from two dimensions to three is in some ways a natural one
with the ever increasing availability of volumetric imaging data, particularly in the medical
imaging arena. However it is not a straightforward development, partly due to the increased
visualisation and conceptual burdens, the non-trivial extension of 2D algorithms and also the
increased storage and computational demands imposed by this new data. The visualisation and
conceptual burden can be demonstrated by considering the visualisation of a 2D image as a
surface as mentioned above: the grey level values providing the z coordinates. If this process
was to be repeated in 3D we would need a 4D volume to represent the grey level at each x,
y, z position. Initial attempts at 3D texture analysis were pseudo-3D methods: applying 2D





















Figure 3.1: Diagrams showing the 4 directions in which texture is usually calculated in 2D
(right) and the 13 directions used in 3D (left).
techniques in a slice-wise fashion or by projecting a 3D image onto a plane before calculating
a 2D texture descriptor. Neither of these methods come close to fully exploiting the information
that is gained by moving from a 2D to 3D interpretation in the presence of isotropic imaging
data. (If ∆z >> ∆x,∆y, where ∆x, ∆y and ∆z are the pixel spacings in the x, y and z directions,
then it is necessary to use a slice wise approach.) Volumetric texture analysis is a relatively
new field largely because isotropic volumetric imaging data has not been widely available until
recently. Given the large amount of research and wide applications that have come from 2D
texture, it is expected that 3D texture research will continue to expand and hopefully make a
large contribution to the field of medical image analysis.
As an example of the advantage of moving from 2D to 3D texture [109]: if co-occurrence
or run length features are to be calculated at each point in a image, as may be desirable in a
segmentation task, it is necessary to calculate the texture on a small region around each pixel in
the image. This small region must be large enough for the features to be statistically relevant,
but if the region is too large this will act as an averaging/blurring effect over the calculated
texture. The advantage of 3D (over 2D) texture in this situation is that the same number of
pixels may be included while remaining spatially closer to the central pixel. For example a
square of length 5 has only 25 sample pixels while a cube of length 5 contains 125 pixels for
analysis.
However the large number of pixels available in 3D also brings challenges in capturing all of
the information present in a volume. Since images are quantised to a grid the standard method
for calculating texture in various directions is to examine the space in 4 directions in 2D and
13 unique directions in 3D. These are calculated by considering a 3×3 or a 3×3×3 volume
and can be seen in Figure 3.1. As the size of the region increases, the number of pixels not
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considered also increases. In 3D this effect greater than in 2D, as can be seen in Figure 3.2.
This graph clearly displays how many more pixels are discarded in 3D for larger box sizes.
This suggests that for smaller volumes GLCMs and similar methods may be more appropriate
whereas for larger volumes signal processing methods may be better suited as they do not suffer
from this “structuring element” problem.
Figure 3.2: Visualisation of how the number of pixels not considered by the usual 4 directions
(2D) and 13 directions (3D) varies with box size. The curves in the graph are given by n2D =
d2−4(d−1)−1 and n3D = d3−13(d−1)−1.
Most of the texture descriptors described in this chapter were originally described in 2D and
have been extended to 3D. The suitability of their extension to 3D and the “naturalness” of
their three dimensionality are discussed within each of their sections.
3.5 First Order Statistics
First Order Statistics are derived from the image histogram (or grey level probability) which
means that no higher order information about the spatial relation between pixels is taken into
account, hence the name. This means that first order statistics are trivial to compute, but have
limited discriminatory power. This can be seen in Figure 3.3: each image has identical first
order statistics but because only the grey level probability is used to calculate the features the
(noisy) chequerboard cannot be distinguished from the union jack.
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where P(x) is the image histogram.
First order statistics are often included in many texture analysis studies and combined with
more advanced features as they are both trivial to compute and may contain information com-
plementary to other texture descriptors and in the case of obviously distinguishable textures the
mean and entropy are often useful features. It is for these reasons that they are also included in
this work.
3.6 Grey Level Co-occurrence Matrices
Grey Level Co-occurrence Matrices (GLCM) are used to measure the second order statistics
present in an image by considering the relationship between pairs of pixels in a given direction
at a given distance.
A rotationally invariant GLCM may be calculated by considering all pairs of pixels at a given
distance. These can be more appropriate when the texture in an image is rotationally invariant.
Another motivation for the use of rotationally invariant descriptors is in scenarios where the
images of textured objects have been acquired from different perspectives and viewing angles.
This is not the case for the medical images considered in this study. Patients were all placed
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Figure 3.3: Four example images with identical first order statistics - a system based only
on FOS would be unable to discriminate between each of these images despite their very
obvious differences.
in a head first supine position which aligns all the patients in the same, or very similar, frame
of reference before image acquisition. (This rule would apply to most CT and MR imaging
as a group of scans are likely to share a common frame of reference even though MR can
be acquired in any arbitrary plane. However this may need to be reconsidered for ultrasound
imaging where the probe is free to move and images will not normally be aligned.) For this
reason the rotationally invariant GLCM was not considered. Instead the rest of this section
focuses on GLCMs that incorporate the directional information as it should allow the extraction
of more information from textured regions.
In 2D a GLCM is formally defined as the number of occurrences of a pixel with grey-level,
i, at a distance, d, and angle, α , from a pixel with grey-level, j, in an image, I (∆x = d cosα ,
∆y = d sinα):




1, if I(p,q) = i and I(p+∆x,q+∆y) = j0, otherwise (3.3)
It is possible to generate as many GLCMs as there are combinations of angles and distances
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1 1 2 2 4
1 1 2 2 2
1 3 3 3 1
3 3 4 4 3
idx 1 2 3 4
1 6 1 3 0
2 1 4 2 1
3 3 2 2 2
4 0 1 2 0
Figure 3.4: Example of a 4×4 GLCM (right) calculated from the matrix on the left - the values
of the grey levels are displayed in the matrix.
in an image. Since images are made up of values on a discrete grid the available distances
and angles are quantised (unless interpolation is used): for a distance of one, there are 8
neighbouring pixels which results in 8 directions (0°, 45°, 90°, 135°, 180°, 225°, 270°, 315°)
from which to choose. However GLCMs are symmetric matrices as can be trivially deduced
from Equation 3.3 so the 0° GLCM is equivalent to the 180° GLCM, 45° to 225°, 90° to 270°
and 135° to 315°. This results in only 4 unique directions in two dimensions for a distance
of one, see Figure 3.1 for an illustration of these. When the distance is increased, however,
there are more neighbours to consider. These neighbours can be found by finding all the pixels
that satisfy, d− 0.5 ≤
√
∆x2 +∆y2 < d + 0.5, where d is the distance being considered. This
leads to 6 unique directions for d = 2, 8 unique directions for d = 3, etc. In order to keep the
number of GLCMs reasonable, only the four unique directions from the d = 1 case have been
considered in this work when d > 1.
Equation 3.4 shows the extension of co-occurrence matrices to 3D. The GLCM is still two
dimensional but is now parameterised by an additional angle, β .






1, if I(p,q,r) = i and I(p+∆x,q+∆y,r+∆z) = j0, otherwise (3.4)
The extension to three dimensions increases the number of directions that must be considered.
For d = 1 there are 13 unique directions, as illustrated in Figure 3.1. As with the 2D case, only
these 13 directions will be considered for d > 1, the effects of discarding pixels as d increases
was discussed in Section 3.4.
GLCMs produce a very rich representation of an image and its texture but can be very unwieldy
and bulky as they have (Number of Grey Levels)2 elements. One method for extracting features
to characterise the texture is to use the ratio of elements in the GLCM which expresses the
relative abundance of co-occurrences in the image. The problem with this approach is the large
number of features it can generate and the inability to know a priori which of these features
will be significant for a given task. These features must be tuned on a per task basis. The
more frequently used method for feature extraction was proposed by Haralick [50], where 14
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characteristics of the GLCM are computed and used as features:


























(i−µ)2 p(i, j) (3.5d)


























p(i, j)log(p(i, j)) (3.5i)










Information Measure of Correlation 2 = (1− exp(−2(Hxy2−Hxy)))0.5 (3.5m)
Maximal Correlation Coefficient = (Second largest eigenvalue of Q)0.5 (3.5n)
where Ng = number of grey levels, px(i) = ∑
j
p(i, j), py(i) = ∑
i











p(i, j), µx = mean(px), µy = mean(py), σx = std(px), σy = std(py),




. This method of com-
puting a set of descriptive statistics is appropriate because the GLCM can be thought of as a
joint probability density function, and probability density functions can be well characterised
by computing a set of statistics to describe them.
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3.7 Grey Level Run Length Matrices
Grey Level Run Length Matrices (GLRLMs) count the number of “runs” in an image in a
particular direction, a run is a series of collinear pixels of the same value (or which lie in a
range of values). This can be thought of as a higher order approach than GLCMs - instead of
looking at pairs of pixels the number of runs in a image are counted for each grey level, as such
the interactions between many pixels instead of between pairs of pixels are now considered.
Galloway [46] defined the GLRLM:
“The [GLRLM] matrix element (i, j) specifies the number of times that the picture
contains a run of length j, in the given direction, consisting of points having grey
level i (or lying in grey level range i).”
Galloway also described five statistics derived from this matrix to be used as features:





















p(i, j) j2 (3.6b)






























where p(i, j) is the RLM and nr, np are the total number of runs and pixels. However, in these
first five features there is a bias towards consideration of the runs in the image, in order to
correct for this and make better use of the grey level information Chu et al [25] proposed two
more features which are analogous to the first two above as can be seen by comparing their
equations:






















Subsequently four more features were defined by Dasarathy and Holder [34] based on the joint
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distribution probabilities rather than the grey level and run length probabilities separately:













































p(i, j)i2 j2 (3.8d)
These 11 features make up the standard set of features that are usually calculated when using
GLRLMs. Typically they will be calculated in the same 4 directions in 2D and 13 directions
in 3D as described in Section 3.6. Like the GLCM features, many of the GLRLM features are
correlated with one another and a feature reduction/selection technique is usually required. The
extension of GLRLMs from 2D to 3D is a simple one requiring the additional directions to be
taken into account and all the relevant pixels to be properly counted.
3.8 Grey Level Size Zone Matrices
Grey level size zone matrices (GLSZMs) are an analogous extension to GLRLMs, instead of
counting the number of a runs in a particular direction, the number zones (areas or volumes,
defined by an arbitrary connectivity matrix) are counted [110]. A zone is defined as a region of
connected pixels of the same grey-level.
An entry, (i, j), in a GLSZM is the number of zones with grey-level, i, and of size, j, found in
an image. The number of rows in the matrix is fixed by the grey level range in the image but
the number of columns will vary according to the texture in the image - the more homogeneous
an image, the wider and flatter the matrix will be, while an image with many inhomogeneities
will be more compact, with larger values. Once the GLSZM has been calculated, a set of
features analogous to the 11 GLRLM features are calculated, for example, long run emphasis
becomes large zone emphasis and Long Run High Gray-Level Emphasis becomes Large Zone
High Gray-Level Emphasis. The equations for each feature are not repeated here as they are
identical to the GLRLM equations but with any reference to runs replaced by zones.
The connectivity matrix that is used to define zones can be any arbitrary logical matrix and can
therefore be either 2D or 3D, meaning that GLSZMs can be thought of as “natively” volumetric
rather than being “extended” to 3D as with GLCMs and GLRLMs. That GLSZMs are not
tied to a particular dimensionality means that this approach is also capable of avoiding the
problem with not examining all the pixels in a volume as described in Section 3.4. If a full
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Figure 3.5: Diagrams displaying the connectivity matrices used for GLSZM calculation. From
left to right 4, 8 (2D) connectivity, 6, 18, 26 (3D) connectivity.
connectivity matrix is used (the 26-connectivity in Figure 3.5) then a GLSZM will take into
account all the pixels in a volume - alleviating one of the issues with statistical approaches
versus filtering/transform approaches. In the work presented later in Chapter 5, 5 connectivity
matrices were used to generate GLSZMs: each with connectivity of 4, 8 (2D) and 6, 18, 26
(3D), these can be seen in Figure 3.5.
3.9 Gabor Filters
The Gabor transform, first introduced by Gabor [45], is a special case of the short-time Fourier
transform (STFT) and provides information about the frequency and phase content of a signal
in a localised window as it changes over time. The STFT is calculated by applying a windowing
function (which is only non-zero in a local region) to a time varying signal and sliding the
window along the time axis. The Fourier transform is then calculated on the resulting signal
which generates a two dimensional output signal that measures the frequency and phase of
the original signal as it changes in time. The Gabor transform of the signal x(t) at time τ and
frequency f is




exp(−π(τ− t)2)exp(− j2π f τ)x(τ)dτ (3.9)
Two dimensional Gabor filters are the elliptic generalisation of the one dimensional transform
and when applied to a 2D image (here we move away from considering a time-varying signal to
a spatially varying signal: an image) they are capable of characterising the spectral and spatial
content of an image. The human visual cortex representation was shown to closely correspond
to two dimensional Gabor filters [35, 73] and this is thought to be the reason that Gabor filters
are well suited to pattern recognition and texture classification problems.
Gabor filters have also been extended to 3D [9]:

















× exp( j2π(xu+ yv+ zw)) (3.10)
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where u = Fsinφcosθ , v = Fsinφsinθ , w = Fcosφ , [x′y′z′]T = R× [xyz]T , S is a normalisation
scale and F =
√
u2 + v2 +w2 is the amplitude of the complex sinusoid wave with frequency
(u,v,w). θ ∈ (0 ≤ θ < π) and φ ∈ (0 ≤ φ < π) are the orientations of the wave vector in the
3D frequency domain and σx,σy,σz define the width of the Gaussian envelope in the x, y and
z axes, respectively. R defines the rotation matrix for transforming the Gaussian envelope to











Figure 3.6: Illustration of how pixel wise features are generated using Gabor (or filters in
general) filters. On the far left there is a toy image with four pixels. Ten Gabor filters are applied
and the filtered value for each pixel is put into a 10×1 feature vector. These feature vectors are
then concatenated to form a 4×10 feature matrix for use in a classification/segmentation/etc
task.
Features are typically generated by constructing a filter bank over a range of φ ,θ and F .
The application of a Gabor filter bank to an input image generates a set of filtered images
representing the response of the image to the filter. In order to construct a texture descriptor
from these filtered images a choice must be made between the extraction of local or global
features according to the task at hand. For the purposes of classification, one may wish to:
1. Classify an image as a whole. In this case a global feature or set of features is required:
A first order statistic or several statistics of each filtered image are calculated and used
as the texture descriptors - the energy is usually the statistic of choice, though less
frequently the mean and variance are used. This results in a total number of features
equal to the product of the number of filters and the number of statistics. In Chapter 5
this approach was chosen, using the energy as the feature as it measures the amount of
information in the image at the given scale and direction determined by the filter.
2. Or to classify sub-regions of an image for segmentation/retrieval. In this case a local
feature or set of features is required: Local descriptors can be generated for each pixel in
the original image by concatenating the value of the pixels in each of the filtered images
into a feature vector. This generates a feature vector at each location in the original
image, whose length is the number of filters in the filter bank.
Gabor filters have seen widespread use in image processing (medical and otherwise) tasks
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including: image registration [21, 69, 98] segmentation and classification [27, 28, 37, 57, 68,
78, 87, 99, 117], content based image retrieval [3, 6, 77, 83, 120] and motion tracking [52].
3.10 Local Binary Pattern
Local binary patterns [79] (LBP) offer another statistical measure of texture. A local binary
operator is applied to each pixel in the image to convert the pixel to a binary number. The
operator takes a central pixel and its neighbours, the neighbours are thresholded and set to 0
if their value is less than that of the central pixel and set to 1 if higher than the central pixel.
These neighbours are then transversed in a clockwise fashion and concatenated to form a binary
number. This binary number, or its decimal conversion, is assigned to the central pixel. This
results in the generation of a new image made up of the binary numbers. This operator can be
extended and made multi-resolution by changing the radius of the neighbours used. However
when the radius (R) is increased, the number of pixels also increases and so it is necessary to
limit the number of neighbours on the circle to a smaller number of equally spaced points (P).








1, if x≥ 00, otherwise (3.12)
This operator is grey scale (or illumination) independent because it measures how texture is
varying in relation to the grey level value of the central pixel.
At this point the LBP operator is both sensitive to the orientation of texture and the choice of
which neighbour to start with when assigning the binary bits. In order to make the operator
rotationally invariant a bit wise right shift is applied to the LBP numbers (this is equivalent to
circularly shifting the numbers, while maintaining their order) until we find the sequence with
the lowest value.
In order to generate a set of features for use in a classification or segmentation task, a histogram
of the binary patterns is calculated over a local region around each pixel in the image. The
values of each bin in the histogram may be used as features or a dissimilarity measure between
histograms may be used to segment an image. The histograms are calculated to extract more
information surrounding the pixel than the size of the LBP neighbourhood.
Uniform patterns [80] are another extension to LBPs which involve the observation that the
majority of texture patterns have a small number of transitions from 0 to 1. A pattern is defined
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The histogram is then calculated, as described above, for LBPriu2R,P and features are generated
accordingly. As there are small numbers non-uniform patterns in most images, which could
lead to under sampling of these bins in the LBP histogram, the grouping of all these patterns
into a single miscellaneous bin helps to mitigate against this. The uniform pattern operator also
brings with it an increased rotational invariance and an increased noise insensitivity (uniform
patterns are some times called “stable” patterns).
Another feature that may be computed is a measure of the local contrast [118] which is other-
















This measure is complementary to the LBPriu2R,P operator and so these features may be combined
to improve texture description and discriminatory power.
The extension of LBP to 3D is a simple one that involves redefining the neighbourhood from a
circle of radius r to a sphere of radius r and sampling equally spaced points on the surface of the
sphere. This modification is similar to the GLSZM and Gabor methods in that it can be thought
of as a natural extension to 3D because only the neighbourhood metric must be changed.
However this technique will still suffer from ignoring pixels at larger distances, primarily
due to memory constraints. An efficient FFT based implementation of 3D LBP computation
has also been developed [40]. LBP methods have seen extensive usage in the literature and
are a valuable tool for analysing texture - they are conceptually simple but have significant
discriminatory power. However the main disadvantage is that the radius and the number of
points on the circle/sphere require optimisation for a given task.
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3.11 Summary
Texture is a concept with a broad scope and many definitions depending on the field in question.
In this chapter we have introduced the subject and argued for a narrower definition in the current
context. The notion of texture in volumetric data has been explored and an introduction to the
applications of various texture analysis methods has been presented alongside the theory behind
a number of techniques that are later used in Chapters 5 and 6. In summary texture analysis is a
powerful tool with many wide ranging applications. Texture is an important tool in the toolbox
for those interested in the field of medical image analysis and should continue to provide further
avenues for research and development of novel methods and techniques to make better use of
the increasing amount of imaging data that is acquired in the modern hopsital.
Chapter 4
Machine Learning and Medical Image
Analysis
“Machine Learning: Field of study that gives computers the ability to learn with-
out being explicitly programmed.” - Arthur Samuel (1959)
“A computer program is said to learn from experience E with respect to some task
T and some performance measure P, if its performance on T, as measured by P,
improves with experience E.” [75]
4.1 Introduction
Machine learning is a broad and developing field that is a confluence of developments in statisti-
cal theories and computer science. The statistical problem was conceived as “what information
can be extracted from a set of data when using particular modelling assumptions”, whilst the
computer science question was concerned with building machines that can solve problems
and with the determination of which problems were tractable [76]. Machine learning seeks to
answer both of these questions and also the implementation of systems and algorithms that
allow a computer to represent data sets and build a generalised model capable of predicting
an outcome from previously unseen samples. There are many different applications of machine
learning in use today including voice recognition, computer vision, news aggregation, self driv-
ing cars, recommendation systems and medical diagnosis. This is a rapidly growing field that
will undoubtedly change greatly in the coming decades, especially given the ever increasingly
widespread data acquisition and storage facilities made available by recent advancements in
and the relative ubiquity of computing technology.
The rest of this chapter will further explicate the field of machine learning with a description of
applications, focussing on the field of medical image analysis. Section 4.2 presents a taxonomy
of learning techniques. Various supervised learning methods are presented in Section 4.3 and
finally the chapter is completed with some discussions of feature preprocessing, performance
evaluation and training strategies.
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4.2 Taxonomy of Approaches
Machine learning algorithms can be divided into clear categories based on the learning style
they use. Categorisation by the underlying algorithm involved is another complementary di-
vision of machine learning algorithms, though it can be more ambiguous as some techniques
may fit into more than one category. The division outlined below is robust, if rather broad.
4.2.1 Supervised Learning
Supervised learning methods operate on a set of samples for which both features and known
class labels are available. This means that the learning algorithm must find a way to represent a
relation between the features and the class labels while maintaining a level of generalisation so
that the model is capable of also predicting on previously unseen samples. Supervised learning
methods can be used for classification tasks where a discrete label is to be predicted or for
regression tasks where a continuous variable is the desired output. Examples of supervised
learning in action include handwriting and optical character recognition [70], email spam
detectors [11] and tissue classification [115]. More details of some supervised learning methods
that have been used in Chapters 5 and 6 are explained later in Section 4.3.
4.2.2 Unsupervised Learning
In contrast to supervised learning, unsupervised learning does not require any correct labels for
the learning step. This is advantageous as the acquisition of features may be cheap while the
acquisition of correct labels is expensive. For example, it can be cheap and easy to calculate
texture features on a CT scan, but it is a time consuming task for a clinician to outline all
the organs and any disease present on an image. Another example of unsupervised learning
can be seen in the use of clustering algorithms to serve similar news articles together within
news aggregators. Some unsupervised methods, like the K-means algorithm [71] require, the
number of classes to be provided. This must be determined by prior domain knowledge or
by trial and error. Other unsupervised methods are capable of inferring the number of classes
or clusters to use, an example of one of these algorithms is DBSCAN (Density-based spatial
clustering of applications with noise) [39]: another clustering algorithm which views clusters
as areas of high density separated by areas of low density. Other types of unsupervised learning
methods include Gaussian mixture models, manifold learning methods and matrix factorization
approaches[51]. PCA, which will be described later in terms of feature preprocessing, can also
be considered an unsupervised learning technique.
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4.2.3 Semi-Supervised Learning
Semi-supervised learning methods have been developed to take advantage of situations where
there are is a mixture of labelled and unlabelled data available. The structure of unlabelled
data can allow a better and more generalised decision boundary to be formed (and over fitting
avoided) than when only labelled data is used. An example of a semi-supervised algorithm is
the transductive support vector machine (t-SVM) [8] which aims to draw a decision boundary
that maximises the margin over all the unlabelled data by way of an additional loss function
for the unlabelled data, more details of the SVM algorithm are presented in Section 4.3.2.
4.2.4 Reinforcement Learning
Reinforcement learning [105] is a technique used particularly in the field of robotics where
a programme is designed to learn behaviour as it is exposed to penalties and rewards in the
surrounding environment. As such there are no class labels or continuous variables to predict,
rather the aim is to achieve certain goals. Google’s self-driving car utilises an A* search
algorithm and reinforcement learning in the planning stages of a drive.
4.3 Supervised Classification Models
The remainder of this chapter focuses on supervised learning methods as they are the most
appropriate for the class of problems that are tackled in this work (see Chapters 5 and 6), where
ground truth class labels are available. Focus will only be given to classification models and not
regression. Issues involving model complexity and bias-variance trade-offs will be discussed in
Section 4.6. The main advantage of supervised learning methods is the ability for an algorithm
to correct itself by punishing wrong predictions. The disadvantages of supervised learning
methods lie in the collection of labels: a learned model can only be as good as the reliability of
the class labels which may be costly to acquire in many scenarios. For example, in the medical
field, it can be time consuming for a clinician to outline regions on a CT scan (which provides
class labels for each pixel/voxel), additionally there is no guarantee that regions are outlined
correctly - this will introduce incorrect class labels, introducing noise at the training, cross
validation and testing steps of a classification regime.
4.3.1 k-Nearest Neighbours
k-nearest neighbours (kNN) is an instance based approach that holds all the samples in an
optimised data structure. Predictions on new samples are carried out by finding the nearest k
neighbours and assigning a class label based on a majority vote of the neighbours. kNN is a non-
generalising model because it simply holds all the training data in memory for classification.
k must be chosen beforehand: varying values of k will affect the performance of the algorithm
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and so this may be tuned by cross validation. (An odd k is obviously desirable to prevent tied
votes.) As k increases the classifier is less susceptible to noise in the data but will result in
a smoother decision boundary. Any distance metric can also be used, though the Euclidean
distance is most common. For a binary classification task (class labels y = [−1,1]), once the
training examples have been sorted according to their distance from the sample to be classified,






This formula can be easily extended to a multi-class problem.
The non-parametric nature of kNN allows it to easily represent very complicated decision
boundaries, which is one of the reasons why it remains a successful algorithm, despite its
simplicity.
Variations of kNN include using a radius (rNN) instead of a fixed number of points when
finding the neighbours of a sample. This allows for more votes to be taken in high sample
density areas and prevents neighbours that are a long distance away from making contributions
to the classification for samples in low density areas. Another variation is to weight the votes
according to their distance from the sample to be classified, where the predicted classification






kNN performance suffers as the number of features increases because the number of dimen-
sions in which the distance metric is calculated necessarily increases. This is an example of
the so called “curse of dimensionality”: as the number of dimensions increases, the distance
metric between points decreases: consider the Euclidean distance for two points separated by
unit distance in each dimension is given by (1+ 1)
1
2 = 1.414 in 2D, by (5)(
1
5 ) = 1.38 in 5D
and by (1000)(
1
1000 ) = 1.01 in 1000D. This results in all points in higher dimensional space
appearing to be “near” each other - rendering the kNN approach nearly useless. However,
kNN has been used successfully in many arenas including gene expression analysis [84], face
recognition [106] and breast cancer detection [2].
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4.3.2 Support Vector Machine
The support vector machine [29] is a model based algorithm. Unlike kNN there is a distinct
model training step and this model is then later used for classification. SVMs have proven
popular in the last 20 years and as a result they are well understood and there are several mature
open source implementations available. SVMs are formulated for the binary classification task,
though they have been extended to multi-class problems by using one-vs-one or one-vs-all
strategies and there are also extensions of the SVM to regression problems. In addition to the
training step, a cross validation step is usually used with SVMs to tune one or more hyper-
parameters of the model.
The SVM is a development of the support vector classifier (SVC) which itself is a generalisa-
tion of the maximal margin classifier: the rest of this section will explain how a SVM functions,
beginning with the maximal margin classifier.
A hyperplane is a flat subspace, that is not required to pass through the origin, of one less
dimension than the space in which it is present. That is, a hyperplane in 2D is a line and in 3D





βiXi = 0 (4.3)
If a point X = (X0, ...,Xp)T does not satisfy this equation, then the function on the left hand side
will have either a positive or a negative value, that is the hyperplane partitions a p dimensional
space into two segments. A hyperplane can then be used as a classifier by partitioning a space
into two segments: an observation, x, can be tested by determining





and the magnitude of the right hand expression will give a measure of the confidence of a label.
The closer an observation is to the hyperplane, the less confidence about the class label.
However for a perfectly separable data set there are an infinite number of hyperplanes which
separate the classes. The obvious choice of hyperplanes is the one that is furthest away from







βiXi = 1, (4.5b)
yi(β0 +β1xi1 + ...+β1xi1)≥M ∀ i = 1, ... , n (4.5c)
Equations 4.5b and 4.5c constrain the hyperplane such that each point is on the correct side
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and at least a distance, M, away from it. Not all the training points determine the position of the
hyperplane, only the samples that are closest to the hyperplane determine the margin, any other
training sample is free to move as long as it does not cross the margin or the hyperplane. These
training samples that determine the hyperplane’s position are said to support the hyperplane.
The maximum margin classifier breaks down when no separating hyperplane exists - in order
to treat this case the concept of a soft margin must be added. A soft margin allows for a number
of training points to be within the margin or even on the wrong side of the hyperplane in order
to better classify most of the training data and to make the model more robust to variations in
individual training instances - this is the essence of the SVC. There is a parameter, C, in the
SVC that controls the number of and the severity of violations of the margin. This parameter is
usually tuned using cross validation. A high value of C will allow many violations and hence
be a softer fit to the data than a lower value of C would permit. In a fashion similar to the
maximal margin classifier, only the samples that lie on the margin or within the margin affect







βiXi = 1, (4.6b)






The SVC only supports linear classification boundaries and one way to overcome this limitation
is to calculate new features from the original ones and use these for classification. For example
using the square of each feature in addition to the original features. This allows for the creation
of non-linear decision boundaries in the original feature space with the trade-off of a very quick
increase in computational complexity as the overall number of features rises as higher order
polynomials are used or other interactions between features are taken into account. An SVM,
however, uses a kernel function to allow for a non-linear class boundary without a large increase
in computational complexity. This is achieved by observing that the SVC can be calculated in
terms of the inner products of feature vectors, rather than the vectors themselves, which allows
for the replacement of the inner product with a generalisation of the inner product: a kernel.
By using a polynomial kernel an SVC is fitted in higher dimensional space than in the original
feature space; the combination of an SVC and a kernel is an SVM.
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Figure 4.1: Support vector classifier hyperplane separation. This figure shows, diagrammati-
cally, the optimisation problem in Equation 4.6.
(d and γ) that must be tuned, typically by cross validation.
The main advantage of the SVM is that it allows for the fitting of a classification boundary in
a higher dimensional feature space than that represented by the training data, indeed the kernel
trick enables the calculation in some feature spaces which would otherwise be intractable due
to the computational requirements if attempted without the kernel parametrisation.
SVMs were initially thought to be a completely new class of machine learning methods,
however, subsequent research has demonstrated a close connection between SVMs and logistic
regression methods due to the similarities of the loss functions that are minimised by the
models. As mentioned above, SVMs have been extended to multi-class problems, regression
and semi-supervised learning problems. The SVM continues to be a popular machine learning
technique and should remain so given that it is well understood, performs well on a range
of data sets and because there a number of popular libraries implementing the algorithm.
Some examples of its use are for liver disease discrimination [68], hyperspectral image clas-
sification [108], breast cancer detection [19], facial recognition [49] and the use of SVMs as
components of deep learning frameworks [107].





A Naive Bayes Classifier (NBC) is based on Bayes’ theorem (Eq. 4.7) and the assumption that
all features are independent of each other. This is almost always a poor assumption (hence
“naive”), but the NBC can still demonstrate good performance even when this assumption is
unjustified. An NBC is also easy to implement and computationally inexpensive, making it
attractive for a variety of applications [11].
The NBC is formulated as follows. Given C j are class labels and xi are the features:
P(C j|x1, . . . ,xn) =
P(C j)P(x1, . . . ,xn|y)
P(x1, . . . ,xn)
(4.8)
The assumption of independence gives:
∀i : P(xi|C j,x1, . . . ,xi−1,xi+1, . . . ,xn) = P(xi|C j) (4.9)
That is, the probability of a feature taking a value given a class label is not dependent on the
value of the other features.
Equation 4.8 then becomes:
P(C j|x1, . . . ,xn) =
P(C j)∏ni=1 P(xi|C j)
P(x1, . . . ,xn)
(4.10)
Since the denominator is constant for a given input:













Different NBCs can be constructed by varying the distribution used to model P(xi|C j).
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4.3.4 Decision Trees
Decision trees are a model based supervised learning method that partitions the feature space
by binary recursion: the feature space is split in two over and over again at the training stage.
This generates a tree which is traversed in order to test a sample. Decision trees are capable of
regression, multi-class classification, can make use of numerical and categorical features and
are able to handle missing values. The rest of this section focuses on classification decision
trees and binary classification problems, though the modifications to regression/multi-class are
trivial.
A decision tree is constructed by splitting the training set into two groups according to a single
feature. Each feature is used to split the classes into regions and the split that minimises the
impurity is chosen. This creates two new “leaf nodes” which are also split in the same fashion
as the first node and this process is repeated until one of the stopping criteria is reached. The
impurity is a measure of the number of each class correctly partitioned by the decision made at
each node, one measure could be the classification error but this performs poorly and so either
the “Gini impurity” or the “cross entropy” are used:
Gini H(Xm) = ∑
k
pmk(1− pmk) (4.13a)
Cross-Entropy H(Xm) = ∑
k
pmklog(pmk) (4.13b)
where pmk = 1Nm ∑xi∈Rm
I(yi = k) for a node m, representing a region in the feature space R with
Nm samples.
The stopping criteria are a set of hyper-parameters that must be chosen prior to training:
• maximum depth of nodes permitted in the tree: high values will lead to over fitting while
low values may prevent the tree from obtaining sufficient complexity,
• minimum samples per split: the minimum number of samples required to split a node,
high values will prevent small numbers of samples from skewing the model,
• minimum samples per leaf: the minimum number of samples required to form a new
leaf, again high values should prevent over fitting,
• maximum leaf nodes: this is usually used instead of maximum depth and controls the
overall size of the tree rather than the depth.
Decision trees have many advantages; they are easy to understand, conceptually easy to explain
and it is believed that they may more closely reflect human decision making processes. In
addition it is easy to visualise a decision tree as a flow chart which exposes the importance
of each feature at each stage and so a decision tree is a “white box” model - it is transparent
(unlike, for example, artificial neural networks). Decision trees are also capable of handling
missing values. If a test case is missing a value, both branches of a node are traversed and the
predicted probabilities are used to choose the more likely label. Categorical and numerical data
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are both first class citizens in decision trees - qualitative features do not have to be converted
to a numerical scale to be used as a decision tree can split using categorical data in the same
fashion as numerical data.
However decision trees also have significant disadvantages - they tend to over fit problems
easily and do not generalise well and it is for this reason that they can be very unstable - small
changes in a training set can generate a very different looking decision tree. These problems
can be mitigated against and overcome by the use of bagging (Section 4.3.4), Random Forests
(Section 4.3.5) or Boosting (Section 4.3.6). Even with these advances, decision trees have some
disadvantages. For example, finding the optimal decision tree is a NP-complete and so a greedy
algorithm (binary recursion) must be used to build the tree. Some concepts such as XOR can
be difficult for a decision tree to learn as it is not well represented by a tree. A decision tree is
susceptible to bias if the training set is heavily biased towards one class - this can be seen by
inspecting the impurity measures above. Despite these disadvantages, decision trees are useful
learners, especially in their use as “weak learners” as the basis for more complicated learning
algorithms like AdaBoost.
Bagging
Tree bagging [15] averages the predictions of many decision trees in order to reduce the vari-
ance of the trained model, which should allow for more stability and more generalisation. This
averaging would ideally be done on a number of different training sets, but data is expensive
to collect, so a single training set is instead sub-sampled and each sub-sample is used to train
a decision tree. Thousands of trees may be constructed and bagged. Each tree will have a very
high variance and a low bias, but the averaging over the trees lowers the overall variance again.
When doing classification the bagged trees are averaged by taking the majority vote of the tree
or by averaging over the probabilistic prediction of each tree, in order to form a single predictor.
One benefit of bagging is that the number of trees is not a crucial parameter as the model will
not over fit with large numbers of trees. Very large numbers of trees may be used: the only
constraint on the number of trees is that enough trees have been used to ensure that the error
rate has stabilised. The main disadvantage of bagging is that it obscures the importance of each
feature that is so easily available when using a single tree - it is no longer possible to display
a single, interpretable, tree. One way around this problem is to measure the feature importance
by finding the total decrease in impurity over all the splits caused by each feature, averaged
over all the bagged trees.
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4.3.5 Random Forests
A disadvantage of bagging trees is that they will be highly correlated, as the same features
are used for training each tree. This is because the sampling is only performed on training
examples, not on the features. If there is one particularly dominant feature, then this feature
will almost always be the first used to split the first node and from there the generated trees
will all look similar - the particular values used for splitting may change, but the features used
to split remain similar across trees. Averaging over a large number of similar (correlated) trees
does not decrease the variance as much as averaging over dissimilar (decorrelated) trees.
In order to overcome this problem, a random forest [16] of trees is created by a similar approach
to bagging, but instead of choosing to use all the features for training each tree, only a subset
of features is used at a time. A number of features are chosen randomly and used to train each
tree. This removes any strong predictors from a number of the trees allowing other features to
be considered for the first split which may radically alter the structure of the tree. The same
processes of casting a majority vote from the trees or averaging the probabilistic prediction of
each tree can be used to determine the predicted label from the random forest. If there are a
total of n features available, then each decision tree in the forest is usually trained with
√
n
features, though any number of features (< n) can be chosen.
The main advantage of random forests over decision trees is the increased performance by the
reduction in variance, with a small increase in the bias (compared with an individual tree).
However just like the bagging method, the random forest obscures the importance of features,
although the feature importance method described above can again be used to gain an indication
of the most significant features. Additionally, over fitting is still a danger with the random forest
if the individual trees are too complex.
4.3.6 Boosting
Boosting is another method for improving the performance of decision trees, though it can be
used with almost any weak learner to improve classification performance. For example, a series
of kNN classifiers could be used as a set of weak learners. For the sake of discussion the rest
of this section will assume that decision trees are the weak learners used.
A weak learner is a classifier that achieves a misclassification rate less than 50% but does
not otherwise provide satisfactory performance. Instead of creating a forest of independent
trees like the random forest classifier, it is possible to use the predictions of previous trees to
help train subsequent trees. The first practical algorithm that was able to achieve this boosting
was the “AdaBoost” algorithm (Adaptive Boosting) [43, 44]. AdaBoost works by training a
weak learner on the training set and up-weighting incorrectly classified samples while down-
weighting correctly classified samples. This leads to previous misclassified (harder) samples
being given greater focus in subsequent training rounds. AdaBoost trains trees sequentially
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while the random forest trains trees in parallel, this typically allows for the use of smaller
trees as AdaBoost enables trees to cooperate. Once the AdaBoost model is built, predictions
are made in the same manner as the random forest. There are two parameters, in addition to
any parameters for the weak learners, that must be tuned when using AdaBoost: the number
of learners to use and the learning rate. The learning rate is a value ≤ 1 that reduces the
contribution of the classifier at each learning step when building the model.
One of the main advantages of AdaBoost comes from the fact that it is simpler to design a weak
learner, a weak learner only needs to be right most of the time rather than achieve some higher
performance demands. Therefore, it is possible to design a weak learner and use AdaBoost with
it rather than putting effort and time into developing a strong learner. One of the problems with
AdaBoost is that it also obscures relative feature importance, though if many decision stumps
(trees that only make one decision) are used it is possible to determine which features are
important. Remarkably, a large number of these very weak learners are capable of performing
well on a number of data sets.
4.4 Feature Preprocessing
Many complications arise when dealing with real world data sets. Typically there may be
an abundance of features, these features may be highly correlated, there may be many noisy
features present in a data set and some features may be numerical and some categorical. Some
features may have missing values and some features may be several orders of magnitude
larger than others. Each of these situations can be problematic depending on the machine
learning algorithm used: for example, an over abundance of features can lead to the “curse of
dimensionality”. However a range of techniques have been developed to solve these problems.
Categorical data can be used by some learning algorithms (decision trees) but not others (SVMs).
In order to make use of what can be valuable information contained in categorical variables it
is possible to convert categorical data to a numerical scale. For instance, whether a person is a
smoker or not can be converted to a binary value, which allows a model like the SVM to make
use of this information. Yet this becomes more complicated if the categorical feature cannot be
represented as a binary. To return to the smoking example, if it is desirable to capture whether






but this is a rather arbitrary approach. How much separation should there be in the feature
space? Should current smoker have a value of 5 instead of 2? Despite these problems it is still
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beneficial to convert categorical data to a numerical representation rather than discarding the
information. Another approach is to create a binary variable for each option (never smoked,
former smoker and current smoker) as this removes the question about how the categories
should be scaled, but this can generate a very large number of features if there are many
different categories for each variable.
Data acquisition can result in missing values for some features. The most common solution to
this problem is to calculate the mean of the feature over the remaining samples and use this in
place of the missing data, hoping that the model is still able to correctly classify this sample
using the other remaining features that were correctly collected.
Different features can often vary widely in their absolute values: one feature may have a
range of −0.1 ≤ f1 ≤ 2.3 while another may lie in the range 0 ≤ f2 ≤ 10000. This can be
problematic for algorithms like kNN or SVMs that use the distance between samples since
a change in f2 would dominate almost any change in f1. To overcome this problem features
can be scaled or normalised. Scaling features involves converting all the features so that they
lie in the same range, typically 0 ≤ f ≤ 1 or −1 ≤ f ≤ 1 while normalised features are
calculated by subtracting the mean and dividing by the variance of the feature vector to ensure
that all the features have zero mean and unit variance. This means that all features are now
equally weighted in the feature space and any relatively large changes in one feature will not
inappropriately dominate the distance metric.
4.4.1 Feature Selection and Reduction
Problems with missing values and different scaled features are relatively easy to overcome, as
explained above. A much more difficult problem arises when the number of features is large
compared to the number of samples, especially if some of these features are redundant or noisy.
Redundant features can suppress other, less abundant, features in the data and compromise
performance. Noisy features can lead to a higher risk of over fitting as they may cause a
model to be built upon chance correlations between the features and the labels - the chance
of these correlations occurring obviously rises with the dimensionality of the feature space.
Adding more features to a classifier, unless they are correlated with the class labels, will
degrade performance. This is why feature selection or reduction methods are a key part of
any machine learning pipeline. There are two solutions to this problem: feature selection and
feature reduction. The former chooses a subset of the features to be used in the model while
the latter combines the features into a smaller number of new features.
A simple feature selection technique is to perform univariate classification with each of the
features, then take the top performers and use them in a multivariate model. The main issue
with this approach is that it completely discards any interactions between features: a pair of
features may be capable of separating two classes while neither of the individual features can.
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Figure 4.2: This figure demonstrates how a pair of variables may be unable to separate two
classes when they are considered in a univariate fashion. The plots along the bottom and
left hand side show the features considered individually, note how there is a large overlap
in the classes (represented by the different markers). However when the two variables are
considered together, as seen in the main plot, a clear decision boundary can be overlaid (the
green line).
Exhaustively searching all the combinations of features will take an infeasible amount of time
on real data and so other methods for feature selection have been developed, such as adaptive
selection methods like sequential floating forward feature selection [101], mutual information
based measures like minimum redundancy maximum relevance [86] and the least absolute
shrinkage and selection operator [111].
Feature reduction methods, on the other hand seek to create a new set of features from the
original features. The most common feature reduction method is principal component analysis
(PCA) which linearly combines the features into a new set of orthogonal features of decreasing
variance. These new features minimise the redundancy, measured by the covariance of features,
and maximise the true signal in the data as measured by the variance. PCA can be efficiently
computed by use of the SVD operator. In order to generate the reduced feature set the covari-





where X is the feature matrix with n features and m samples. The eigenvectors, U, of Σ are then
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calculated and the new feature matrix, Z, is generated according to
Z = XU (4.15)
The first x desired features are then retained by truncating number of columns in the new
feature matrix, x can be chosen so a number of features are retained or so that a portion of the
original variance is retained by the new data set. PCA is a non-parametric method - there are
no parameters to tune, the method is applicable to any feature matrix and it is a good choice
for removing correlation between features. There are two main problems with PCA a) it is
grounded on the assumption that features with high variance are good predictors and so the
new features, while capturing the variance of the data, may not provide good classification
performance and b) PCA assumes a linear relationship between features, though this can be
superseded by using kernel PCA which makes use of a kernel trick, however this requires
a priori knowledge of the feature space in order to choose a suitable kernel. Other feature
reduction methods exist, including independent component analysis, Sammon mapping and
non-negative matrix factorisation [104].
4.5 Classification Performance Evaluation
There are a variety of methods to measure the performance of a learning algorithmi. The most
basic and obvious method is the accuracy:
accuracy =
number of incorrect classifications
number of test samples
(4.16)
however this measure very quickly breaks down when the number of each class is unbalanced.
Take, for example, a problem with 1000 test samples, 990 of which are “dogs” and 10 are
“cats”. If our classifier assigns every test case the label “dog” then the accuracy is 0.99 -
indicating that the classifier seems to be performing well. Yet it will never get the “cat” samples
correct. In order to properly measure the performance other metrics have been devised that are
i. This section will focus on binary classification tasks.
4.5. Classification Performance Evaluation 67















T P+T N +FP+FN
(4.17d)




where T P = the number of true positives, T N = true negatives, FP = false positives and FN =
false negatives. (A true positive, for example, is when the true label and the predicted label are
both positive.) These summary statistics allow for the assessment of a classifier on a data set
even if it is unbalanced, it is best to make use of several of these measures when assessing the
performance of a classifier as edge cases like the example above can still be masked even with
these statistics. The number of TP, TN, FP and FNs are nearly always a good indicator of the
performance - these can be summarised in the form of a confusion matrix, an example of which







TP = 50 FN = 50
FP = 50 TN = 1000
Table 4.3: An example confusion matrix. Two views of the same confusion matrix for a
toy classification case. This matrix shows the need for careful examination of classification
performance when looking at unbalanced data. The accuracy of this classifier is 91% even
though it only has a precision and recall of 50%.
4.5.1 ROC and PRC
Instead of using the the stationary sensitivity and specificity of a classifier a, “Receiver Op-
erator Curve” (ROC) can be constructed that gives a better indication of the model perfor-
mance. A ROC is a plot of the false positive rate (1− Specificity) against the true positive
rate (Sensitivity). In order to generate the data for the plot the classifier must be capable of
returning a probabilistic prediction (or a score of some sort). This probabilistic prediction
is then thresholded at different levels producing different sets of class labels for which the
sensitivity and specificity are calculated in order to generate a series of points to plot in the
ROC space. The ROC then allows for the examination of the trade-off between sensitivity
and specificity. An example of several ROCs can be seen in Figure 4.4. The dashed line
from (0,0) to (1,1) represents the performance by guessing the class randomly and better
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performing classifiers are represented by curves in the top left of the plot as they are capable
of maintaining a high sensitivity and specificity simultaneously. An additional measure of a
classifiers performance naturally drops out of the ROC: the area under the curve. The larger
the area under the curve, the better the classifier with a value of 1 being a perfect learner and a
value of 0.5 being equivalent to random guessing.
A similar approach may be taken with the precision and recall scores achieved by a classifier,
but now curves in the top right section of the plot are high performing classifiers. The area
under precision recall curves is another good measure of the performance of a classifier.
Figure 4.4: Left: Two examples of Receiver Operator Curves, the green curve represents
a superior classifier than the blue curve. Right: Two examples of Precision Recall Curves
corresponding to the same classifiers as the Receiver Operator Curves in the left hand plot.
4.5.2 Bias-Variance Trade-Off
Model complexity is a very important property when trying to build a classifier. Naïvely one
would expect that reducing the training error will always generate a better model, yet Figure 4.5
demonstrates that a reduction in the training error may lead to an increase in the error on an
unseen test set. This is described as over fitting the model or having a model with high variance.
The model is well fitted to the training data but is not well generalised to properly predict new
data.
Many classifiers have parameters that can tune the model complexity - for kNN it is k, for
SVMs it is C and for trees it is the parameters that control the size and depth of the tree. These
parameters must be chosen to optimise the bias-variance trade-off. It has already been shown
that a “high variance - low bias” scenario will lead to poor results but a “low variance - high
bias” model will result in a model that is under fit: it will not be sufficiently complex and will
perform poorly on test data. In order to find the optimal variance/bias trade-off another set of
data is usually used: the cross validation set. In a situation where there is an abundance of data
the validation set approach can be used, otherwise k-fold validation is another viable method.
These techniques are described in Section 4.6.









Figure 4.5: This graph displays the trade off between bias variance and the pitfalls of ever
increasing model complexity. At the far left hand side the model is not complex enough to
capture the variance in the data - prediction error is poor for both sets. On the far right hand
side the model performs very well on the training set, but poorly on the test set as it has over
fit the training set. There is a minimum in the test set error where the model is sophisticated
enough to perform well on the training and test sets - this is the optimal balance between bias
and variance of a model.
4.6 Training and Cross Validation Strategies
In order to train a model and to verify its performance, there are a range of different methods
that can be employed, the suitability of each depending upon the size and nature of the data set.
Some of the most common methods and some related concerns are addressed in this section.
Only binary classification tasks will be considered, though many of the methods can be used
for multi-class problems.
4.6.1 Balanced Training
Some learning algorithms such as decision trees and SVMs are susceptible to bias from uneven
numbers of samples of each class in the data set. For example, if there are a large number of
positive samples, then the classifier can be overwhelmed and always predict a positive label.
This susceptibility to a unbalanced training set can be overcome by training with a balanced
subset of the data which is created by using all the samples from the less common class label
and an equal number of randomly selected samples from the other, more common class label.
This proves to be an effective method for training although it can discard a significant number
of training samples. Care must also be taken when measuring the performance when dealing
with unbalanced data sets - this is explained in more detail in Section 4.5.
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4.6.2 Validation Set
Perhaps the simplest manner in which a model can be trained and tested is by the use of a
validation set by which the data set is split into two: a training set and a test set. The learning
model is then trained on the training set, and the test set is used to measure the performance
of the model on unseen data. A typical split would be 70% training, 30% testing. If the
learning model requires a cross validation set, then the data set can be split according to a
70% training, 20% cross validation and 10% testing split. The main problem with this method
is that performance can vary widely according to which samples are used for training and which
are used for testing. It also fails to efficiently make use of the available data - each sample is
used only once for training or for testing.
4.6.3 Leave One Out
Leave one out cross validation is a step up from the validation set approach: instead of splitting
the data into a training set and a test set, only a single case is removed to form the test set, the
model is then trained with the training set and used to predict a label for this test case. This test
case is then returned to the data set and the next sample is set aside to be used as the test case,
this process is repeated until each of the samples have been used as the test case. This allows
every sample to be used for testing and ensures that as much of the data as possible is used
for training. An obvious disadvantage of this method is that many models are trained which
can take a long time on a large data set. As such, this method is ideal when there are a small
number of cases: computation time is not increased dramatically and the small amount of data
is fully exploited.
Leave x Out
This method is identical to the leave one out approach above but x cases are set aside to form
the test set. For n training samples, this creates n!x!(n−x)! (overlapping) pairs of test sets.
Leave One Label Out
In order to perform leave one label out validation, an additional label - not the class labels -
must be assigned to each sample. This could be date or time information or perhaps gender.
For example, taking the “year” as the extra label, all samples for year 1 would be assigned to
the test set and training is carried out on the rest of the samples before testing on the test set
and repeating for each of the other labels. This method could be useful to track how a model
performs on data from different years, or how a model performs differently on patients with
different stages of disease.
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4.6.4 k-Fold Cross Validation
k-fold cross validation is typically used for larger data sets when model training may take a
significant period of time making leave one out impractical. The data set is split into k, roughly,
equal size groups. For each of these groups a model is trained with the remaining k−1 groups
and testing is performed on the group left out. This generates k measures of the performance,
which are then averaged to provide the k-fold performance. Usually k = 5 or k = 10 to limit the
computational burden. Obviously if k = (number of samples) then this is equivalent to leave
one out validation. Stratified k-fold cross validation is an extension of this method that ensures
that each of the k groups used for training are balanced and must be used with some learning
algorithms.
4.7 Summary
Machine learning is a fast growing area of research due to the large amount of commercial and
academic interest in its theory and applications. It is used extensively in the wider medical field
and particularly in medical imaging. Applications of machine learning and artificial intelligence
will only continue to grow and develop. It is this author’s belief that they will become an
integral part of patient care over the coming years and decades. In particular, the use of machine
learning to aid the interpretation of medical images should reduce the burden and errors caused
by intra- and inter-clinician variability when assessing images.
Chapter 5
Predicting the Occurrence of
Radiation Induced Pneumonitis
5.1 Introduction
As outlined in Section 2.5.4, treatment of lung cancer using radiotherapy can cause radiation
induced pneumonitis in 13-37% of patients. This is a debilitating condition that can be very
serious in already ill patients. There is currently no reliable way to predict whether a particular
patient will develop radiation induced pneumonitis. This chapter uses a cohort of 57 patients to
investigate the feasibility of using features derived from a patients planning CT scan to predict
the occurrence of radiation induced pneumonitis. The rest of this chapter details the data used
(5.2), outlines the method (5.3), describes the features used (5.4) and then presents the results
(5.6), followed by a discussion (5.7).
5.2 Study Data
The data used in this retrospective study consists of radiotherapy planning CT scans and
associated clinical parameters from 83 patients treated at the Edinburgh Cancer Centre, Western
General Hospital between January 2009 and September 2010. Of the 83 patients, 21 were
excluded due to uncertain patient outcome (although all 21 cases were thought to be asymp-
tomatic, the clinician was either unable to determine the outcome or the patient died before a
diagnosis could be made) and a further 5 were excluded due to data processing complications
leaving a total of 57 patients, 14 of which developed radiation induced pneumonitis and 43
remained asymptomatic after radiotherapy. The outcome of each patient was assessed in the
standard post-radiotherapy follow up by an expert clinician familar with each case.
Each of the 57 patients were treated with external beam radiotherapy: 48 on a Varian Clinac
600C/D, 2 on a Varian Clinac iX and 7 on a Varian Clinac 21EX. All radiotherapy plans were
calculated using the Varian Pencil Beam Convolution algorithm (v8.1.2). 32 of the patients
were treated with a 55Gy in 20 fractionation schedule and 15 with a 60Gy in 30 fractionation
schedule, the remaining fractionation schedules, alongside a summary of various radiotherapy
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V20/% 4.0 36.5 23.7
V10/% 5.0 70.0 42.5
V5/% 6.0 80.0 51.2
MLD/Gy 2.3 20.7 14.3
PTV/cm3 87.4 1323.3 463.1
Table 5.1: Left: Summary of the fractionation schemes used in the treatment of patients in this
study. *60/30 was planned but stopped early due to traumatic spinal injury. Right: Summary
of the radiotherapy dose delivered and the size of the PTV. Vx is the volume of lung receiving
at least x Gy.
parameters can be seen in Table 5.1. 3 patients received sequential chemotherapy (2, 3 or 4
cycles of carboplatin/gemcitabine), 16 patients received concurrent chemotherapy (2, 3 or 4
cycles of cisplatin/vinoreline) and 37 of the patients received no chemotherapy. The radiother-
apy planning CT scans were acquired using a 3mm CT slice thickness, (IGE HiSpeed Fx/i, GE
Medical Systems, Milwaukee, WI, USA) resulting in a resolution of approximately 1mm in the
axial plane with a 2048 HU range.
5.3 Methodology Overview
In order to automatically predict whether a patient is likely to develop radiation induced pneu-
monitis during lung cancer treatment a set of texture features are calculated from the radio-
therapy planning CT scan and combined with 13 clinical features into a feature vector for
each patient. PCA is then applied to reduce the dimensionality of the feature space and a
classification model is trained and tested in a leave one out fashion to determine the viability
of this approach.
The full procedure for predicting the outcome for a single patient is:
1. Lung parenchyma is extracted from the planning CT scan,
2. Blood vessels and airways are removed by a simple thresholding technique,
3. The remaining lung volume is then resampled to create an isometric array to compensate
for the 3mm slice thickness,
4. Volume is then scaled to a lower number of grey levels,
5. A number of texture features are calculated from the volume,
6. A feature matrix is created by the concatenation of texture and clinical feature vectors,
7. Classification is performed in a leave one out fashion with an optional PCA step.
It should be noted that the PCA step was carried out outside the leave one out loop for the
SVM classifier. That is, the PCA was applied to the whole feature matrix once before splitting
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Acquire CT Scan Acquire Clincial Parameters
Extract parenchyma
Rescale grey levels
Calculate Texture Features Combine Features Perform Classification
Figure 5.1: Flow chart outlining the main steps in the pipeline for predicting pneumonitis from
lung CT scans.
to do the leave one out classification. This should have a minimal effect on the results as
PCA is an unsupervised method - it is not exposed to the class labels and so there should
not be any inappropriate information “leakage”. (The PCA was implemented outside the loop
to avoid slowing down already extensive execution times.) However, the when the Decision
Tree classifier was used, the PCA step was implemented inside the leave one out loop - that
is, PCA was applied at each step of the leave one out process. (This was possible due to the
much smaller execution times for the Decision Trees compared to the SVM method). The
comparable results between the SVM and the Decison Tree methods provide evidence to back
up the assertion that the PCA outside the loop does not have a large effect on the results.
5.4 Feature Extraction
5.4.1 Clinical Features
There are a number of clinical and dosimetric features that have been shown to be significant
when predicting radiation induced pneumonitis (see Section 2.5.4). 13 such features were
chosen from a much larger set of parameters collected in the course of the normal clinical work
flow for a patient with lung cancer. This had the advantage of not adding an additional burden
to the existing clinical work flow. The 13 features were chosen because of their completeness
across the 83 subjects, that is the vast majority of the subjects had values recorded for each
feature. Additionally, each of the features were easy to convert to a numerical/boolean value in
order to be used as inputs to a classification model (Section 4.4).
The 13 features used were age, smoker/non-smoker, if the patient suffers from asthma or similar
conditions, T-stage, N-stage, if the patient was treated with chemotherapy, the radiotherapy
dose and number of fractions, the V20,V10,V5, MLD and the size of the planning treatment
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volume (PTV). Table 5.2 shows these features and their division into pre-treatment features
and treatment dependent parameters.
Pre-Treatment Treatment Dependent
Age Integer Treated with Chemotherapy [0,1,2]
Smoker/non-smoker [0,0.5,1] Radiotherapy dose Double
COPD Boolean Radiotherapy fractions Integer
T-stage Integer V20 Double
N-stage Integer V10 Double
V5 Double
Mean Lung Dose Double
Size of PTV Double
Table 5.2: A summery of the clinical parameters (and their formats) used as features in the
prediction of radiation induced pneumonitis.
All of the treatment dependent features are numerical, except for the chemotherapy based
feature which was assigned to a ternary scale: 0 for no chemotherapy, 1 for a patient treated
with sequential chemotherapy and 2 when a patient is treated with concurrent chemotherapy.
Age, T-stage and N-stage are also numerical features but smoking history and COPD were
converted from categorical features to a numeric scale. COPD was converted to a binary feature
and smoking history was converted to a ternary scale: 0 for never smoked, 0.5 for ex-smoker
and 1 for current smokers (which is equivalent to [0,1,2] or [−1,0,1].
5.4.2 Texture Features
In order to extract meaningful texture features, the lung parenchyma was extracted from the
CT scans. The lungs on each of the CT scans were automatically segmented using the Varian
Eclipse™ software which is able to extract the outside contour of the lungs. The GTV contour
defined by the clinicians was then used to remove the tumour from the image volume for the
same reason that the bone and blood vessels were removed: the tumour itself does not develop
pneumonitis. In principle this step could also be done automatically as the tumour volume
usually falls into a significantly different grey level range than the parenchyma, however the
clinical volume was used here for simplicity and to focus on the outcome prediction task.
Following the extraction of the lungs, a threshold was applied to the image to remove the ma-
jority of blood vessels, airways and bone, which do not develop pneumonitis and may interfere
with the texture calculation and add noise to the features in the form of unrelated information.
This threshold was determined by manual inspection of the lung volume histograms from a
sample of the patient population (both symptomatic and asymptomatic) and was tuned to ensure
that the maximum amount of parenchyma was retained while removing the majority of other
tissues.
When using 3D texture analysis, best practice requires isomorphic sampling resolution of the
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3D volume. However, the slice thickness of this CT data is 3mm, with a 1mm resolution in the
x- and y-directions. Thus a resampling is required to produce an isometric volume: in order to
keep as much information as possible, the data was upsampled in the z-direction to produce
a pseudo-isomorphic resolution of 1mm. This upsampling was carried out by repeating each
of the slices in the z-direction. An interpolation method could have been used here instead,
but it is believed that this would not have made an appreciable improvement to the feature
matrices. For example, the interpolation would result in a “blurring” effect in the GLCMs. The
upsampling is sufficient as the main aim is to ensure the information present in the z-direction
is not unfairly downweighted due to the increased pixel spacing.
Finally grey level resampling was used to convert the images from 2048 grey levels to a more
manageable 8, 16, 32 or 64 grey level range, this step is required for the statistical texture
measurements used (Sections 3.5-3.8). If this step was omitted, a very sparse GLCM, for
example, would be generated from the 2048 grey level image.
FOS (n=7: mean, variance, coarseness, skew, kurtosis, energy and entropy), GLCM (n=1820:
14 Haralick features in 13 directions over 10 different pixel distances), GLRLM (n=143: 11
features in 13 directions), GLSZM (n=55: 11 features for 5 different connectivity matrices) and
Gabor (n=144: a filter bank constructed using F = [25 : 25 : 100], [θ =−π/3 : π/6 : π/2] and
[φ =−π/3 : π/6 : π/2] was applied to an image and the energy in the filtered result was used as
a feature) features were calculated for each of the rescaled lung volumes, all of these methods
are described in more detail in Chapter 3, all of the calculations were computed using custom
implementations in MATLAB. This procedure resulted in a total of 2162 texture features, in
addition to the 13 clinical features, being available for use in the classification pipeline.
Typical execution timei is in the region of 15-20 minutes per case for all of the texture excluding
the Gabor features and of the order of an hour per case when including the Gabor features.
These times are achieved by use of a vectorised GLCM method and an FFT based Gabor
implementation. This is too slow for a real time application, but for the proposed use case
where texture and classification would be run offline (perhaps overnight) on a clinical system
then these execution times are acceptable - the texture stage is the longest of any with the
preprocessing taking less than a minute and the label prediction stage taking no more than a
few seconds. Further optimisation of the texture calculations is likely possible by translating
the functions to a native implementation or by parallelising portions of the code, for example,
the application of multiple Gabor filters is an “embarrassingly parallel” operation. The classifi-
cation model (training) would only need to be precomputed once and so the time taken for this
computation is largely irrelevant in terms of a real world application.
i. All calculation times recorded on an Intel (R) Xeon (R) 5150 Dual Core CPU @ 2.66Ghz.
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5.4.3 Feature Reduction
Given the highly correlated nature of many of the features (GLCMs calculated in different
directions at different distances, for example) it is desirable to reduce the feature space signif-
icantly. PCA was used (Section 4.4.1) to reduce the redundancy of features by mapping to a
new feature space. The number of eigenvectors (new features) retained was either set to a fixed
number or determined by measuring the amount of variance explained by the new features, that
is, the number of eigenvectors that were retained was the smallest number of eigenvectors that
account for x% of the original variance where, for example, x = [90,95,99].
5.5 Preliminary Analysis
This section consists of a short, preliminary, analysis of the clinical and imaging data to
demonstrate that there is relevant information within the CT data and within the 13 clinical
features that is indicative of the radiation induced pneumonitis outcome and hence warrants
further investigation of the viability of the approach outlined above.
Imaging Data
A simple comparison of the histograms of the HU values (from the CT data) from each patient
group (symptomatic and asymptomatic) was carried out. The results from this can be seen in
Figure 5.2. The figure shows a subtle, but distinct difference between the two groups and after
fitting a probability distribution to the data, a two-tailed Kolmogorov–Smirnov (KS) test found
(at the p = 0.01 level) that the two population samples were drawn from different distributions.
This suggests that there is a distinct difference in the HU distributions in the two different
patient groups and therefore there is information in the CT data that may be exploited to predict
the occurrence of radiation induced pneumonitis.
Further tests were carried out on a per-patient basis in an attempt to use only the probability
distributions to predict the occurrence of radiation induced pneumonitis. KS tests were used
to compare all the cases to each other and to a “global” population distribution. However, no
viable method was found using such a relatively simple approach. Texture analysis methods
are much more capable of extracting information from the CT images than a simple his-
togram/probability distribution approach.
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Figure 5.2: Comparison of the (normalised) histograms of the Hounsfield units for symp-
tomatic and asymptomatic populations. The red histogram was generated from all the HU
values from all 14 symptomatic cases. The blue histogram is a random sampling of all the
HU values from the asymptomatic cases, sampled to ensure an equal amount of data in each
group. The x-axis is HU.
Clinical Data
The 13 clinical features were analysed to determine if any were capable of separating the
classes. Figure 5.3 shows a summary plot of all the features. From these plots it is clear to
see that none of the features are individually capable of separating the classes. However, most
notably, the age at the time of diagnosis displays the most obvious difference between the two
patient groups.
After this analysis, leave one out classification was performed on the 13 clinical parameters.
An SVM classifier performed with 56.6% Sensitivity, 65.7% Specificity and an Area Under
ROC of 0.58. This is poorer performance than reported by Chen et al [22, 23]. This is expected
given that there are far fewer features used in this study (93 compared to 13).
These results are obviously not good enough to predict pneumonitis reliably. This level of
performance is likely due to the small number of features used and perhaps due to the relative
lack (compared with Chen et al [22, 23]., for example) of disease state information encoded
in the features. A possible line of further research could be to include such information from
the patient records. It would be possible to add more clinical features directly related to the
disease such as tumour position or more histological information. However, one advantage of
the limited number of features used is the ease of collection - they are readily collected in the
standard lung cancer treatment pathway without the need for extra tests. As will be seen later,
combining these features with the texture information derived from the imaging data improves
the predictive performance.
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Figure 5.3: Plots showing the variation in clinical parameters between the two classes
(symptomatic and asymptomatic). Box plots have been used for the non-categorical features
and scatter plots have been used for the categorical feature as box plots were found
to collapse and provide misleading results. In each plot the box plot on the left is the
asymptomatic cases (blue in the scatter plots) and the symptomatic cases are on the right
(red in the scatter plots). The plots show that no single feature is capable of separating the
two classes. Note that a small amount of noise has been added to the class labels on the
scatter plots to visualise the density of overlapping points.
5.6 Results
This section presents the results from a variety of methods that were employed to test the
hypothesis that it is possible to use image analysis of radiotherapy planning CT scans to
predict the occurrence of radiation induced pneumonitis. Several different approaches were
undertaken, beginning with the whole lung volume. Subsequent analysis was then performed
on sub-regions of the lung: regions near the GTV and regions defined by the planned dose. The
results in this section demonstrate that all three of these methods are capable of predicting the
occurrence of radiation induced pneumonitis.
Because of the size of the data set (n = 57, nsym = 14, nasym = 43) leave one out classification
was used. If a simple split into a training and test set was employed, there would be very few
symptomatic cases to test with (4 cases, using a typical 70/30 train/test split). However, by
using a leave one out approach it is possible to maximise the data - every case can be used as a
test case and every other case can be used for training (or cross validation). However, the usual
disadvantages with this approach apply: a new model must be trained for each test case.
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A number of classifiers were tested in this work, including a Naive Bayes Classifier (NBC),
Support Vector Machines (SVM), Decision Trees and k-Nearest Neighbours (kNN). The NBC
and kNN classifiers were not capable of reliably predicting the occurrence of radiation induced
pneumonitis on the whole lung data set and so these two classifiers were not used on the
subsequent permutations of the data. With a larger corpus of data, these classifiers may be of use
and should be reconsidered for any real world application of the work presented in this chapter.
Additionally, once it was demonstrated that the Decision Tree performance was, at least on
par with the SVM performance for the whole lung volume data set, the SVM classifier was
dropped from subsequent analysis. This was due to the much faster run time of the Decision
Tree algorithm versus the prohibitively slow SVM - the Decision Tree method provided a
(approximately) 100 times speed up. It should be noted that the SVM was slow, primarily,
because of the cross validation grid search to optimise its internal parameters for each step in
the leave one out process. Pre-calculating these values from the data was not an option as that
would have been “cheating” by using the same data for training and cross-validation.
Other variables in the classification scheme are the number of grey levels the image was
rescaled to before texture calculation (8, 16, 32 or 64) and whether a balanced training set
was used. That is, whether all the available cases (56) were used at each step of the leave one
out training, or if a balanced number of cases were used for training. For example, if the test
case that was removed from the leave one out pool was asymptomatic, then a balanced training
set would consist of all 14 symptomatic cases and 14 randomly sampled asymptomatic cases.
If the test case was a symptomatic case, then 13 cases from each class would form a balanced
training set. The main advantage of a balanced approach is to prevent a more prevalent class
from dominating the training step and impairing the ability of the classifier to train a model that
is capable of representing both classes - a particular problem with Decision Trees. See Section
4.6.1 for more details.
5.6.1 Whole Lung
The obvious first region to calculate texture features from is the whole of the lung volume. The
main advantages of this method are that it requires no further preprocessing and that it will
make use of as much information within the lung tissues as possible.
Initial results using SVMs are presented, followed by subsequent results using Decision Trees.
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SVM
An SVM classifier with a Gaussian kernel was used in a leave one out fashion, with a cross
validation carried out for each fold in order to tune the hyperparameters C (the soft-margin
parameter) and γ (the exponent of the Gaussian). As an unfortunate side-effect of this process
it is much more difficult to ascertain the relative feature importance as the performance of the
features is now obscured by the training of multiple SVMs - one for each case.
In order to determine the best performing set of features, the performance of an SVM was eval-
uated for all combinations of grey levels, of variance retained after PCA, whether a balanced
training set was used and of different combinations of the texture features used. This gives a
large hyperparameter space over which to assess the predictive ability of this approach. A full
list of the different combination of features is laid out in Table 5.3.
Grey Features Balanced PCA Variance
Levels Used Training Retained/%
8 All texture Yes 99
16 All texture with clinical No 95





Table 5.3: Summary of the different hyperparameters for the SVM classification scheme.
The maximum classification performance achieved was: Area Under ROC = 0.873, Sensitivity
= 92%, Specificity = 72%, and Accuracy = 87%. This was achieved by training an SVM with a
balanced training set of all the texture features combined with the clinical features, having used
PCA to retain 95% of the variance explained by the features. This result and the nine next best
combinations (sorted by Area Under ROC) are presented in Table 5.4. The table shows that the
balanced approach is likely to yield better results and so the results in Tables 5.5 and 5.6 only
consider SVMs trained with balanced feature matrices.
Classifier Grey Features Used Variance Sensitivity Specificity Accuracy Area Under
Levels retained/% ROC
SVM-bal 8 All texture with clinical 95 0.923 0.721 0.772 0.873
SVM-bal 8 All texture with clinical No PCA 0.929 0.767 0.807 0.867
SVM-bal 8 GLCM 99 0.857 0.767 0.790 0.823
SVM-bal 16 All texture with clinical 99 0.786 0.837 0.825 0.804
SVM-bal 64 Gabor Filter 99 0.857 0.651 0.702 0.804
SVM 8 All texture 99 0.857 0.814 0.825 0.794
SVM 16 All texture No PCA 0.786 0.721 0.737 0.779
SVM 16 All texture 99 0.786 0.837 0.825 0.770
SVM 64 All texture 99 0.786 0.837 0.825 0.736
SVM 8 All texture No PCA 0.786 0.767 0.772 0.732
Table 5.4: Top performing SVMs for the whole lung data set.
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Table 5.5 displays the average performance of the SVMs trained with balanced data sets. The
values have been averaged over the number of grey levels and different values of PCA used
(the first and the last column of Table 5.3). This averaging allows a measure of the stability of
the texture features and their relation to the occurrence of radiation induced pneumonitis. The
average AUROC (0.699) is lower than the top performing classifier, but still demonstrates a
promising level of performance.
Table 5.5 shows that there is a increase in performance when the texture features are combined
with the clinical features compared to using either set independently. A t-test was used to
determine whether the increase in performance, when using both feature sets together, was a
statistically significant improvement over using the clinical features alone. The performance
improvement when comparing “Texture with clinical” vs “Texture alone”, however, was not
found to be statistically significant. These results can be seen in Table 5.6. These results indicate
that the texture features are capable of adding new information in addition to the information
provided by the clinical features.
Specificity Sensitivity Accuracy Area Under ROC
All texture features with clinical 0.6899 0.7321 0.7003 0.6990
All texture features 0.6705 0.6964 0.6769 0.6521
Clinical features 0.6570 0.5655 0.6345 0.5815
Table 5.5: Average performance of the SVMs trained with a balanced training set. The table
displays an improvement in average performance when the texture features are combined
with the clinical features.
“Texture with Clinical” vs “Clinical” Specificity Sensitivity Accuracy Area Under ROC
Significant Increase No Yes Yes Yes
p-value 0.2067 0.0101 0.0084 0.0136
“Texture with Clinical” vs “Texture” Specificity Sensitivity Accuracy Area Under ROC
Significant Increase No No No No
p-value 0.2839 0.2304 0.2127 0.1144
Table 5.6: p-values from a t-test comparing the performance of SVMs that were trained
with either the texture features combined with the clinical features or trained with one of the
individual feature sets. The results presented are for the SVMs trained with a balanced training
set. The p-values demonstrate a significant increase in performance.
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Decision Trees
A Decision Tree classifier was used instead of the SVM classifier above in an attempt to speed
up the classification run time. Furthermore, using a different classifier may validate the use of
the chosen features - if multiple learners are capable of achieving similar levels of performance,
then it further suggests that the underlying features have predictive power.
The Decision Tree classifier was run in the same manner as the SVMs - a leave one out approach
was used to maximise amount of training and test data at each stage and a balanced data set was
used for each training step. It should also be noted that cross validation step was not carried out
on a per-case basis. Instead a preliminary grid search over sensible Decision Tree parameters
was performed. It is often simpler to interpret the parameters of a Decision Tree than those
used in an SVM and so a range of parameters were chosen in an attempt to prevent over-fitting.
For example, it is possible to reason about how shallow a tree should be to avoid over fitting.
Table 5.7 shows the top performing Decision Tree classifiers (compare with the SVM results
in Table 5.4). The top performing classifier showed a Sensitivity of 93%, a Specificity of 79%
and an Area Under ROC of 90%. This demonstrates performance of the Decision Tree classifier
was at least comparable to that of the SVM based approach.
Figure 5.4 shows the AUROC performance of the trained models (using only the GLCM
features) as the number of components selected during PCA and the number of grey levels
used for texture calculation varied. The Figure demonstrates that the performance is relatively
stable across these two parameters. The model parameters used in training of the Decision Trees
shown in the Figure were a max depth of 2, a minimum samples per split of 4 and a minimum
samples per leaf of 7. These parameters produce a shallow tree with (given the size of the data
set) fairly strict requirements on the number of samples at each leaf node. This should mean
that the tree was not over fitted - this suggests that the method should be generalisable on a
larger data set.
Discussion
The results presented here (using texture calculated on the whole lung volume) demonstrate
that it is possible to predict the occurrence of radiation induced pneumonitis using texture
features with clinical features or with texture features alone. Additionally, both the SVM
and the Decison Tree classifiers perform well on this data set. Both these facts suggest that
there is an underlying difference in the lung tissue of a patient that remains asymptomatic
versus a patient that develops radiation induced pneumonitis and that this difference can be
characterised using texture features.
Given that performance of the Decision Trees are comparable to the results from the SVMs,
the Decision Tree classifier will be preferred over the SVMs for subsequent results. This is
primarily due to the much shorter training time requried for the Decision trees.
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Grey Features PCA Area
Levels Components Under ROC
64 GLCM 7 0.9020
64 GLCM 9 0.8945
64 GLCM 0.95 0.8870
8 GLSZM 9 0.8704
64 GLCM 8 0.8696
8 GLCM 8 0.8530
32 GLCM 8 0.8430
64 GLSZM 8 0.8239
8 GLCM 9 0.8231
64 All texture 9 0.8189
Table 5.7: Top performing Decision Tree Classifiers. The PCA column corresponds to the
number of new features retained after PCA if the value is an integer. If the value is less than
one, then it corresponds to the variance retained after PCA.
The following sections present the results from applying the same approach to different sub-
sections of the lung volume: the region surrounding the GTV (5.6.2) and the V20 (5.6.3).
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Figure 5.4: Illustration of the stability of a Decision Tree classifier as both the number of
grey levels used for texture calculation and the number of PCA components retained varies.
This stability is suggestive of a significant underlying difference in the lung tissue of the
symptomatic and asymptomatic populations.
5.6.2 Region Surrounding the GTV
After the GTV, the surrounding lung is the area that receives the largest dose during radiother-
apy. Indeed, some of the surrounding tissue will be within the defined PTV and will receive
a therapeutic dose. It may be the case that the lung tissue surrounding the GTV plays a more
significant role in the pneumonitis outcome than the rest of the lung volume.
To investigate if features derived from this sub-region of the lung volume were capable of
predicting pneumonitis, the parenchyma in a 20mm strip around the GTV was extracted.
Texture was calculated on this smaller volume in the same manner as the whole lung (with
the volume padded with the HU values equivalent to air to create a regular shaped array). The
texture features were then fed into the same classification pipeline as before.
An ancillary advantage of this approach is a quicker run time due to the analysed volume being
significantly smaller than the whole lung volume. However, one significant disadvantage is that
the GTV must be segmented for this approach to work. This means that this method could not
be used on diagnostic CT scans as they are not usually segmented in the normal clinical work
flow - the GTV is only segmented on the planning CT scan to enable a radiotherapy plan to be
created. In effect, this means that the prediction of pneumonitis outcome could only be made
once the decision to use radiotherapy has been taken.
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Decision Trees
As described above, only the Decision Tree classifier was used on this data set. The results
can be seen in Table 5.8. These results show that while the performance is comparable to that
of the whole lung results, there is a small drop in performance. Further work is required to
determine if this method performs consistently worse than the whole lung approach or if it is
an insignificant variation. In either case, the texture calculated from this sub region of the lung
volume is able to discriminate between the symptomatic and asymptomatic subjects.
These results further reinforce the notion that there is any underlying difference in the lung
tissue in the two populations and that this difference can be characterised by texture features
derived from CT data.
Grey Features PCA Area
Levels Components Under ROC
16 GLSZM 9 0.8738
8 GLRLM 8 0.8480
16 GLRLM 0.95 0.8040
16 GLRLM 9 0.7940
8 GLCM 0.95 0.7899
8 GLCM 9 0.7890
32 GLRLM 9 0.7874
64 GLRLM 9 0.7874
64 GLCM 8 0.7807
16 GLRLM 8 0.7799
Table 5.8: Top performing Decision Tree Classifiers for the region near the GTV data set.
Texture features were calculated on a 20mm strip of parenchyma extracted from the whole
lung volume. The PCA column corresponds to the number of new features retained after PCA
if the value is an integer. If the value is less than one, then it corresponds to the variance
retained after PCA. Compare with the whole lung results in Table 5.7.
5.6.3 Dose Map Information
An alternate approach to the region near the GTV method from the previous section is to
leverage the dose information from the radiotherapy plan to extract the lung volume to be
used for feature extraction. The V20 is believed to be an important factor in the pneumonitis
outcome so it may be reasonable to assume that texture features extracted from this region may
have predictive power. To this end, the dose map was extracted from the DICOM data and used
to calculate the region that received 20% of the dose. The lung parenchyma from this region
was then extracted from the CT data and the same texture features as before were calculated.
The features were then fed into the same classification scheme. The Decision Tree classifier
was again used for the same reasons as outlined above.
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Decision Trees
As per the previous two regions used, only the Decision Tree classifier was used on this data
set. The results can be seen in Table 5.9. The results in the table are poorer than the previous
two methods - the top performing classifier only manages an Area Under ROC of 0.72. This is
still a respectable level of performance, but is not as high as the performance demonstrated by
the whole lung and the region near the GTV approaches.
As with the results in the previous section, further work on a larger data set would be required
to determine if this method is consistently less reliable than the previous two. Despite the drop
in performance it was still possible to use texture features calculated from the V20 to predict
whether a subject would develop radiation induced pneumonitis after radiotherapy.
Grey Features PCA Area
Levels Components Under ROC
16 GLCM 7 0.7234
16 GLCM 0.95 0.7209
8 All Texture 0.95 0.7168
32 All Texture 0.95 0.7101
8 All with Clinical 7 0.6993
16 All Texture 7 0.6985
16 GLCM 0.95 0.6885
64 GLCM 7 0.6752
16 All Texture 0.95 0.6586
64 All Texture 7 0.6561
Table 5.9: Top performing Decision Tree Classifiers for the V20 data set. Texture features were
calculated on the parenchyma extracted from the V20. The PCA column corresponds to the
number of new features retained after PCA if the value is an integer. If the value is less than
one, then it corresponds to the variance retained after PCA. Compare with the whole lung
results in Table 5.7.
5.7 Discussion
This chapter has shown that it is possible to use texture features (alone or combined with a
small number of clinical features) to predict the occurrence of radiation induced pneumonitis
from CT planning scans. This is a novel approach as related research has typically focussed on
using a large number of clinical features or attempting to identify already existing lung disease
on CT images.
Three regions of the lung tissue were used to calculate texture features: the whole lung; the
20mm adjacent to the GTV and the V20. Texture features derived from each of these regions
were capable of predicting the occurrence of radiation induced pneumonitis. This seems to
indicate that the region chosen for analysis is not important (or plays a minor role). This may
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indicate some level of uniformity of the importance of each lung region in the prediction of
pneumonitis. That is, all the lung parenchyma may share the same characteristics that are
picked up by the texture calculation and so the area of the lung exposed to radiation may
not be relevant - if any of the lung is exposed in such a patient, they may develop pneumonitis.
The performance of multiple learners suggests an inherent stability in the results - multiple
learners achieving similar levels of performance should reduce the likelihood of over-fitting
and is another reason for further investigation with a much larger data set.
These results are promising and display a proof of concept approach to this problem. However,
a much larger data set is required for further testing and optimisation of the approach. The
simplicity of the training models used here should allow for the method to be easily scaled up
- there should be no time or memory constraints at the classification stage if a much larger data
set is used. Any future work with a larger data set should begin with the same classification
scheme used here and move on to a more complicated learner if necessary. For instance, no
ensemble methods (such as Random Forests or AdaBoost) have been used due to the limited
size of the data set available, but these may be suitable if several hundred cases were used.
Several modifications to the methods presented were also attempted, some of them are listed
here:
• An adaptive thresholding method was created to remove non-parenchyma regions in the
CT data and substitute the mean of the local region. This approach made no noticeable
difference and was laid aside in favour of simpler removal only threshold.
• The lung was divided into physiological sections (lobes) to calculate texture on different
regions. Averaging over these regions or using a single region did not yield useful results.
It is unclear why this approach failed when the dose based method and the region near
the GTV method both worked.
• Each case was registered onto a common frame of reference before texture calculation.
This was an attempt at a basic normalisation process. This method did not yield any
worthwhile results - probably due to the registration deforming the information before
the texture features were extracted.
• Sequential Floating Forward Selection [90] was implemented and used with the SVM
classifier. However, this resulted in impractical run times (of several days) and was
abandoned.
The original CT data was rescaled from 2048 HU to prevent the formation of very sparse
GLCMs (and GLRLMS, etc) which can result in poor texture descriptors. The CT data was
scaled to 8, 16, 32 and 64 grey levels to test if the number of grey levels used impacted the
performance of the classifier. Since this rescaling is carried out after the extracting of the
parenchyma, the range of grey levels of the remaining data is already somewhat reduced from
2048 HU to approximately 1000 HU (as can be seen in Figure 5.2). This range can still lead to
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where GL is the number of grey levels in the rescaled image. The performance seems to be
uniform across the grey levels used. This seems to be an additional indication of the stability
of the approach outlined in this chapter. It may be interesting to further investigate the impact
of increasing the grey levels used beyond 64 or to combine features derived from different grey
level scalings (however these features are likely to be highly correlated). It seems remarkable
that the CT data can still predict pneumonitis outcome when reduced to only 8 grey levels.
The best performing feature set with the SVM classifier trained with whole lung data was
made up of all the texture features and the clinical features combined (Table 5.4). Intuitively,
this makes sense as this is the data set containing the most texture and clinical information.
However, the GLSZM and the GLCM features also perform very well (Tables 5.7, 5.8 and
5.9) across the different regions. It is difficult to speculate upon why each of these descriptors
performs well as both the PCA and the leave one out scheme makes it difficult to interrogate
the relative feature importance. However it is possible to note that the FOS features are missing
- they perform poorly which suggests there is some higher level interaction between pixels
that is indicative of the pneumonitis outcome. The differences in the underlying tissues cannot
be characterised solely by the simple first order methods. Again, it should be noted that the
same sets of features repeatedly performing well indicates that the stability of the underlying
relationship between the texture in the image and the pneumonitis outcome.
5.7.1 Avenues for Further Investigation
Avenues for future work in this problem space may include:
• Testing the method on diagnostic CT scans. The disadvantage of using planning CT
scans is that they are acquired after the decision to use radiotherapy has been made.
However diagnostic CT scans are acquired much earlier in the treatment process and the
pneumonitis prediction would be more valuable at this stage. The planning CT data was
used in this study as it was the only suitable data set available at the time. The approach
should work equally well on the diagnostic scans, but this requires validation.
• The main issue with using PCA or any other feature reduction method is that - when
coupled with the ‘leave one out’ classification scheme used in this work - the relative
importance of each feature is obscured. This makes it much more difficult to tune the
overall system and choose better features for classification.
• Further investigation into the relevance of the different texture features should be under-
taken. This would potentially allow for a determination of the underlying tissue changes
in the two populations and may even suggest clues as to the underlying biological
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differences.
• If follow up CT data were available, it may be possible to further test if there is the
possibility for intra-patient prediction. That is, if texture features are generated from sub-
images of the lung (similar to the approach used in Chapter 6), it may then be possible
to test if these features could be used to identify local regions of the lung that are at
higher risk. This approach could then generate multiple class labels per patient, rather
than focussing on a global approach where a patient is given a single label. These class
labels could then be used during the radiotherapy planning stage as additional planning
constraints to attempt to reduce the risk of triggering pneumonitis.
• Testing of this approach using EPID imaging (acquired during radiotherapy) could lead
to inter-fraction determination of the risk of pneumonitis. That is, if texture calculated on
the regions of the lung from EPID images could be correlated with pneumonitis outcome,
it may be possible to identify patients early (during treatment).
5.7.2 Clinical Work Flow
The method presented here could easily fit into the typical clinical work flow used in the
treatment of lung cancer. As an example:
1. A CT scan of a patient is acquired for the purposes of radiotherapy planning and stored
in the hospital’s PACS system.
2. The texture features are calculated by the PACS system. This process takes approxi-
mately 20 minutes (or less with native code) and may be run over night or during another
period of time when the PACS system is under a light load.
3. The texture features are combined with the clinical factors present in the PACS system
and passed to a classifier (trained once off line on historic data).
4. The classifier reports a binary value (or a probability that can be converted to a risk
score).
5. The result of the classifier is stored in the PACS system, ready for a clinician to make
use of in the planning of the patient’s treatment.
5.7.3 Summary
In summary, a proof of concept automated approach to predicting radiation induced pneumoni-
tis has been presented. One distinct advantage of this approach is the minimal effort required for
data collection - the clinical information and the CT images are collected in the normal course
of treatment for lung cancer and the methods outlined above could easily fit into a standard
clinical work flow. The results outlined above are promising and warrant future research with
a much larger cohort of patients.
Chapter 6
Automatic Segmentation of Prostate
Focal Lesion
6.1 Introduction
As outlined in Section 2.6.4, a dominant unifocal lesion greater than 0.5cm3 may be present
in up to 70% of newly diagnosed prostate cancer patients. There is significant potential for
improving treatment by treating this dominant focus or boosting the dose to the area while
lowering the dose delivered to the surrounding healthy tissue. There are many challenges
associated with this approach, including identifying the focal disease in a manner that enables a
radiotherapy planning volume to be delineated, planning a suitable radiotherapy plan, executing
on the plan and verifying the new method is curative and improves patient outcome.
This chapter focusses on the first step: attempting to automatically identify the focal disease
on T2 MR scans that were acquired for diagnosis. This would be a key first step as it could
greatly assist clinicians in the difficult and time consuming task of identifying the focal disease
within the prostate. Subsequent steps would involve the registration of the generated contour to
a CT scan, and then the use of this contour to generate a radiotherapy plan that meets the dose
restraints required to “boost” the disease.
The rest of this chapter will detail the data used, explain the methods and examine the results
of the approach. An overview of the model can be found in Section 6.3 and the final results are
analysed in Section 6.6.
6.2 Data
The data set used for this retrospective study came from 14 patients with confirmed prostate
cancer treated at the Edinburgh Cancer Centre, Western General Hospital between August
2012 and April 2013. T2 MR scans were acquired with a Symphony 1.5T (Siemens, Erlangen,
Germany) for the purpose of diagnosis. Each patient was treated with androgen deprivation
therapy over the course of three months before returning for gold marker seed implantation (for
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Feature Details Total
FOS standard first order features 7
GLCM 14 Haralick features calculated in 13 directions 182
GLRLM 11 standard run length features calculated in 13 directions 143
GLSZM 11 standard features calculated for 5 connectivities 55
LBP a u2 mapping with 8 neighbours was used on a slice wise
basis, with the final feature vector computed as the mean
of the vectors
59
Table 6.1: Details of the features calculated for classifying the focal lesion.
alignment) and a planning CT scan in preparation for external beam radiotherapy. The prostate,
bladder and rectum were contoured by an experienced consultant oncologist on both the MR
and the CT scans and the focal disease was contoured on the MR scan only. It is not possible
to identify the focal disease region on the CT images due to the poor soft tissue contrast.
Additionally, the whole prostate and the focal lesion shrinks due to the hormone treatment
administered between the MR scan and the CT scan, further confounding the identification of
the focal lesion. The T2-weighted MR data and the outlined contours form the data set for this
investigation. In the absence of histological data, the ground truth labels are the segmentations
provided by the expert clinician.
6.3 Model Overview
In order to automatically segment the focal lesion a set of features were extracted using the
methods described in Chapter 3. The approach taken was to classify each pixel in the region of
interest in order to generate a mask of class labels that can then be converted back to a contour.
The region of interest (ROI) was defined as the joint prostate-focal lesion volume (for some
cases the focal lesion lay outside of the prostate volume).
This approach requires the calculation of a feature vector at each pixel within the ROI. This
was carried out by extracting a 3D box (5×5×5) around each pixel and deriving 446 texture
features for each subimage. See Table 6.1. This box size was chosen as a starting point in an
attempt to balance the trade off between the amount of information contained in a subimage
(increases with box size) and the locality of this information (decreases with box size).
These features were used to train a series of AdaBoost models (with Decision Trees as the base
classifier) using a 5-fold cross validation scheme (Section 4.6.4) to determine the optimal set
of hyperparameters. This optimisation step was carried out as a grid search over a range of the
total number of estimators in the model and the maximum depth of each tree. The results of
this optimisation step can be seen in Section 6.4.3.
An AdaBoost model with the optimal hyperparameters was then trained and used to classify
each case in a leave one case out fashion. These classification labels were then mapped back
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onto the MR space before being cleaned with the use of morphological operations. The re-
sulting binary masks were then converted to a contour and compared with the original clinical
segmentation.
In summary:
1. The prostate and focal lesion are outlined by an expert radiologist to establish the ground
truth labels.
2. A set of features (n = 446) is calculated on a subimage extracted around each pixel
within the prostate (and focal lesion).
3. Feature matrices and class labels are created using the 446 texture feature vectors.
4. A cross validation step is carried out to find the optimal hyperparameters.
5. A leave one out classification process is carried out:
• The current case is withheld for later testing, while the other 13 cases are concate-
nated together to form a single training matrix.
• An AdaBoost model is trained.
• The trained model is then used to predict class labels on the test case.
• This is repeated for each case.
6. Predicted labels are subsequently mapped back into the MR volume frame of reference
to generate a binary mask of focal disease that can be compared with the original clinical
contour.
7. The predicted masks are cleaned up by slice wise morphological operations.
8. Dice coefficients are calculated to assess the agreement between the clinical and pre-
dicted masks.
9. The predicted mask is converted to a contour for display.
6.4 Classification
6.4.1 Feature Extraction
A (5× 5× 5) subimage was extracted around each pixel from the prostate and focal lesion.
Texture features (see Table 6.1) were then calculated to generate a feature vector at every point.
These feature vectors were labelled “prostate” or “focal lesion”.
In a clinical scenario these calculations could easily be performed off line by a PACS system,
post-MR acquisition and before the image is inspected by a clinician, perhaps overnight to
avoid unnecessary load on the system. If these features are calculated ahead of time on the
whole of the MR scan, then a near real time segmentation becomes possible once a clinician
has outlined the prostate: all the points within the prostate are classified and a predicted focal
lesion is displayed on the screen.
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All algorithms used for texture calculation were implemented in MATLAB by the author or
another member of the author’s group.
6.4.2 AdaBoost Classifier
An AdaBoost meta-classifier (Section 4.3.6), using Decision Trees (Section 4.3.4) as the base
classifiers, was chosen for this application. AdaBoost trains a series of base classifiers, fo-
cussing on previously misclassified training samples, to achieve better performance on subse-
quent iterations. The AdaBoost and Decision Tree parameters used in this work are shown in
Table 6.2, more details of the role of each parameter are provided in Sections 4.3.4 and 4.3.6.
AdaBoost





Minimum Samples: Leaf 20
Minimum Samples: Split 50
Table 6.2: Table showing the parameters used in the AdaBoost model used for the focal lesion
classification. The decision tree parameters are those used for each of the base learners.
The number of learners and maximum tree depth were determined by a grid search with a
5-fold cross validation strategy as described in the next section. PCA was included in this grid-
search, but when PCA was used the results were uniformly and significantly poorer and are not
included here. PCA was not included in the classification pipeline.
The Scikit-learn [85] implementation of AdaBoost was used in this work.
6.4.3 Model Development Using Cross Validation
In order to test the classification model and to determine if the texture features were capable
of discriminating between prostate and focal disease tissue 5-fold stratified cross validation
was employed and used to search for the best combination of model parameters, this cross
validation strategy is outlined in more detail in Section 4.6.4. Due to memory constraints a
traditional stratified cross-validation strategy was not used, rather, each case was individually
“balanced” before the cross validation steps. The balanced feature matrices for all 14 cases
were grouped together into one consolidated data set for this test. A random subset of the data
was used for balanced training and testing was carried out on the remaining data. This was
then repeated for a total of 5 “folds”, with replacement. At each fold a series of classification
performance metrics (Sensitivity, Specificity and Area Under ROC) were calculated to assess
the performance of the classification system.
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The advantage of this cross validation step is that it allows quick and efficient prototyping and
testing of classification models and their stability over a series of trials. The results of the grid
search can be seen in Table 6.3.
Number of Maximum Area Under
Estimators Depth Sensitivity Specificity ROC
10 1 0.6052 0.5799 0.6302
10 10 0.5422 0.6755 0.6501
10 50 0.5150 0.7014 0.6506
10 100 0.5150 0.6999 0.6496
100 1 0.6014 0.6412 0.6604
100 10 0.5181 0.7152 0.6612
100 50 0.5259 0.7497 0.69105
100 100 0.5278 0.7472 0.6884
500 1 0.5916 0.6566 0.6652
500 10 0.5265 0.7478 0.6895
500 50 - - -
500 100 - - -
1000 1 0.5831 0.6607 0.6619
1000 10 - - -
1000 50 - - -
1000 100 - - -
Table 6.3: Performance metrics from the grid search over the number of estimators and the
maximum depth parameters in the AdaBoost model. Some classifiers (blank entries) were
terminated early due to exceedingly long run times. Each aborted run was allowed to continue
for 48 hours before termination. See Appendix B for full results.
Once the optimal maximum depth and number of estimators were found, the cross validation
strategy was repeated with 10 folds. The performance metrics can be seen in Figure 6.1 and
Table 6.4.
The scores in Table 6.4 show reasonable performance from the classifier. Note that there are
equal numbers of each class due to the the balancing carried out prior to the cross validation
strategy. This has the side effects of making the classification metrics simpler to interpret and
of losing a significant portion of the data available for testing - this is because the focal lesion
is much smaller than the whole prostate volumei and the balancing of the data set (necessary
due to memory constraints) discards a large number of the prostate test examples.
The model is better capable of correctly identifying the prostate tissue than the focal disease
tissue. That is, the specificity is consistently higher than the sensitivity - the model tends to
favour classifying points as “healthy”. The use of the stratified cross validation removes the
possibility that this is due to a training bias produced by a majority of samples being from the
i. On average, the focal lesion makes up 14.6% of the total prostate volume. Notably, this figure is 69% for case
4, 44% for case 5 and 29% for case 9. If these three cases are excluded, the mean ratio falls to 5.7%
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Figure 6.1: Receiver operator curves for each fold of the 10-fold stratified cross validation
test using features calculated on all 14 patients as the consolidated feature matrix. See
Table 6.4 for detailed performance metrics from each fold. The mean area under ROC = 0.71
demonstrates promising performance with this classification problem.
prostate. This difference is inherent in the model. It is reasonable to suppose that the classifier
is better capable of representing the prostate tissue as it will be more regular and consistent
than the focal disease tissue: by definition a tumour is an out of control growth of tissue.
Allowance must also be made for class label noise - the ground truth labels provided by the
expert radiologist are not absolute - histological information registered back to the MR volume
would provide more certain identification of the underlying tissue type (class label) at each
point in the MR image.
The graphs and the table of results demonstrate that the performance of the classification model
is fairly stable with a small number of poor performing folds (fold 8, AUROC = 0.5149).
As can be seen later in this Chapter, there are 3 cases (10, 11 and 12 - see Figure 6.2) that
perform poorly, one possible explanation for the poor performance on fold 8 is that more of
the samples used in this fold were drawn from these cases. The performance of these cases are
discussed in more detail later in the chapter. The small standard deviations for the Specificity
and AUROC also demonstrate the stability of the model. This is a good indication of the
veracity of the methodology so far - the hypothesis that the two tissues can be discriminated
by the texture features seems plausible at this stage. Additionally, the much larger standard
deviation (0.1775) and range (0.6485) for the Specificity show that the model is much better at
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Area Under Area Under
Fold TP TN FP FN Sens Spec ROC Precision Recall PRC
1 3281 4469 1745 2933 0.5280 0.7192 0.6758 0.6528 0.5280 0.6714
2 4591 4417 1797 1623 0.7388 0.7108 0.8027 0.7187 0.7388 0.7957
3 3896 4811 1403 2318 0.6270 0.7742 0.7789 0.7352 0.6270 0.7666
4 5436 3971 2243 778 0.8748 0.6390 0.8254 0.7079 0.8748 0.7868
5 2525 5135 1078 3688 0.4064 0.8265 0.6714 0.7008 0.4064 0.6669
6 3278 4829 1384 2935 0.5276 0.7772 0.7285 0.7031 0.5276 0.7054
7 3856 4757 1456 2357 0.6206 0.7657 0.7672 0.7259 0.6206 0.7395
8 1406 5341 872 4807 0.2263 0.8597 0.5149 0.6172 0.2263 0.5475
9 3081 5158 1055 3132 0.4959 0.8302 0.7353 0.7449 0.4959 0.7488
10 3121 4160 2053 3092 0.5023 0.6696 0.6256 0.6032 0.5023 0.5909
Mean - - - - 0.5548 0.7572 0.7126 0.6910 0.5548 0.7019
Min. - - - - 0.2263 0.6390 0.5149 0.6032 0.2263 0.5475
Max. - - - - 0.8748 0.8597 0.8254 0.7449 0.8748 0.7957
Std. Dev. - - - - 0.1775 0.0720 0.0935 0.0494 0.1775 0.0831
Table 6.4: Detailed classification performance, using a range of metrics, for each fold of the
10-fold stratified cross validation test using features calculated on all 16 patients as the initial
feature matrix. Data corresponds to the curves in Figure 6.1. The mean values of each metric
demonstrates promising performance while the standard deviations display the stability of the
model.
correctly identifying healthy tissue than diseased tissue.
Within each cross validation fold the training and test sets are made up of samples drawn from
all the 14 cases available. Although these results are encouraging, further investigation into
mapping the classification labels back to the original frame of reference of the MR scan for
comparison with the original contours is required for any clinical application.
6.4.4 Leave One Case Out Testing
The next step after initial model validation using cross validation is to train and test in a manner
which allows for the classification labels to be mapped back to their corresponding location
on the MR images. As there were only 14 cases available to this study a leave one case out
approach was chosen. This approach maximises the number of test instances available without
reducing the amount of training data and allows us to generate a set of contours for every case.
Balanced feature matrices were created for each case, as described above. Then a single case
was removed from the pool of feature matrices and designated the test case, the full, unbal-
anced, feature matrix for this test case is then loaded in order to generate predicted class labels
for the whole of the ROI. The remaining 13 cases were then combined into a single feature
matrix and used to train the AdaBoost classifier. Predicted labels were generated for the test
case and the case returned to the pool, the AdaBoost model discarded and the process repeated
for all the remaining cases. This results in predicted labels being generated for every sample in
the data set without compromising the training or test steps. At this stage, a limited assessment
of the results can be made as no direct comparison to the clinical contours can be made until
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Figure 6.2: Receiver operator curves for each step of the leave one case out process.
The legend provides the area under the curve for each instance. See Table 6.5 for detailed
performance metrics from each case.
the labels are converted to a mask and contour.
The classification results can be seen in Figure 6.2 and Table 6.5. The mean area under ROC
(AUROC) is 0.6, but the performance of the classifier varies greatly among the cases with a
minimum of 0.26 and a maximum of 0.80. This variation among the cases should be examined
further and shall be discussed in Section 6.7.
The four best performing cases are cases 4, 5, 6 and 14. Each of these cases have an AUROC >
0.73 and can be seen towards the top left of ROC in Figure 6.2. It should be noted that Case 4
has a very large amount of disease - there are 17,177 diseased pixels and 7,777 healthy pixels.
In other words, 69% of the prostate volume is cancer tissue. This can no longer be considered
“focal disease” and this particular case is unlikely to be suitable for a boosted treatment plan
to spare the healthy prostate. However, it is encouraging that the classifier still performs well
on this case and it should be noted that it may still be possible to boost the dose to this region
if a confident determination of the disease can be made. This would not help spare the healthy
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Area Under Are Under
Case TP TN FP FN Sensitivity Specificity ROC Precision Recall PRC
1 1038 77275 18006 2058 0.3353 0.8110 0.6314 0.0545 0.3353 0.0552
2 1603 12746 9479 779 0.6730 0.5735 0.6664 0.1446 0.6730 0.1563
4 10819 5653 2144 6358 0.6299 0.7250 0.7333 0.8346 0.6299 0.8440
5 4401 6120 2609 2349 0.6520 0.7011 0.7378 0.6278 0.6520 0.6638
6 4175 21849 17462 309 0.9311 0.5558 0.8033 0.1930 0.9311 0.2376
8 866 119383 21835 1881 0.3153 0.8454 0.6120 0.0381 0.3153 0.0332
9 7742 31047 12281 10381 0.4272 0.7166 0.6211 0.3867 0.4272 0.3804
10 44 81879 5147 1822 0.0236 0.9409 0.4432 0.0085 0.0236 0.0174
11 35 9582 2376 1312 0.0260 0.8013 0.3128 0.0145 0.0260 0.0674
12 44 95733 10498 1421 0.0300 0.9012 0.2552 0.0042 0.0300 0.0083
14 2958 56831 10791 3055 0.4919 0.8404 0.7343 0.2151 0.4919 0.2698
15 631 8162 5766 779 0.4475 0.5860 0.5395 0.0986 0.4475 0.1102
16 1343 50025 25301 968 0.5811 0.6641 0.6650 0.0504 0.5811 0.0523
18 1102 37905 15885 1241 0.4703 0.7047 0.6383 0.0649 0.4703 0.0588
Mean - - - - 0.4310 0.7405 0.6000 0.1954 0.4310 0.2111
Min. - - - - 0.0236 0.5558 0.2552 0.0042 0.0236 0.0083
Max. - - - - 0.9312 0.9409 0.8033 0.8346 0.9311 0.8440
Std. Dev. - - - - 0.2687 0.1212 0.1611 0.2529 0.2687 0.2565
Table 6.5: Detailed classification performance, using a range of metrics, for each case in the
leave one case out process. The data corresponds to the curves shown in Figure 6.2.
tissue in this case, but the higher dose may itself be of use. The size of the focal disease is
further considered in Section 6.7.
But cases 10, 11, 12 perform much more poorly with AUROC of 0.44, 0.31 and 0.26 respec-
tively. These three cases can been seen in Figure 6.2 - they are the three lines that fall below the
dashed line that represents randomly guessing the class labels. Examination of Table 6.5 shows
that the model classified nearly all the points as healthy, resulting in a very low sensitivity and
an artificially high specificity due to the much larger number of healthy pixels. It is not clear
why these three cases have performed poorly - the ratio of healthy tissue to prostate tissue
does not correlate with the performance. So it is not due to unusually large or small tumour
volumes. Future research could investigate this further - it may be that with more subjects the
performance on these cases improves or there may be a link between this poor performance
and information about the disease state or other demographic data. If such a link were found,
it may be possible to train multiple models for different population groups in order to identify
the focal lesion reliably.
6.4.5 Feature Importance Investigation
When using an AdaBoost meta-classifier the relative importance of each feature can be de-
termined if the base estimator supports it. The decision trees used in the current work support
reporting the relative importance and it is therefore possible to determine the overall importance
across the ensemble of decision trees. In the AdaBoost implementation used here the feature
importances are defined as the summed importances across all the base estimators.
The feature importance for each step of the leave one out classification can be seen in Fig-
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ure 6.3. The level of importance is stable across the cases - all of the lines are in agreement,
this suggests that the classification model is not over fitting on each stage of the leave one out
scheme, but is consistently finding the same features to be good predictors of focal disease.
The step down at the end of the graph is one set of GLSZM features (connectivity of 26) and the
LBP features - these are the least important features. The low importance of the LBP features
may be due to the parameters used to create the LBP operator used, or it may be because these
features do not take into account the inter-slice information in the same manner as the other
features. That is the LBP features are the only ones that are not natively 3D, but are the mean of
a set of slice-wise features. It is less clear why there is a sudden drop off in importance for the
GLSZM features with a connectivity of 26. A connectivity of 26 means all possible pixels are
included in the structuring element. Intuitively, one would expect this to lead to better results
and it is currently unclear why this is not the case.
Figure 6.3: Top: Relative importance of the features in the AdaBoost model. Each line
corresponds to the test case used. Note that the importances are relatively stable across the
cases. (Each feature importance vector was normalised by dividing by its peak value.) Bottom:
The standard deviation divided by the sum of the normalised importances for each case. This
is a measure of the relative variation across the cases. The black dashed lines demarcate the
different types of features - the first region are FOS, followed by GLCM, GLRLM, GLSZM and
LBP.
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A series of repeating patterns can easily be seen in Figure 6.3 - this is not unexpected as
a number of the features are correlated. Take, for example, the GLCM features - there are 14
features calculated over 13 different directions and examination of the plot shows that the tallest
peaks in this section of the feature vector are separated by a distance of 14, that is, the same
feature repeatedly shows a high level of importance in multiple directions. A similar pattern is
also visible for the GLRLM features and the GLSZM features being separated by 11.
If the mean (across the cases) of the normalised feature importance is sorted, the top two
features are the skew and the kurtosis (both first order statistics). Of the top 10 features, 7 are
the GLCM Correlation in different directions and the remaining GLCM Correlation features
are present in the 75 best performing features. The GLCM features dominate, with 16 of top
20 features and 50 of the top 100 being GLCM features. The rest of the top 100 performing
features are made up of 39 from the GLRLMs, 8 from the GLSZMs and the first order energy.
The high importance of the two first order features validates their inclusion in the feature set
and suggests that it is always worth including them given the triviality of their calculation.
Furthermore, the GLCM features clearly play a major role in the classification performance
with the GLCM Correlation being consistently important across a range of directions.
Two insights from this data suggest that the texture in the prostate and the texture in the
focal lesion are fairly anisotropic: a) the high importance of the skew and kurtosis, and b) the
consistency of the performance of several features when calculated over different directions.
If the texture in the two regions had a distinct directionality, then it would be likely that a
particular direction would dominate the feature importance list. Perhaps it is more correct to
conclude that the texture features that differ between the two regions are isotropic.
6.4.6 Effect of subimage size
The size of the subimages (defined by a cube around each pixel in the prostate ROI) may play
a role in the effectiveness of the texture features calculated from the volume. For large boxes,
there is much more information at the cost of a smearing effect due to the information being
taken from further away from the central pixel. Yet, a smaller box results in a more localised
measure at the cost of being unable to encapsulate the same amount of information. Therefore
we expect a trade-off with the size of the subimage.
The 5× 5× 5 subimage size was chosen as a starting point as there are 125 pixels in the
box, each pixel still touches the central pixel (though the corner pixels are only connected by
a point). The same texture features were calculated for box sizes of (6× 6× 6), (7× 7× 7),
(8×8×8), (9×9×9) and an AdaBoost model (with the same parameters used above) applied
to these features following the same leave one out scheme outlined earlier.
Figure 6.4 shows various performance metrics (averaged over the 14 cases) as the box size
varies. All three measures do not vary greatly with the change in box size. Though there is a
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Figure 6.4: Variation in classification performance with different subimage sizes used for
texture feature calculations.
drop in the AUROC when moving from subimages with length 5 to 9.
It is also interesting to note that the AUROC is lower for the even numbered subimage sizes.
That is the AUROC for n = 6 and n = 8 is worse than the performance of n = 7 and n = 9,
despite the overall trend of performance decreasing as the box size increases. This is likely due
to a simple indexing (without interpolation) being used to create the subimages: the subimages
are created by extracting the pixels around the current pixel of interest. When the box size is
odd the pixel of interest is located in the centre of the subimage. When the subimage size is
even the subimage is off-centre and means that the texture features are not a true representation
of the space around the pixel of interest. Interpolation may be used to fix this issue - but this
may also cause artefacts which may negatively impact classification performance. The simplest
fix for this potential issue is to only used odd numbered box sizes.
Given the results of this analysis of the effect of the subimage size, the 5×5×5 subimage size
will be used throughout the rest of this chapter.
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6.5 Predicted Labels Post-Processing
Obtaining predicted class labels for each pixel in isolation is useless - the labels must be trans-
ferred back onto the original MR scan for visualisation, evaluation and (eventually) clinical use.
This transfer is a simple matter of reconstructing a logical mask from the predicted class labels
and their corresponding pixel locations that were stored during the feature matrix generation.
Once this mask has been generated it can be overlaid on the MR scan for inspection. However,
post processing of these masks is required as they are not suitable for clinical use due to holes,
small islands and other artefacts in the masks, such as large numbers of disjoint regions that
can cause an unrealistically complex contour to be drawn around the predicted focal lesion.
The masks are post processed by slice wise operations outlined and explained below (positive
pixels have been predicted to be focal disease):
• The largest connected region on the slice is found and if it contains fewer than 20 pixels
the whole slice is set to zero, otherwise the following operations are applied,
• The slice is morphologically opened (with a square structuring element with a side of
length 3) to further remove artefacts,
• The slice finally has a morphological closing operation applied, using a disk structuring
element of radius 5, to close any holes in the mask.
Because the classification is carried out on the prostate volume as a whole, a small number
of pixels on slices just above and below the true focal disease volume may be falsely labelled
as a positive result. An efficient way of dealing with this problem is to examine each slice
and apply a threshold to the size largest connected region. The threshold was manually tuned
by inspecting slices that contained no true focal disease for predicted focal disease and set to
20 pixels, that is if a slice’s largest connected region is less than 20 pixels all predicted focal
disease is removed and we move on to the next slice. If the largest connected region is greater
than 20 pixels, then a series of morphological operations, described below, are applied to the
slice. This threshold could be tuned on a large data set before any real world application.
Morphological Operations
A brief outline of the morphological operations used in this chapter can be found in Ap-
pendix A.
In order to process the focal disease masks opening and closing operations are applied to the
slices after the initial thresholding step:
• Opening: an opening using a 3× 3 ones matrix is applied to the slice. This operation
removes sharp edges from the mask and any small islands of isolated regions.
• Closing: a closing is then applied using a disk of radius 5 as the structuring element.
This operation fills in the gaps in the masks to ensure the final contour has no holes in it.
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6.6 Results
Section 6.6.1 presents the results after the post processing of the predicted class labels. Dice
coefficients are calculated to assess the overlap of the clinical mask and the predicted mask in
3D and on a slice by slice basis for each case. These results are presented for the preprocessing
pipeline explained in Section 6.5. Subsequent analysis of the generated masks before the
morphological processing revealed that the opening step caused too many of the pixels to be
removed and so the analysis was repeated with the opening step removed. These results are
presented in Section 6.6.2.
6.6.1 Contour Evaluation
The Dice coefficients can be seen in Tables 6.6 and 6.7 and corresponding graphs in Figure 6.5.
It should be noted that only slices where there the clinical focal disease contour is present are
displayed. The cleaning step (removing all focal disease pixels on a slice if there are fewer than
20 pixels present) was successful in ensuring there was no incorrectly focal disease on any slice
that the clinical contour is not present.
The tables and graphs show that the variability seen in the bare classification results have
carried through to the contours. The three cases (10, 11 and 12) with very poor classification
performance have all resulted in a Dice coefficient of 0 - there is no overlap between the correct
contour and the predicted contour. The algorithm has catastrophically failed on these cases by
not identifying any of the tissue as diseased.
Figure 6.6 shows the clinical contour and the predicted contour for case 2 (overall Dice= 0.62).
The algorithm displays a limited capability of predicting clinical disease on this case. Note that
the predicted contour is wholly within the clinical contour - this shows a high specificity and
low sensitivity, just like the bare classification results.
Figure 6.7 shows case 6 (overall Dice = 0.97), this is the case on which the algorithm performs
best with a near perfect overlap. Note that the algorithm also displays a higher specificity than
sensitivity on this case.
Three dimensional visualisations of some of the results can be seen in Figures 6.8 and 6.9.
(The steps in the surfaces are due to the contours being delineated on slices of the image
which creates a discrete step change in the 3D contours - these have been smoothed slightly
by the interpolation used for plotting). Figure 6.8 shows cases 2 and 6. From case 2 and 6 it is
apparent that when the algorithm performs well, the misclassifications are located on the edge
of the focal disease, as one would expect.
The relationship between the AUROC and the Dice coefficients can be see in Figure 6.10. The
plot suggests that there is a linear relationship between the AUROC and the Dice coefficient
once a minimum classification performance has been achieved. And below this threshold there
is no correlation between the AUROC and Dice.
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Case 1:
Slice 6 7 8 9 10 3D
Dice 0 0 0 0 0.230 0.012
Case 2:
Slice 14 15 16 17 18 19 3D
Dice 0.406 0.593 0.650 0.364 0.867 0.646 0.620
Case 4:
Slice 15 16 17 18 19 20 21 22 3D
Dice 0.723 0.625 0.382 0.419 0.349 0.793 0.284 0.404 0.480
Case 5:
Slice 22 23 24 25 26 27 3D
Dice 0.369 0.519 0.760 0.612 0.778 0.404 0.582
Case 6:
Slice 12 13 14 15 16 3D
Dice 0.966 0.979 0.989 0.985 0.946 0.977
Case 8:
Slice 11 12 13 14 15 3D
Dice 0.169 0 0 0 0 0.0329
Case 9:
Slice 7 8 9 10 11 12 13 14 3D
Dice 0.156 0 0.006 0 0.138 0.101 0.010 0.044 0.053
Table 6.6: Dice coefficients computed for comparison of the clinical segmentation and the
automatic segmentation. Dice coefficents were calculated in 2D (on each slice) and in 3D
(whole patient comparison) for each of the patients. Table is continued in Table 6.7.
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Case 10:
Slice 11 12 13 14 3D
Dice 0 0 0 0 0
Case 11:
Slice 25 26 27 3D
Dice 0 0 0 0
Case 12:
Slice 7 8 3D
Dice 0 0 0
Case 14:
Slice 7 8 9 10 11 12 13 3D
Dice 0 0.110 0.423 0.264 0.089 0.053 0 0.161
Case 15:
Slice 17 18 19 3D
Dice 0.772 0.087 0 0.255
Case 16:
Slice 11 12 13 14 3D
Dice 0 0.217 0.571 0.613 0.296
Case 18:
Slice 18 19 20 21 22 23 24 3D
Dice 0 0.187 0.366 0.038 0.059 0 0.419 0.153
Table 6.7: Dice coefficients computed for comparison of the clinical segmentation and the
automatic segmentation. Dice coefficents were calculated in 2D (on each slice) and in 3D
















































































































































































































































Figure 6.5: Dice coefficients computed for comparison of the clinical segmentation and the
automatic segmentation. Dice coefficents are calculated on each slice for all of the patients.
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Figure 6.6: Comparison of the clinical (blue) and predicted (red) contours for case 2. Slice
numbers increase clockwise from the top left. Note that the blue line is drawn twice as thick
as the red line to aid interpretation.
Figure 6.7: Comparison of the clinical (blue) and predicted (red) contours for case 6. Slice
numbers increase clockwise from the top left. Note that the blue line is drawn twice as thick




Figure 6.8: A 3D visualisation of the clinical focal lesion mask (red) and the predicted mask





Figure 6.9: A 3D visualisation of the clinical focal lesion mask (red) and the predicted mask
(green) for three of the poorer cases. Figure 6.8 shows the same visualisation for two of the
better performing cases.
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Figure 6.10: A plot showing how the Dice coefficients are related to the Area Under Receiver
Operator Curve for each case. The plot shows a steep rise in the Dice coefficient once the
AUROC is greater than 0.5.
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6.6.2 Contour Evaluation - No Opening Step
In the process of analysing the results presented in the previous section, it was realised that the
morphological opening step was discarding a large number of the pixels predicted to be focal
disease. An example of this can be seen in Figure 6.11 - the top left image shows the predicted
disease in white and the top right image shows the result after the morphological processing
described in Section 6.5.
The morphological opening was removed from the processing pipeline and the result can be
seen in the bottom left image in Figure 6.11. The clinical mask is shown in the bottom left for
comparison. It is immediately apparent that the performance of the algorithm is much better
having removed the opening. The rest of this section will present the Dice coefficient results
like the previous section, but without the morphological opening step.
The Dice coefficient results for the approach without the opening step are shown in Figure 6.12
and in Tables 6.8 and 6.9. The increase in performance across the cases is immediately appar-
ent. The Dice coefficients rise for 11 of the 14 cases. Notably, and as expected, the performance
does not change for cases 10, 11 and 12: a very poor classification performance cannot be
rescued with morphological processing.
These much higher Dice coefficients provide much more evidence that this overall approach
may be viable in a clinical work flow - there is a high level of agreement between the predicted
focal masks and those outlined by an expert clinician.
Figure 6.14 shows the new relationship between the AUROC and Dice coefficients. Comparing
this with Figure 6.10 highlights the increase in performance with this new approach and shows
that there is still a minimum required AUROC in order to achieve a reasonable Dice score.
However the linear relationship between AUROC and Dice that was apparent in the previous
plot has been changed significantly: it now suggests that once an AUROC around 0.65 or
greater has been achieved, there is no further jump in the Dice performance. Further results
would be required to validate this conclusion.
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Case 1:
Slice 6 7 8 9 10 3D
Dice 0 0.9457 0.9526 0.8941 0.8726 0.8010
Case 2:
Slice 14 15 16 17 18 19 3D
Dice 0.9431 0.9828 0.9635 0.9759 0.9911 0.9924 0.9714
Case 4:
Slice 15 16 17 18 19 20 21 22 3D
Dice 0.9964 0.9953 0.9967 0.9923 0.9914 0.9947 0.9919 0.9918 0.9937
Case 5:
Slice 22 23 24 25 26 27 3D
Dice 0.9901 0.9829 0.9760 0.9901 0.9680 0.9787 0.9825
Case 6:
Slice 12 13 14 15 16 3D
Dice 0.9767 0.9839 0.9974 0.9927 0.9950 0.9894
Case 8:
Slice 11 12 13 14 15 3D
Dice 0.8913 0.8833 0.9730 0 0 0.7603
Case 9:
Slice 7 8 9 10 11 12 13 14 3D
Dice 0.9880 0.9837 0.9817 0.9787 0.9881 0.9727 0.9684 0.9788 0.9804
Table 6.8: Dice coefficients computed for comparison of the clinical segmentation and the
automatic segmentation. Dice coefficents are calculated in 2D (on each slice) and in 3D
(whole patient comparison) for each of the patients. The morphological opening step has
been skipped. (Table is continued in Table 6.9.)
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Case 10:
Slice 11 12 13 14 3D
Dice 0 0 0 0 0
Case 11:
Slice 25 26 27 3D
Dice 0 0 0 0
Case 12:
Slice 7 8 3D
Dice 0 0 0
Case 14:
Slice 7 8 9 10 11 12 13 3D
Dice 0.8982 0.9883 0.9853 0.9829 0.9783 0.9514 0.9442 0.9660
Case 15:
Slice 17 18 19 3D
Dice 0.9353 0.9545 0 0.6821
Case 16:
Slice 11 12 13 14 3D
Dice 0.9610 0.9905 0.9739 0.9912 0.9768
Case 18:
Slice 18 19 20 21 22 23 24 3D
Dice 0.9049 0.9059 0.9753 0.9658 0.9613 0.9336 0.9369 0.9420
Table 6.9: Dice coefficients computed for comparison of the clinical segmentation and the
automatic segmentation. Dice coefficents are calculated in 2D (on each slice) and in 3D
(whole patient comparison) for each of the patients. The morphological opening step has
been skipped. (Continued from Table 6.8).
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Figure 6.11: Top left: the predicted class labels for a single slice from case 9. Top right: the
labels after morphological processing. Bottom left: the same labels, but with the opening step
removed from the morphological processing. Bottom right: the reference mask, delineated by
















































































































































































































































Figure 6.12: Dice coefficients computed for comparison of the clinical segmentation and
the automatic segmentation. The morphological opening described in Section 6.5 has been




Figure 6.13: A 3D visualisation of the clinical focal lesion mask (red) and the predicted mask
(green) for two of the cases with the omission of the morphological opening step. Note that
the improved performance is accompanied by some artefacts - small islands of predicted focal
disease. These artefacts could be easily removed with a further opening step, or by removing
all regions smaller than the largest region.
Figure 6.14: A plot showing how the Dice coefficients are related to the Area Under Receiver
Operator Curve for each case when the morphological opening step is omitted.
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6.6.3 Contour Evaluation - 3D
It is possible to perform the morphological operations carried out in the previous sections in
3D rather than 2D. Performing these operations in 3D is more in line with the overall approach
taken in this Chapter as all the texture has already been calculated in 3D. The change to 3D
is a simple one - the disc structuring element used before is replaced with a ball structuring
element. Given that the slice separation (∆z = 0.54mm) of the images is not identical with the
pixel spacing (∆x = ∆y = 0.4688mm), an anisotropic ball element was used to compensate for
the larger distances between pixels in the z-direction.
The Dice coefficient results for the 3D method are shown in Figure 6.15 and in Tables 6.10
and 6.11. The results are broadly comparable with those in Section 6.6.2 - overall the 3D
method is slightly poorer than the 2D approach (with the exception of case 8 where the 3D
method very slightly outperforms the 2D method - an increase of 0.0015). The three failed
cases (10, 11 and 12) remain problematic with 3D processing due to the previously discussed
effect of low classification performance on these cases. The mean absolute deviation between
the two sets of 3D Dice coefficients is 0.0506, while the mean Dices are 0.7110 for the 2D case
and 0.6606 for the 3D case.
The author suspects that the results are poorer for the 3D method due to a smoothing effect
caused by changing from a 2D to a 3D structuring element that naturally results in a larger
structuring element. This results in a smoother predicted contour/volume focal lesion.
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Case 1:
Slice 6 7 8 9 10 3D
Dice 0 0.9111 0.8898 0.8541 0.8179 0.7770
Case 2:
Slice 14 15 16 17 18 19 3D
Dice 0.7418 0.7547 0.8460 0.8178 0.8380 0.7937 0.8035
Case 4:
Slice 15 16 17 18 19 20 21 22 3D
Dice 0.8507 0.9196 0.9503 0.9518 0.9492 0.9423 0.9372 0.9052 0.9391
Case 5:
Slice 22 23 24 25 26 27 3D
Dice 0.9240 0.8980 0.8966 0.9044 0.8868 0.8626 0.9013
Case 6:
Slice 12 13 14 15 16 3D
Dice 0.8028 0.8675 0.8828 0.8623 0.8567 0.8574
Case 8:
Slice 11 12 13 14 15 3D
Dice 0.8887 0.9050 0.9109 0 0 0.7593
Case 9:
Slice 7 8 9 10 11 12 13 14 3D
Dice 0.9074 0.9470 0.9554 0.9541 0.9467 0.9275 0.9306 0.9309 0.9420
Table 6.10: Dice coefficients computed for comparison of the clinical segmentation and the
automatic segmentation. Dice coefficents are calculated in 2D (on each slice) and in 3D
(whole patient comparison) for each of the patients. The morphological operations have been
performed in 3D. (Table is continued in Table 6.11.)
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Case 10:
Slice 11 12 13 14 3D
Dice 0 0 0 0 0
Case 11:
Slice 25 26 27 3D
Dice 0 0 0 0
Case 12:
Slice 7 8 3D
Dice 0 0 0
Case 14:
Slice 7 8 9 10 11 12 13 3D
Dice 0.8911 0.9134 0.8995 0.9151 0.9098 0.9006 0.7935 0.8976
Case 15:
Slice 17 18 19 3D
Dice 0.7132 0.8634 0 0.6101
Case 16:
Slice 11 12 13 14 3D
Dice 0.8993 0.8984 0.8927 0.7801 0.8872
Case 18:
Slice 18 19 20 21 22 23 24 3D
Dice 0.9100 0.8938 0.8558 0.8895 0.8526 0.8540 0.8356 0.8737
Table 6.11: Dice coefficients computed for comparison of the clinical segmentation and the
automatic segmentation. Dice coefficents are calculated in 2D (on each slice) and in 3D
(whole patient comparison) for each of the patients. The morphological operations have been


































































































































































































































Figure 6.15: Dice coefficients computed for comparison of the clinical segmentation and the
automatic segmentation. The morphological operations have been performed in 3D. Dice
coefficents are calculated on each slice for all of the patients.
6.7 Discussion
This chapter has sought to identify an approach that is capable of automatically identifying
the focal lesion disease within a prostate on MR data. To this end, texture features, machine
learning and morphological processing have been combined to create a pipeline which may be
able to fit into a clinical work flow and assist clinicians in the identification of focal disease. The
identification of a focal lesion can be a difficult and time consuming process, so any method
that can ease this burden may open up avenues for the improved treatment of patients with
prostate cancer.
This work presents a method that is capable of showing significant agreement with contours
outlined by an expert clinician. 11 of the 14 cases tested had a final Dice score greater than
0.65 and 8 of the 14 cases had a score greater than 0.9, indicating very good agreement with the
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clinical segmentations. However 3 of the cases suffered catastrophic failure and the method was
unable to successfully identify the diseased region within the prostate. The author believes that
this is a very promising first step towards an automated approach for automatically identifying
prostate focal disease.
The rest of this section will examine some of the areas were future work should focus and
outline a potential way to integrate this approach with a modern clinical work flow.
6.7.1 Avenues for Further Investigation
The first issue with this data is that the reference is a contour outlined by a single expert clini-
cian. This brings with it several key issues - there is great inter- and intra-clinician variability
when identifying regions on clinical images. This is likely further compounded by the difficulty
in accurately identify the focal disease. That is to say, the results presented here can only ever
be as good as the reference data. Future work should use a larger corpus of data, ideally with
segmentations by multiple clinicians and/or histological data (though registering histological
information to the imaging frame of reference comes with its own challenges).
As explored above, some features (and the directions in which they are calculated) make a
much larger contribution to the classification performance than others. The relevance of these
important features should be investigated to determine what (if any) biological significance
they may have. Removing the unimportant features can also provide an overall speed increase.
It will take less time to calculate fewer texture features and the AdaBoost model will also
require less time for training and testing.
The size of the subimages used to calculate the texture features does not seem to play much
of a role in the classification performance. Further work should be carried out to stress test
this conclusion - smaller and larger volume should be used until the classification performance
breaks down. Additionally, the combination of features from different scales should be imple-
mented. It should be possible to combine features calculated from different subimage sizes and
determine if this provides a meaningful increase in performance.
In three of the cases the cancer makes up a large proportion of the prostate (Case 4: 69%, Case
5: 44% and Case 9: 29%). The validity of calling these regions “focal lesions” is questionable
and perhaps they should be removed from the data set and treated separately. Additionally, the
stage of the disease for each of these patients should be considered as it is likely that these
patients’ MR scans were acquired at a much later stage of the disease’s development.
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6.7.2 Clinical Work Flow
One key aspect of any research into improving radiotherapy with image analysis is the feasibil-
ity of incorporating the developed approach into a clinical work flow. The method presented in
this chapter could easily fit into the clinical work flow after an initial training step with a large
amount of labelled prostate data. An example integration is outlined below:
1. A diagnostic MR scan is acquired and the data is added to the hospital’s PACS system.
2. The PACS system then calculates the required texture features for each pixel in an off
line stage. This is feasible because there is usually a period of days or at least several
hours before a clinician interrogates a scan. This step may take several hours depending
on the features calculated and the size of the image.
3. The texture features for each pixel are passed through the precomputed classifier to
predict the class label for each pixel - “healthy” or “focal disease”. This is near in-
stantaneous.
4. Once a clinician views the patient’s MR scan and outlines the prostate volume, they
request an automated segmentation of the focal disease. At this point, the predicted labels
in the prostate (and optionally within a small radius of the prostate - in case the focal
disease is protruding from the prostate volume) are extracted and the morphological
processing steps are applied on the fly. This step should also be near instantaneous.
5. The clinician may now use the automatic segmentation as a starting point for identifying
the focal disease.
6.7.3 Integration with CT
As already mentioned, in order to make use of the automatically segmented focal disease,
the contour would need to be transferred to a CT planning scan. Recent work [41] by the
research group I am a member of has demonstrated that this may be possible using registration
techniques. Further refinements could include further evolving the registered contour on the CT
scan by using texture features and level sets, for example. However the lower contrast on CT
images makes the verfication of this approach extremely difficult and proper validation may
require using gold standard histological information to determine the presence of focal disease.
6.7.4 Summary
This chapter has demonstrated that it is possible, with even a small cohort of patients, to develop
a model that is capable of automatically identifying the prostate focal lesion in a number of
cases. Further work is required in this area to study the importance of the features and to
investigate the underlying reasons for the different performance of the features. Additionally,
future work should use a much larger cohort of patients that would allow for the training of
models based on disease stage and demographic information. Such a data set would allow
6.7. Discussion 123
for a parametric study of the different texture features, different learning models and different




The overall aim of this thesis was to apply three dimensional texture analysis and machine
learning methods to the field of medical imaging to improve radiotherapy. To this end, three
dimensional implementations of texture features were implemented and applied to the predic-
tion of radiation induced pneumonitis from CT planning scans (Chapter 5) and to identifying
cancerous regions within the prostate from MRI scans (Chapter 6). Both of these applications
may have the potential to improve the treatment of patients with lung or prostate cancer.
The aim of the radiation induced pneumonitis work was to determine if it was possible to use
imaging data, acquired in the normal course of treatment, to predict if a patient was likely
to develop pneumonitis post radiotherapy. Prediction of the occurrence of pneumonitis may
allow for alternative treatment in an attempt to prevent the disease. Alternatively, high risk
patients could be identified for a different follow up schedule. With the increasing use of
SABR treatments for lung cancer which result in a higher dose delivered to the GTV, but also
a significant dose wash from the VMAT such a predictive scheme may be timely. As explained
in Chapter 2, it is thought that an increase in the low level dose wash (a little dose to a large
region) may be correlated with radiation induced pneumonitis. If this proves to be the case, this
would further underline the need for predicting a patient’s risk of pneumonitis occurring as a
larger number of lung cancer patients may be treated using radiotherapy plans likely to trigger
the development of pneumonitis.
Identifying the focal disease within the prostate can be a time consuming and difficult under-
taking for a clinician. The aim of this work was to define an automatic segmentation approach
that could allow for easier and faster identification of the cancer within the prostate volume.
Demonstration of the efficacy of such an approach could enable an easier path towards “focal
boosting” by speeding up one of the more manual steps that would be required for such a
treatment. This focal boosting could simultaneously facilitate an increase in the dose delivered
to the cancer and a lower dose delivered to surrounding healthy tissues. Much work would
be required to validate such an approach: the work in this thesis has focussed solely on the
automatic identification of the disease on MRI scans.
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The remainder of this chapter will cover how these aims have been met and lay out a potential
pathway for a clinical deployment of the methods developed in this work. Finally, potential
future work will be laid out.
7.2 Review of Contributions and Future Work
Chapter 2 laid out the relevant clinical background required as a foundation for understanding
the applications presented in later Chapters. There was a particular focus on CT and MR
imaging and on prostate cancer and lung cancer.
Chapter 3 introduced the concept of texture in an image before explaining texture’s relation to
human vision. A taxonomy of texture was then presented to place the methods used in this work
in context. The remainder of the chapter described three dimensional texture and the specific
methods used in the rest of this thesis.
Chapter 4 covers the machine learning techniques used in Chapters 5 and 6. There is an
introduction to machine learning before the supervised learning methods used are covered.
The chapter also includes the methods used for feature preprocessing and model evaluation
used in this thesis.
Chapter 5 demonstrates that it is possible to predict if a patient with lung cancer will develop
pneumonitis after radiotherapy by combining a small amount of clinical data with texture
features calculated from a CT planning scan. An Area Under ROC of 0.873 was achieved
using an SVM and further results showed the efficacy of multiple Decision Tree models using
different regions of the lung volume. Furthermore, the use of multiple learners and multiple
regions of the lung volume demonstrated the stability of the approach and reinforces the find-
ings. These results seem to indicate that there is an inherent difference in the lung tissue of a
patient at risk of pneumonitis and the lung tissue of a patient that does not develop pneumonitis
post radiotherapy. This warrants further investigation with a much larger data set to test this
hypothesis and the wider applicability of the approach. Additionally, future work should also
focus on identifying the features that contribute most during the learning phase - if these
features can be better understood, they may reveal something of the nature of the underlying
tissue differences. That is, if it can be determined which features have the most discriminatory
power, it may be possible to discern the underlying structures these features describe. Such
information could lead to clues as to the biological nature of the differences of the lung tissues
in the symptomatic and asymptomatic populations.
In Chapter 6 an automated pipeline for the identification of focal disease in patients with
prostate cancer was developed. This pipeline made use of texture analysis to derive a number
of features for each pixel in the prostate volume. These features were then used as inputs into
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a classification scheme before being mapped back onto the MRI frame of reference and post-
processed with morphological operations to produce a contour of the focal disease within the
prostate. The results in Chapter 6 demonstrate the viability of this approach and display the
need for more work in this area. A mean Area Under ROC of 0.713 was demonstrated on
an aggregate data set (made up of the prostate volumes of all 14 subjects) using a 10-fold
stratified cross validation strategy - this demonstrated that it is at least possible for a classifier
to use texture features to discriminate between healthy prostate and focal disease tissues. A
leave one case out strategy was then used to test the approach on a more clinically relevant
footing. After the classification of the regions for each subject the class labels were mapped
back onto the MRI space. Morphological operations were then used to produce a segmentation
of the focal disease. The segmentations on all 14 subjects resulted in a mean DICE of 0.710.
That is, there was a very significant overlap of the clinical contours and the predicted contours
for the majority of the cases. This shows that texture descriptors are capable of discriminating
between healthy and cancer tissues within the prostate. The methods outlined could easily fit
into a clinical work flow: the texture analysis and prediction could be carried out off line on a
hospital’s PACS system so that the identification of the focal disease could be made in pseudo
real time when a clinician is examining the MRI. If this approach could be incorporated with
a method that allows for the transfer of the predicated focal disease contours to planning CT
scans, this work could play an important role in the boosting of focal lesions.
7.3 Clinical Pathways
Any new technology or innovation must have a clear pathway to clinical use. This pathway
must involve extension auditing and proof that there is a real benefit to the patient or the
clinician. Two such pathways are laid out below, one for the radiation induced pneumonitis
work and one for the prostate focal disease application.
A first step towards the use of the radiation induced pneumonitis prediction method would be
to validate the approach on a much larger data set. This could be achieved using retrospective
data. It would only be necessary to collect the CT scans, the clinical features and the associated
outcome data for a large number of lung cancer patients. Standard methods for the evaluation
of the performance of machine learning methods could then be applied to verify the efficacy
of the techniques. Ideally, this data would be a multi-centre study to allow for the method
to be tested with different CT scanners and to ensure there are multiple clinicians involved
in the determination of the gold standard class labels - the diagnosis of pneumonitis. If this
stage were successful, the next step would be to undertake a prospective clinical trial wherein
a protocol would be devised for the treatment of patients determined to be at a higher risk
of pneumonitis. The trial would then seek to determine if altering treatment based upon the
prediction of pneumonitis improves patient outcome.
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A similar approach would be required for the prostate work. An initial clinical audit could
be performed where the approach is implemented as part of a hospital’s PACS system and
contours automatically created. These contours would then be evaluated by clinicians to assess
the viability of the approach. An alternative avenue would be to collect retrospective data and
have a clinician (or multiple clinicians) outline the focal disease to allow testing on a much
larger data set. After this initial validation of the approach, a next step could involve a clinical
trial based around prostatectomy - if the MRI data from men scheduled for prostatectomy was
collected this would provide histological ground truth for the location of the focal disease. This
ground truth could be used to further tune and test the classification pipeline. In order to use
this approach for a focal boosting treatment, the contours would need to be mapped to the
planning CT scan and suitable plans developed. This would likely need to be a clinical trial to
demonstrate that the boosted plans provide an improved outcome for the patient. If the focal
boosting was not viable, the automatic identification of the disease may still prove useful to
clinicians during diagnosis and if proved on a large cohort, may provide an automatic, non-
invasive indication of the extent of the cancer in the prostate.
7.4 Summary
In summary, this thesis has combined texture analysis of medical images with machine learning
to present two applications to radiotherapy that are clinically relevant.
Both applications exploit the information contained in the (ever increasing) image data avail-
able in modern radiotherapy departments. It is the author’s belief that in the coming years and
decades there will be manifold applications of this kind due to the wide availability of imaging
data, computing power and the ever growing interest in machine learning and its applications.
The prediction of radiation induced pneumonitis and the identification of prostate focal disease
are both possible using texture analysis and it is this author’s belief that both avenues display
promise and warrant further investigation and evaluation.
Appendix A
Morphological Operations
Mathematical morphology is a field that considers the analysis and processing of geometrical
structures. In this section the more narrow field of morphological operations on binary images
will be looked at, though it is trivial to expand this to grey level images (and more generally to
complete lattices).
Erosion and dilation are the cornerstone of processing an image using morphology and the
combination of these operations allows for more advanced operations.
Structuring element: A structuring element is a small reference shape which is applied to
the image under consideration. In effect, any details smaller than the structuring element are
removed from the image. Typical structuring elements are disks of various sizes or lines of
various orientations. A particular structuring element must be chosen for the task at hand.
Dilation: is the process of overlaying the structuring element at every object point in the
original image and filling in all empty points covered by the structuring element. This process
results in the filling in of gaps and the enlargement of the objects in the original image. A large
square being dilated by a disc structuring element of radius, a, would result in a new image of
a square with rounded corners, the rounded corners also having a radius of a.
Erosion: is the process of overlaying the structuring element at every object point in the
original image and removing the object points at which the structuring element cannot fit within
the image object. This process results in the removal of pixels and a reduction in the size of the
objects in the image. If we again consider a square of side, b, and a disc structuring element of
radius a, the result of erosion would be a new square of length (b−a).
Erosion removes details of an image smaller than the structuring element and dilation fills in
details that are smaller than the structuring element. By combining these two operations we
can keep details at one scale while removing them at another.
Opening: is when a dilation is applied after an erosion. This has the effect of removing the
“hairs” of an image - sharp, distinct structures are removed and smoothed.
Closing: is when an erosion is applied following a dilation. This has the effect of closing
up narrow holes in an image without increasing the size of the object (assuming the same
structuring element is used for both operations).
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More complex operations can be constructed by using different structuring elements during
each phase of the opening or closing, by chaining multiple operations together or by addition
and subtraction of images after the application of operations. One example of such an operation
is the top-hat transform in which the opening of an image is subtracted from the original image,
this results in structures smaller than the structuring element remaining and can be used to




This appendix covers two HPC use cases extracted from the work presented in the main body
of this thesis. Section B.1 describes the use of a small cluster of computers in order to speed up
the calculation of texture features from the MRI data used in Chapter 6. Section B.2 lays out
an additional piece of work that was carried out in addition to the cross validation described in
Section 6.4.3 in order to complete the grid search over a range of model paramters.
B.1 Texture Feature Calculation
The calculation of texture features (described in Section 6.4.1) on a number of subregions of
an image is an “embarrassingly parallel” problem: the texture from each subregion may be
calculated completely independently of its neighbours. This allows for the computation to be
split into discrete independent chunks to be run concurrently. In the ideal case, a problem such
as this could be speed up by a factor equal to the number of computing resources used to
process the individual calculations. However, in practice, there are other overheads such as IO
that result in a smaller increase in computation speed.
A 32 node MATLAB cluster at the Western General Hospital was used calculate the texture fea-
tures at each point in the prostate for each subject. This allowed for a much faster computation
than would be possible on a single machine.
The computing pipeline was constructed as follows. Note that a master node was used to
orchestrate the process and submit jobs to the cluster at which point the cluster nodes performed
the following tasks in parallel:
• The imaging and contour data for each subject was loaded from a common data store.
• A series of subregions of varying size were extracted from each subject and saved to
the common data store alongside the positional information required to reconstruct the
images.
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• Each set of subregions were loaded from the data store and texture features calculated.
The resulting features were then saved to the common data store.
Finally, the master node gathered the texture features and assembled a feature matrix, the class
labels and the positional information required for reconstruction. This data was then used for
classification as described in Chapter 6.
B.2 Cross Validation Grid Search
As explained in Section 6.4.3, Table 6.3 is incomplete due to extremely long run times on
the hardware resources that were available at the time. This section presents the result of
calculating the missing values in Table 6.3 using a combination of a parallelised method and
more powerful hardware.
Originally the computation of the results in Table 6.3 were abandoned if the run time exceeded
48 hours. Each row in the table represents a 5-fold cross validation of an AdaBoost model
for different model parameters (number of estimators and the maximum tree depth). Due to
the iterative nature of the AdaBoost algorithm, it is not an inherently parallel problem, like,
for example, a Random Forest classifier. However, each fold in the cross-validation can be
computed independently (ensuring the data chosen for each fold is not the same on independent
nodes). As a result, there are 25 distinct units of work (five rows multiplied by 5 folds).
The original script to generate the data for this table was adapted to make use of the Python
multiprocessing module which allowed for a simple parallelisation this problem on a multi-
core machine. A 20 core (64Gb RAM) machine was then rented from a cloud provider i to run
the modified script. This is a cheap and quick way to parallelise an operation. Each core of the
machine was then able to run a cross validation fold.
The modified script took approximately 9 hours to complete. The longest fold took approxi-
mately 4 hours, but since there were more jobs than cores, the total time was greater than the
longest individual time. The total cost of this operation was approximately $9.
In principle, each fold could be calculated on a different machine, each of which could be less
powerful. This would result in an increased orchestration overhead (which, would be easily
managed) and a lower cost as the overall time and cost per machine would decrease. If a
separate instance was used for each fold, then the overall cost would have been approximately
$4.
The updated results are presented in Table B.1. The classification performances for the rows
are fall short of the existing best classifier. This is most likely because the larger tree depths
and the large number of learners causes the model to overfit the data at the training stage.
i. Digital Ocean was chosen for ease of use, per hour billing and low cost. At the time of writing the rented
machine cost approximately $1 per hour or $640 per month.
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Number of Maximum Area Under
Estimators Depth Sensitivity Specificity ROC
10 1 0.6052 0.5799 0.6302
10 10 0.5422 0.6755 0.6501
10 50 0.5150 0.7014 0.6506
10 100 0.5150 0.6999 0.6496
100 1 0.6014 0.6412 0.6604
100 10 0.5181 0.7152 0.6612
100 50 0.5259 0.7497 0.69105
100 100 0.5278 0.7472 0.6884
500 1 0.5916 0.6566 0.6652
500 10 0.5265 0.7478 0.6895
500 50 0.5548 0.7282 0.6790
500 100 0.5534 0.7249 0.6793
1000 1 0.5831 0.6607 0.6619
1000 10 0.5544 0.6959 0.6674
1000 50 0.5561 0.7293 0.6840
1000 100 0.5540 0.7296 0.6827
Table B.1: Performance metrics from the grid search over the number of estimators and the
maximum depth parameters in the AdaBoost model.
B.3 Conclusions
Techniques from the field of HPC can be very useful in early stages of research as they may
allow for increased development, testing and iteration of novel techniques and enabling more
data to be processed at an earlier stage of the research. However a there is a large amount of
specialist knowledge required to fully exploit HPC architectures and this is beyond the scope
of this current thesis. For example, it may be possible to port the texture calculations to a GPU
and greatly reduce the execution time using only a single machine.
Furthermore, this thesis has not explored this topic in depth as the author believes that there
is great value in developing techniques that can be run on today’s commodity hardware as it
reduces at least one barrier to future adoption of new methods and techniques. For example,
it is easier for a hospital to invest in a technology if it only involves a software license than it
would be for a hospital to purchase a large scale computing infrastructure or incur a possibly
large monthly bill from a cloud computing provider.
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